id	sid	tid	token	lemma	pos
aiua-5030	1	1	stesura	stesura	PROPN
aiua-5030	1	2	seveso	seveso	PROPN
aiua-5030	1	3	archivio	archivio	PROPN
aiua-5030	1	4	italiano	italiano	X
aiua-5030	1	5	di	di	X
aiua-5030	1	6	urologia	urologia	PROPN
aiua-5030	1	7	e	e	PROPN
aiua-5030	1	8	andrologia	andrologia	NOUN
aiua-5030	1	9	2014	2014	NUM
aiua-5030	1	10	;	;	PUNCT
aiua-5030	1	11	86	86	NUM
aiua-5030	1	12	,	,	PUNCT
aiua-5030	1	13	4284	4284	NUM
aiua-5030	1	14	original	original	ADJ
aiua-5030	1	15	paper	paper	NOUN
aiua-5030	1	16	transrectal	transrectal	NOUN
aiua-5030	1	17	versus	versus	ADP
aiua-5030	1	18	transperineal	transperineal	NOUN
aiua-5030	1	19	14	14	NUM
aiua-5030	1	20	-	-	PUNCT
aiua-5030	1	21	core	core	NOUN
aiua-5030	1	22	prostate	prostate	NOUN
aiua-5030	1	23	biopsy	biopsy	NOUN
aiua-5030	1	24	in	in	ADP
aiua-5030	1	25	detection	detection	NOUN
aiua-5030	1	26	of	of	ADP
aiua-5030	1	27	prostate	prostate	NOUN
aiua-5030	1	28	cancer	cancer	NOUN
aiua-5030	1	29	:	:	PUNCT
aiua-5030	1	30	a	a	DET
aiua-5030	1	31	comparative	comparative	ADJ
aiua-5030	1	32	evaluation	evaluation	NOUN
aiua-5030	1	33	at	at	ADP
aiua-5030	1	34	the	the	DET
aiua-5030	1	35	same	same	ADJ
aiua-5030	1	36	institution	institution	NOUN
aiua-5030	1	37	maria	maria	PROPN
aiua-5030	1	38	angela	angela	PROPN
aiua-5030	1	39	cerruto	cerruto	PROPN
aiua-5030	1	40	1	1	NUM
aiua-5030	1	41	,	,	PUNCT
aiua-5030	1	42	fabio	fabio	ADJ
aiua-5030	1	43	vianello	vianello	PROPN
aiua-5030	1	44	2	2	NUM
aiua-5030	1	45	,	,	PUNCT
aiua-5030	1	46	carolina	carolina	PROPN
aiua-5030	1	47	d’elia	d’elia	PROPN
aiua-5030	1	48	1	1	NUM
aiua-5030	1	49	,	,	PUNCT
aiua-5030	1	50	walter	walter	NOUN
aiua-5030	1	51	artibani	artibani	PROPN
aiua-5030	1	52	1	1	NUM
aiua-5030	1	53	,	,	PUNCT
aiua-5030	1	54	giovanni	giovanni	PROPN
aiua-5030	1	55	novella	novella	NOUN
aiua-5030	1	56	1	1	NUM
aiua-5030	1	57	1	1	NUM
aiua-5030	1	58	department	department	NOUN
aiua-5030	1	59	of	of	ADP
aiua-5030	1	60	surgery	surgery	NOUN
aiua-5030	1	61	,	,	PUNCT
aiua-5030	1	62	urology	urology	NOUN
aiua-5030	1	63	clinic	clinic	NOUN
aiua-5030	1	64	,	,	PUNCT
aiua-5030	1	65	aoui	aoui	PROPN
aiua-5030	1	66	verona	verona	PROPN
aiua-5030	1	67	,	,	PUNCT
aiua-5030	1	68	italy	italy	PROPN
aiua-5030	1	69	;	;	PUNCT
aiua-5030	1	70	2	2	NUM
aiua-5030	1	71	urology	urology	NOUN
aiua-5030	1	72	clinic	clinic	NOUN
aiua-5030	1	73	,	,	PUNCT
aiua-5030	1	74	university	university	PROPN
aiua-5030	1	75	of	of	ADP
aiua-5030	1	76	padua	padua	PROPN
aiua-5030	1	77	,	,	PUNCT
aiua-5030	1	78	italy	italy	PROPN
aiua-5030	1	79	.	.	PUNCT
aiua-5030	2	1	background	background	NOUN
aiua-5030	2	2	:	:	PUNCT
aiua-5030	2	3	the	the	DET
aiua-5030	2	4	ideal	ideal	ADJ
aiua-5030	2	5	bioptic	bioptic	ADJ
aiua-5030	2	6	strategy	strategy	NOUN
aiua-5030	2	7	for	for	ADP
aiua-5030	2	8	cap	cap	NOUN
aiua-5030	2	9	detection	detection	NOUN
aiua-5030	2	10	is	be	AUX
aiua-5030	2	11	still	still	ADV
aiua-5030	2	12	to	to	PART
aiua-5030	2	13	be	be	AUX
aiua-5030	2	14	completely	completely	ADV
aiua-5030	2	15	defined	define	VERB
aiua-5030	2	16	.	.	PUNCT
aiua-5030	3	1	the	the	DET
aiua-5030	3	2	aim	aim	NOUN
aiua-5030	3	3	of	of	ADP
aiua-5030	3	4	our	our	PRON
aiua-5030	3	5	study	study	NOUN
aiua-5030	3	6	is	be	AUX
aiua-5030	3	7	to	to	PART
aiua-5030	3	8	compare	compare	VERB
aiua-5030	3	9	transperineal	transperineal	NOUN
aiua-5030	3	10	(	(	PUNCT
aiua-5030	3	11	tp	tp	NOUN
aiua-5030	3	12	)	)	PUNCT
aiua-5030	3	13	and	and	CCONJ
aiua-5030	3	14	transrectal	transrectal	ADJ
aiua-5030	3	15	(	(	PUNCT
aiua-5030	3	16	tr	tr	VERB
aiua-5030	3	17	)	)	PUNCT
aiua-5030	3	18	approaches	approach	NOUN
aiua-5030	3	19	,	,	PUNCT
aiua-5030	3	20	in	in	ADP
aiua-5030	3	21	a	a	DET
aiua-5030	3	22	14	14	NUM
aiua-5030	3	23	-	-	PUNCT
aiua-5030	3	24	core	core	NOUN
aiua-5030	3	25	initial	initial	ADJ
aiua-5030	3	26	prostate	prostate	NOUN
aiua-5030	3	27	biopsy	biopsy	NOUN
aiua-5030	3	28	for	for	ADP
aiua-5030	3	29	cap	cap	NOUN
aiua-5030	3	30	detection	detection	NOUN
aiua-5030	3	31	.	.	PUNCT
aiua-5030	4	1	material	material	NOUN
aiua-5030	4	2	and	and	CCONJ
aiua-5030	4	3	methods	method	NOUN
aiua-5030	4	4	:	:	PUNCT
aiua-5030	4	5	a	a	DET
aiua-5030	4	6	prospective	prospective	ADJ
aiua-5030	4	7	controlled	control	VERB
aiua-5030	4	8	study	study	NOUN
aiua-5030	4	9	was	be	AUX
aiua-5030	4	10	conducted	conduct	VERB
aiua-5030	4	11	enrolling	enrol	VERB
aiua-5030	4	12	108	108	NUM
aiua-5030	4	13	consecutive	consecutive	ADJ
aiua-5030	4	14	patients	patient	NOUN
aiua-5030	4	15	with	with	ADP
aiua-5030	4	16	a	a	DET
aiua-5030	4	17	psa	psa	NOUN
aiua-5030	4	18	level	level	NOUN
aiua-5030	4	19	greater	great	ADJ
aiua-5030	4	20	than	than	ADP
aiua-5030	4	21	4	4	NUM
aiua-5030	4	22	ng	ng	NOUN
aiua-5030	4	23	/	/	SYM
aiua-5030	4	24	ml	ml	ADP
aiua-5030	4	25	and/or	and/or	CCONJ
aiua-5030	4	26	an	an	DET
aiua-5030	4	27	abnormal	abnormal	ADJ
aiua-5030	4	28	dre	dre	NOUN
aiua-5030	4	29	.	.	PUNCT
aiua-5030	5	1	tr	tr	VERB
aiua-5030	5	2	versus	versus	ADP
aiua-5030	5	3	tp	tp	ADP
aiua-5030	5	4	14	14	NUM
aiua-5030	5	5	-	-	PUNCT
aiua-5030	5	6	core	core	NOUN
aiua-5030	5	7	initial	initial	ADJ
aiua-5030	5	8	prostatic	prostatic	ADJ
aiua-5030	5	9	biopsies	biopsy	NOUN
aiua-5030	5	10	were	be	AUX
aiua-5030	5	11	performed	perform	VERB
aiua-5030	5	12	on	on	ADP
aiua-5030	5	13	54	54	NUM
aiua-5030	5	14	and	and	CCONJ
aiua-5030	5	15	54	54	NUM
aiua-5030	5	16	patients	patient	NOUN
aiua-5030	5	17	,	,	PUNCT
aiua-5030	5	18	respectively	respectively	ADV
aiua-5030	5	19	,	,	PUNCT
aiua-5030	5	20	with	with	ADP
aiua-5030	5	21	a	a	DET
aiua-5030	5	22	randomisation	randomisation	NOUN
aiua-5030	5	23	ratio	ratio	NOUN
aiua-5030	5	24	of	of	ADP
aiua-5030	5	25	1:1	1:1	NUM
aiua-5030	5	26	.	.	PUNCT
aiua-5030	6	1	results	result	NOUN
aiua-5030	6	2	:	:	PUNCT
aiua-5030	6	3	the	the	DET
aiua-5030	6	4	cancer	cancer	NOUN
aiua-5030	6	5	detection	detection	NOUN
aiua-5030	6	6	rates	rate	NOUN
aiua-5030	6	7	were	be	AUX
aiua-5030	6	8	46.29	46.29	NUM
aiua-5030	6	9	(	(	PUNCT
aiua-5030	6	10	25	25	NUM
aiua-5030	6	11	out	out	ADP
aiua-5030	6	12	of	of	ADP
aiua-5030	6	13	54	54	NUM
aiua-5030	6	14	patients	patient	NOUN
aiua-5030	6	15	)	)	PUNCT
aiua-5030	6	16	,	,	PUNCT
aiua-5030	6	17	and	and	CCONJ
aiua-5030	6	18	44.44	44.44	NUM
aiua-5030	6	19	%	%	NOUN
aiua-5030	6	20	(	(	PUNCT
aiua-5030	6	21	24	24	NUM
aiua-5030	6	22	out	out	ADP
aiua-5030	6	23	of	of	ADP
aiua-5030	6	24	54	54	NUM
aiua-5030	6	25	patients	patient	NOUN
aiua-5030	6	26	)	)	PUNCT
aiua-5030	6	27	,	,	PUNCT
aiua-5030	6	28	respectively	respectively	ADV
aiua-5030	6	29	,	,	PUNCT
aiua-5030	6	30	using	use	VERB
aiua-5030	6	31	the	the	DET
aiua-5030	6	32	tr	tr	NOUN
aiua-5030	6	33	or	or	CCONJ
aiua-5030	6	34	the	the	DET
aiua-5030	6	35	tp	tp	NOUN
aiua-5030	6	36	approach	approach	NOUN
aiua-5030	6	37	(	(	PUNCT
aiua-5030	6	38	p	p	X
aiua-5030	6	39	=	=	NOUN
aiua-5030	6	40	0.846	0.846	NUM
aiua-5030	6	41	)	)	PUNCT
aiua-5030	6	42	.	.	PUNCT
aiua-5030	7	1	the	the	DET
aiua-5030	7	2	overall	overall	ADJ
aiua-5030	7	3	cancer	cancer	NOUN
aiua-5030	7	4	core	core	NOUN
aiua-5030	7	5	rate	rate	NOUN
aiua-5030	7	6	was	be	AUX
aiua-5030	7	7	significantly	significantly	ADV
aiua-5030	7	8	higher	high	ADJ
aiua-5030	7	9	when	when	SCONJ
aiua-5030	7	10	the	the	DET
aiua-5030	7	11	tp	tp	NOUN
aiua-5030	7	12	approach	approach	NOUN
aiua-5030	7	13	was	be	AUX
aiua-5030	7	14	used	use	VERB
aiua-5030	7	15	:	:	PUNCT
aiua-5030	7	16	21.43	21.43	NUM
aiua-5030	7	17	%	%	NOUN
aiua-5030	7	18	(	(	PUNCT
aiua-5030	7	19	162	162	NUM
aiua-5030	7	20	out	out	ADP
aiua-5030	7	21	of	of	ADP
aiua-5030	7	22	756	756	NUM
aiua-5030	7	23	cores	core	NOUN
aiua-5030	7	24	)	)	PUNCT
aiua-5030	7	25	and	and	CCONJ
aiua-5030	7	26	16.79	16.79	NUM
aiua-5030	7	27	%	%	NOUN
aiua-5030	7	28	(	(	PUNCT
aiua-5030	7	29	127	127	NUM
aiua-5030	7	30	out	out	ADP
aiua-5030	7	31	of	of	ADP
aiua-5030	7	32	756	756	NUM
aiua-5030	7	33	cores	core	NOUN
aiua-5030	7	34	)	)	PUNCT
aiua-5030	7	35	,	,	PUNCT
aiua-5030	7	36	with	with	ADP
aiua-5030	7	37	the	the	DET
aiua-5030	7	38	tp	tp	NOUN
aiua-5030	7	39	and	and	CCONJ
aiua-5030	7	40	the	the	DET
aiua-5030	7	41	tr	tr	NOUN
aiua-5030	7	42	approach	approach	NOUN
aiua-5030	7	43	,	,	PUNCT
aiua-5030	7	44	respectively	respectively	ADV
aiua-5030	7	45	(	(	PUNCT
aiua-5030	7	46	p	p	X
aiua-5030	7	47	=	=	NOUN
aiua-5030	7	48	0.022	0.022	NUM
aiua-5030	7	49	)	)	PUNCT
aiua-5030	7	50	.	.	PUNCT
aiua-5030	8	1	the	the	DET
aiua-5030	8	2	cores	core	NOUN
aiua-5030	8	3	were	be	AUX
aiua-5030	8	4	significantly	significantly	ADV
aiua-5030	8	5	longer	long	ADV
aiua-5030	8	6	performing	perform	VERB
aiua-5030	8	7	tp	tp	ADP
aiua-5030	8	8	approach	approach	NOUN
aiua-5030	8	9	:	:	PUNCT
aiua-5030	8	10	at	at	ADP
aiua-5030	8	11	the	the	DET
aiua-5030	8	12	site	site	NOUN
aiua-5030	8	13	“	"	PUNCT
aiua-5030	8	14	1	1	NUM
aiua-5030	8	15	”	"	PUNCT
aiua-5030	8	16	(	(	PUNCT
aiua-5030	8	17	14.92	14.92	NUM
aiua-5030	8	18	versus	versus	ADP
aiua-5030	8	19	12.97	12.97	NUM
aiua-5030	8	20	mm	mm	NOUN
aiua-5030	8	21	,	,	PUNCT
aiua-5030	8	22	p	p	X
aiua-5030	8	23	=	=	NOUN
aiua-5030	8	24	0.02	0.02	NUM
aiua-5030	8	25	)	)	PUNCT
aiua-5030	8	26	;	;	PUNCT
aiua-5030	8	27	at	at	ADP
aiua-5030	8	28	“	"	PUNCT
aiua-5030	8	29	5	5	NUM
aiua-5030	8	30	”	"	PUNCT
aiua-5030	8	31	(	(	PUNCT
aiua-5030	8	32	15.53	15.53	NUM
aiua-5030	8	33	versus	versus	ADP
aiua-5030	8	34	13.69	13.69	NUM
aiua-5030	8	35	mm	mm	NOUN
aiua-5030	8	36	,	,	PUNCT
aiua-5030	8	37	p	p	X
aiua-5030	8	38	=	=	NOUN
aiua-5030	8	39	0.037	0.037	NUM
aiua-5030	8	40	)	)	PUNCT
aiua-5030	8	41	;	;	PUNCT
aiua-5030	8	42	at	at	ADP
aiua-5030	8	43	“	"	PUNCT
aiua-5030	8	44	7	7	NUM
aiua-5030	8	45	”	"	PUNCT
aiua-5030	8	46	(	(	PUNCT
aiua-5030	8	47	15.06	15.06	NUM
aiua-5030	8	48	versus	versus	ADP
aiua-5030	8	49	12.86	12.86	NUM
aiua-5030	8	50	mm	mm	NOUN
aiua-5030	8	51	,	,	PUNCT
aiua-5030	8	52	p	p	NOUN
aiua-5030	8	53	=	=	NOUN
aiua-5030	8	54	0.001	0.001	NUM
aiua-5030	8	55	)	)	PUNCT
aiua-5030	8	56	;	;	PUNCT
aiua-5030	8	57	at	at	ADP
aiua-5030	8	58	“	"	PUNCT
aiua-5030	8	59	9	9	NUM
aiua-5030	8	60	”	"	PUNCT
aiua-5030	8	61	(	(	PUNCT
aiua-5030	8	62	14.92	14.92	NUM
aiua-5030	8	63	versus	versus	ADP
aiua-5030	8	64	13.38	13.38	NUM
aiua-5030	8	65	mm	mm	NOUN
aiua-5030	8	66	,	,	PUNCT
aiua-5030	8	67	p	p	X
aiua-5030	8	68	=	=	NOUN
aiua-5030	8	69	0.038	0.038	NUM
aiua-5030	8	70	)	)	PUNCT
aiua-5030	8	71	;	;	PUNCT
aiua-5030	8	72	at	at	ADP
aiua-5030	8	73	“	"	PUNCT
aiua-5030	8	74	11	11	NUM
aiua-5030	8	75	”	"	PUNCT
aiua-5030	8	76	(	(	PUNCT
aiua-5030	8	77	16.32	16.32	NUM
aiua-5030	8	78	versus	versus	ADP
aiua-5030	8	79	12.31	12.31	NUM
aiua-5030	8	80	mm	mm	NOUN
aiua-5030	8	81	,	,	PUNCT
aiua-5030	8	82	p	p	NOUN
aiua-5030	8	83	=	=	NOUN
aiua-5030	8	84	0.0001	0.0001	NUM
aiua-5030	8	85	)	)	PUNCT
aiua-5030	8	86	;	;	PUNCT
aiua-5030	8	87	at	at	ADP
aiua-5030	8	88	“	"	PUNCT
aiua-5030	8	89	12	12	NUM
aiua-5030	8	90	”	"	PUNCT
aiua-5030	8	91	(	(	PUNCT
aiua-5030	8	92	15.14	15.14	NUM
aiua-5030	8	93	versus	versus	ADP
aiua-5030	8	94	12.19	12.19	NUM
aiua-5030	8	95	mm	mm	NOUN
aiua-5030	8	96	,	,	PUNCT
aiua-5030	8	97	p	p	X
aiua-5030	8	98	=	=	NOUN
aiua-5030	8	99	0.0001	0.0001	NUM
aiua-5030	8	100	)	)	PUNCT
aiua-5030	8	101	;	;	PUNCT
aiua-5030	8	102	at	at	ADP
aiua-5030	8	103	“	"	PUNCT
aiua-5030	8	104	13	13	NUM
aiua-5030	8	105	”	"	PUNCT
aiua-5030	8	106	(	(	PUNCT
aiua-5030	8	107	17.49	17.49	NUM
aiua-5030	8	108	versus	versus	ADP
aiua-5030	8	109	13.98	13.98	NUM
aiua-5030	8	110	mm	mm	NOUN
aiua-5030	8	111	,	,	PUNCT
aiua-5030	8	112	p	p	NOUN
aiua-5030	8	113	=	=	NOUN
aiua-5030	8	114	0.0001	0.0001	NUM
aiua-5030	8	115	)	)	PUNCT
aiua-5030	8	116	;	;	PUNCT
aiua-5030	8	117	at	at	ADP
aiua-5030	8	118	“	"	PUNCT
aiua-5030	8	119	14	14	NUM
aiua-5030	8	120	”	"	PUNCT
aiua-5030	8	121	(	(	PUNCT
aiua-5030	8	122	16.77	16.77	NUM
aiua-5030	8	123	versus	versus	ADP
aiua-5030	8	124	13.36	13.36	NUM
aiua-5030	8	125	mm	mm	NOUN
aiua-5030	8	126	,	,	PUNCT
aiua-5030	8	127	p	p	NOUN
aiua-5030	8	128	=	=	NOUN
aiua-5030	8	129	0.0001	0.0001	NUM
aiua-5030	8	130	)	)	PUNCT
aiua-5030	8	131	.	.	PUNCT
aiua-5030	9	1	as	as	ADP
aiua-5030	9	2	to	to	ADP
aiua-5030	9	3	the	the	DET
aiua-5030	9	4	biopsy	biopsy	NOUN
aiua-5030	9	5	related	relate	VERB
aiua-5030	9	6	pain	pain	NOUN
aiua-5030	9	7	,	,	PUNCT
aiua-5030	9	8	the	the	DET
aiua-5030	9	9	mean	mean	ADJ
aiua-5030	9	10	pain	pain	NOUN
aiua-5030	9	11	level	level	NOUN
aiua-5030	9	12	perceived	perceive	VERB
aiua-5030	9	13	by	by	ADP
aiua-5030	9	14	patients	patient	NOUN
aiua-5030	9	15	during	during	ADP
aiua-5030	9	16	the	the	DET
aiua-5030	9	17	tr	tr	PUNCT
aiua-5030	9	18	approach	approach	NOUN
aiua-5030	9	19	was	be	AUX
aiua-5030	9	20	1.56	1.56	NUM
aiua-5030	9	21	±	±	NUM
aiua-5030	9	22	1.73	1.73	NUM
aiua-5030	9	23	versus	versus	ADP
aiua-5030	9	24	1.42	1.42	NUM
aiua-5030	9	25	±	±	NUM
aiua-5030	9	26	1.37	1.37	NUM
aiua-5030	9	27	registered	register	VERB
aiua-5030	9	28	during	during	ADP
aiua-5030	9	29	tp	tp	ADP
aiua-5030	9	30	approach	approach	NOUN
aiua-5030	9	31	(	(	PUNCT
aiua-5030	9	32	p	p	X
aiua-5030	9	33	=	=	NOUN
aiua-5030	9	34	0.591	0.591	NUM
aiua-5030	9	35	)	)	PUNCT
aiua-5030	9	36	.	.	PUNCT
aiua-5030	10	1	conclusions	conclusion	NOUN
aiua-5030	10	2	:	:	PUNCT
aiua-5030	10	3	no	no	DET
aiua-5030	10	4	significant	significant	ADJ
aiua-5030	10	5	differences	difference	NOUN
aiua-5030	10	6	were	be	AUX
aiua-5030	10	7	found	find	VERB
aiua-5030	10	8	in	in	ADP
aiua-5030	10	9	cancer	cancer	NOUN
aiua-5030	10	10	detection	detection	NOUN
aiua-5030	10	11	rate	rate	NOUN
aiua-5030	10	12	,	,	PUNCT
aiua-5030	10	13	cancer	cancer	NOUN
aiua-5030	10	14	core	core	NOUN
aiua-5030	10	15	rate	rate	NOUN
aiua-5030	10	16	between	between	ADP
aiua-5030	10	17	tp	tp	NOUN
aiua-5030	10	18	and	and	CCONJ
aiua-5030	10	19	tr	tr	NOUN
aiua-5030	10	20	approaches	approach	NOUN
aiua-5030	10	21	for	for	ADP
aiua-5030	10	22	prostatic	prostatic	ADJ
aiua-5030	10	23	biopsy	biopsy	NOUN
aiua-5030	10	24	.	.	PUNCT
aiua-5030	11	1	even	even	ADV
aiua-5030	11	2	in	in	ADP
aiua-5030	11	3	terms	term	NOUN
aiua-5030	11	4	of	of	ADP
aiua-5030	11	5	complication	complication	NOUN
aiua-5030	11	6	rate	rate	NOUN
aiua-5030	11	7	or	or	CCONJ
aiua-5030	11	8	pain	pain	NOUN
aiua-5030	11	9	level	level	NOUN
aiua-5030	11	10	,	,	PUNCT
aiua-5030	11	11	it	it	PRON
aiua-5030	11	12	can	can	AUX
aiua-5030	11	13	not	not	PART
aiua-5030	11	14	be	be	AUX
aiua-5030	11	15	concluded	conclude	VERB
aiua-5030	11	16	that	that	SCONJ
aiua-5030	11	17	one	one	NUM
aiua-5030	11	18	procedure	procedure	NOUN
aiua-5030	11	19	is	be	AUX
aiua-5030	11	20	superior	superior	ADJ
aiua-5030	11	21	to	to	ADP
aiua-5030	11	22	the	the	DET
aiua-5030	11	23	other	other	ADJ
aiua-5030	11	24	one	one	NUM
aiua-5030	11	25	.	.	PUNCT
aiua-5030	12	1	apparently	apparently	ADV
aiua-5030	12	2	,	,	PUNCT
aiua-5030	12	3	strictly	strictly	ADV
aiua-5030	12	4	following	follow	VERB
aiua-5030	12	5	our	our	PRON
aiua-5030	12	6	protocol	protocol	NOUN
aiua-5030	12	7	,	,	PUNCT
aiua-5030	12	8	tp	tp	NOUN
aiua-5030	12	9	approach	approach	NOUN
aiua-5030	12	10	seems	seem	VERB
aiua-5030	12	11	to	to	PART
aiua-5030	12	12	offer	offer	VERB
aiua-5030	12	13	a	a	DET
aiua-5030	12	14	better	well	ADJ
aiua-5030	12	15	sampling	sampling	NOUN
aiua-5030	12	16	at	at	ADP
aiua-5030	12	17	the	the	DET
aiua-5030	12	18	level	level	NOUN
aiua-5030	12	19	of	of	ADP
aiua-5030	12	20	the	the	DET
aiua-5030	12	21	apex	apex	NOUN
aiua-5030	12	22	and	and	CCONJ
aiua-5030	12	23	the	the	DET
aiua-5030	12	24	tz	tz	NOUN
aiua-5030	12	25	,	,	PUNCT
aiua-5030	12	26	however	however	ADV
aiua-5030	12	27	without	without	ADP
aiua-5030	12	28	adding	add	VERB
aiua-5030	12	29	any	any	DET
aiua-5030	12	30	significant	significant	ADJ
aiua-5030	12	31	advantage	advantage	NOUN
aiua-5030	12	32	in	in	ADP
aiua-5030	12	33	terms	term	NOUN
aiua-5030	12	34	of	of	ADP
aiua-5030	12	35	overall	overall	ADJ
aiua-5030	12	36	cancer	cancer	NOUN
aiua-5030	12	37	detection	detection	NOUN
aiua-5030	12	38	rate	rate	NOUN
aiua-5030	12	39	.	.	PUNCT
aiua-5030	13	1	key	key	ADJ
aiua-5030	13	2	words	word	NOUN
aiua-5030	13	3	:	:	PUNCT
aiua-5030	13	4	prostatic	prostatic	ADJ
aiua-5030	13	5	neoplasm	neoplasm	NOUN
aiua-5030	13	6	;	;	PUNCT
aiua-5030	13	7	transrectal	transrectal	ADJ
aiua-5030	13	8	biopsy	biopsy	NOUN
aiua-5030	13	9	;	;	PUNCT
aiua-5030	13	10	transperineal	transperineal	NOUN
aiua-5030	13	11	biopsy	biopsy	NOUN
aiua-5030	13	12	;	;	PUNCT
aiua-5030	13	13	diagnosis	diagnosis	NOUN
aiua-5030	13	14	;	;	PUNCT
aiua-5030	13	15	cancer	cancer	NOUN
aiua-5030	13	16	detection	detection	NOUN
aiua-5030	13	17	rate	rate	NOUN
aiua-5030	13	18	;	;	PUNCT
aiua-5030	13	19	prostatespecific	prostatespecific	NOUN
aiua-5030	13	20	antigen	antigen	PROPN
aiua-5030	13	21	.	.	PUNCT
aiua-5030	13	22	submitted	submit	VERB
aiua-5030	13	23	12	12	NUM
aiua-5030	13	24	february	february	NOUN
aiua-5030	13	25	2014	2014	NUM
aiua-5030	13	26	;	;	PUNCT
aiua-5030	13	27	accepted	accept	VERB
aiua-5030	13	28	30	30	NUM
aiua-5030	13	29	june	june	PROPN
aiua-5030	13	30	2014	2014	NUM
aiua-5030	13	31	summary	summary	NOUN
aiua-5030	13	32	no	no	DET
aiua-5030	13	33	conflict	conflict	NOUN
aiua-5030	13	34	of	of	ADP
aiua-5030	13	35	interest	interest	NOUN
aiua-5030	13	36	declared	declare	VERB
aiua-5030	13	37	.	.	PUNCT
aiua-5030	14	1	introduction	introduction	NOUN
aiua-5030	14	2	the	the	DET
aiua-5030	14	3	widespread	widespread	ADJ
aiua-5030	14	4	use	use	NOUN
aiua-5030	14	5	of	of	ADP
aiua-5030	14	6	serum	serum	NOUN
aiua-5030	14	7	prostate	prostate	NOUN
aiua-5030	14	8	specific	specific	ADJ
aiua-5030	14	9	antigen	antigen	NOUN
aiua-5030	14	10	(	(	PUNCT
aiua-5030	14	11	psa	psa	NOUN
aiua-5030	14	12	)	)	PUNCT
aiua-5030	14	13	measurement	measurement	NOUN
aiua-5030	14	14	as	as	ADP
aiua-5030	14	15	an	an	DET
aiua-5030	14	16	opportunistic	opportunistic	ADJ
aiua-5030	14	17	screening	screening	NOUN
aiua-5030	14	18	tool	tool	NOUN
aiua-5030	14	19	to	to	PART
aiua-5030	14	20	detect	detect	VERB
aiua-5030	14	21	early	early	ADJ
aiua-5030	14	22	prostate	prostate	NOUN
aiua-5030	14	23	cancer	cancer	NOUN
aiua-5030	14	24	(	(	PUNCT
aiua-5030	14	25	cap	cap	NOUN
aiua-5030	14	26	)	)	PUNCT
aiua-5030	14	27	led	lead	VERB
aiua-5030	14	28	to	to	PART
aiua-5030	14	29	optimise	optimise	VERB
aiua-5030	14	30	an	an	DET
aiua-5030	14	31	effective	effective	ADJ
aiua-5030	14	32	biopsy	biopsy	NOUN
aiua-5030	14	33	technique	technique	NOUN
aiua-5030	14	34	.	.	PUNCT
aiua-5030	15	1	unfortunately	unfortunately	ADV
aiua-5030	15	2	,	,	PUNCT
aiua-5030	15	3	the	the	DET
aiua-5030	15	4	ideal	ideal	ADJ
aiua-5030	15	5	bioptic	bioptic	ADJ
aiua-5030	15	6	strategy	strategy	NOUN
aiua-5030	15	7	for	for	ADP
aiua-5030	15	8	cap	cap	NOUN
aiua-5030	15	9	detection	detection	NOUN
aiua-5030	15	10	is	be	AUX
aiua-5030	15	11	still	still	ADV
aiua-5030	15	12	to	to	PART
aiua-5030	15	13	be	be	AUX
aiua-5030	15	14	completely	completely	ADV
aiua-5030	15	15	defined	define	VERB
aiua-5030	15	16	.	.	PUNCT
aiua-5030	16	1	at	at	ADP
aiua-5030	16	2	the	the	DET
aiua-5030	16	3	present	present	NOUN
aiua-5030	16	4	,	,	PUNCT
aiua-5030	16	5	there	there	PRON
aiua-5030	16	6	is	be	VERB
aiua-5030	16	7	still	still	ADV
aiua-5030	16	8	a	a	DET
aiua-5030	16	9	lack	lack	NOUN
aiua-5030	16	10	of	of	ADP
aiua-5030	16	11	standardisation	standardisation	NOUN
aiua-5030	16	12	regarding	regard	VERB
aiua-5030	16	13	both	both	DET
aiua-5030	16	14	transperineal	transperineal	NOUN
aiua-5030	16	15	(	(	PUNCT
aiua-5030	16	16	tp	tp	NOUN
aiua-5030	16	17	)	)	PUNCT
aiua-5030	16	18	and	and	CCONJ
aiua-5030	16	19	transrectal	transrectal	ADJ
aiua-5030	16	20	(	(	PUNCT
aiua-5030	16	21	tr	tr	VERB
aiua-5030	16	22	)	)	PUNCT
aiua-5030	16	23	approaches	approach	NOUN
aiua-5030	16	24	.	.	PUNCT
aiua-5030	17	1	in	in	ADP
aiua-5030	17	2	2003	2003	NUM
aiua-5030	17	3	,	,	PUNCT
aiua-5030	17	4	emiliozzi	emiliozzi	AUX
aiua-5030	17	5	et	et	PROPN
aiua-5030	17	6	al	al	PROPN
aiua-5030	17	7	.	.	PROPN
aiua-5030	17	8	carried	carry	VERB
aiua-5030	17	9	out	out	ADP
aiua-5030	17	10	a	a	DET
aiua-5030	17	11	prospective	prospective	ADJ
aiua-5030	17	12	study	study	NOUN
aiua-5030	17	13	aiming	aim	VERB
aiua-5030	17	14	of	of	ADP
aiua-5030	17	15	comparing	compare	VERB
aiua-5030	17	16	the	the	DET
aiua-5030	17	17	efficacy	efficacy	NOUN
aiua-5030	17	18	of	of	ADP
aiua-5030	17	19	tp	tp	NOUN
aiua-5030	17	20	and	and	CCONJ
aiua-5030	17	21	tr	tr	PUNCT
aiua-5030	17	22	six	six	NUM
aiua-5030	17	23	-	-	PUNCT
aiua-5030	17	24	core	core	NOUN
aiua-5030	17	25	prostatic	prostatic	ADJ
aiua-5030	17	26	biopsy	biopsy	NOUN
aiua-5030	17	27	.	.	PUNCT
aiua-5030	18	1	they	they	PRON
aiua-5030	18	2	performed	perform	VERB
aiua-5030	18	3	both	both	DET
aiua-5030	18	4	biopsy	biopsy	ADJ
aiua-5030	18	5	approaches	approach	NOUN
aiua-5030	18	6	,	,	PUNCT
aiua-5030	18	7	on	on	ADP
aiua-5030	18	8	the	the	DET
aiua-5030	18	9	same	same	ADJ
aiua-5030	18	10	patients	patient	NOUN
aiua-5030	18	11	,	,	PUNCT
aiua-5030	18	12	stating	state	VERB
aiua-5030	18	13	that	that	SCONJ
aiua-5030	18	14	tp	tp	PROPN
aiua-5030	18	15	biopsy	biopsy	NOUN
aiua-5030	18	16	resulted	result	VERB
aiua-5030	18	17	superior	superior	ADJ
aiua-5030	18	18	to	to	ADP
aiua-5030	18	19	tr	tr	VERB
aiua-5030	18	20	one	one	NUM
aiua-5030	18	21	to	to	PART
aiua-5030	18	22	detect	detect	VERB
aiua-5030	18	23	cap	cap	NOUN
aiua-5030	18	24	(	(	PUNCT
aiua-5030	18	25	p	p	X
aiua-5030	18	26	=	=	NOUN
aiua-5030	18	27	0.012	0.012	NUM
aiua-5030	18	28	)	)	PUNCT
aiua-5030	18	29	(	(	PUNCT
aiua-5030	18	30	1	1	NUM
aiua-5030	18	31	)	)	PUNCT
aiua-5030	18	32	.	.	PUNCT
aiua-5030	19	1	in	in	ADP
aiua-5030	19	2	2007	2007	NUM
aiua-5030	19	3	,	,	PUNCT
aiua-5030	19	4	firstly	firstly	ADV
aiua-5030	19	5	,	,	PUNCT
aiua-5030	19	6	kawakami	kawakami	PROPN
aiua-5030	19	7	et	et	PROPN
aiua-5030	19	8	al	al	PROPN
aiua-5030	19	9	.	.	PROPN
aiua-5030	19	10	demonstrated	demonstrate	VERB
aiua-5030	19	11	that	that	SCONJ
aiua-5030	19	12	an	an	DET
aiua-5030	19	13	extended	extended	ADJ
aiua-5030	19	14	tp	tp	NOUN
aiua-5030	19	15	biopsy	biopsy	NOUN
aiua-5030	19	16	was	be	AUX
aiua-5030	19	17	as	as	ADV
aiua-5030	19	18	effective	effective	ADJ
aiua-5030	19	19	as	as	ADP
aiua-5030	19	20	its	its	PRON
aiua-5030	19	21	tr	tr	NOUN
aiua-5030	19	22	counterpart	counterpart	NOUN
aiua-5030	19	23	in	in	ADP
aiua-5030	19	24	detecting	detect	VERB
aiua-5030	19	25	the	the	DET
aiua-5030	19	26	presence	presence	NOUN
aiua-5030	19	27	and	and	CCONJ
aiua-5030	19	28	the	the	DET
aiua-5030	19	29	characteristics	characteristic	NOUN
aiua-5030	19	30	of	of	ADP
aiua-5030	19	31	the	the	DET
aiua-5030	19	32	cap	cap	NOUN
aiua-5030	19	33	,	,	PUNCT
aiua-5030	19	34	as	as	ADV
aiua-5030	19	35	far	far	ADV
aiua-5030	19	36	as	as	SCONJ
aiua-5030	19	37	sampling	sample	VERB
aiua-5030	19	38	sites	site	NOUN
aiua-5030	19	39	were	be	AUX
aiua-5030	19	40	selected	select	VERB
aiua-5030	19	41	to	to	PART
aiua-5030	19	42	maximize	maximize	VERB
aiua-5030	19	43	the	the	DET
aiua-5030	19	44	cancer	cancer	NOUN
aiua-5030	19	45	detection	detection	NOUN
aiua-5030	19	46	rate	rate	NOUN
aiua-5030	19	47	(	(	PUNCT
aiua-5030	19	48	2	2	NUM
aiua-5030	19	49	)	)	PUNCT
aiua-5030	19	50	.	.	PUNCT
aiua-5030	20	1	more	more	ADV
aiua-5030	20	2	recently	recently	ADV
aiua-5030	20	3	,	,	PUNCT
aiua-5030	20	4	hara	hara	PROPN
aiua-5030	20	5	et	et	PROPN
aiua-5030	20	6	al	al	PROPN
aiua-5030	20	7	.	.	PROPN
aiua-5030	20	8	carried	carry	VERB
aiua-5030	20	9	out	out	ADP
aiua-5030	20	10	a	a	DET
aiua-5030	20	11	prospective	prospective	ADJ
aiua-5030	20	12	randomized	randomized	ADJ
aiua-5030	20	13	study	study	NOUN
aiua-5030	20	14	comparing	compare	VERB
aiua-5030	20	15	tp	tp	NOUN
aiua-5030	20	16	with	with	ADP
aiua-5030	20	17	tr	tr	VERB
aiua-5030	20	18	12	12	NUM
aiua-5030	20	19	-	-	PUNCT
aiua-5030	20	20	core	core	NOUN
aiua-5030	20	21	biopsy	biopsy	NOUN
aiua-5030	20	22	,	,	PUNCT
aiua-5030	20	23	in	in	ADP
aiua-5030	20	24	246	246	NUM
aiua-5030	20	25	patients	patient	NOUN
aiua-5030	20	26	with	with	ADP
aiua-5030	20	27	psa	psa	NOUN
aiua-5030	20	28	levels	level	NOUN
aiua-5030	20	29	ranging	range	VERB
aiua-5030	20	30	from	from	ADP
aiua-5030	20	31	4.0	4.0	NUM
aiua-5030	20	32	to	to	PART
aiua-5030	20	33	20.0	20.0	NUM
aiua-5030	20	34	ng	ng	NOUN
aiua-5030	20	35	/	/	SYM
aiua-5030	20	36	ml	ml	PROPN
aiua-5030	20	37	(	(	PUNCT
aiua-5030	20	38	3	3	NUM
aiua-5030	20	39	)	)	PUNCT
aiua-5030	20	40	.	.	PUNCT
aiua-5030	21	1	with	with	ADP
aiua-5030	21	2	patients	patient	NOUN
aiua-5030	21	3	in	in	ADP
aiua-5030	21	4	lithotomy	lithotomy	ADJ
aiua-5030	21	5	position	position	NOUN
aiua-5030	21	6	,	,	PUNCT
aiua-5030	21	7	all	all	DET
aiua-5030	21	8	procedures	procedure	NOUN
aiua-5030	21	9	were	be	AUX
aiua-5030	21	10	performed	perform	VERB
aiua-5030	21	11	using	use	VERB
aiua-5030	21	12	spinal	spinal	ADJ
aiua-5030	21	13	anaesthesia	anaesthesia	NOUN
aiua-5030	21	14	(	(	PUNCT
aiua-5030	21	15	0.5	0.5	NUM
aiua-5030	21	16	%	%	NOUN
aiua-5030	21	17	bupivacaine	bupivacaine	NOUN
aiua-5030	21	18	)	)	PUNCT
aiua-5030	21	19	or	or	CCONJ
aiua-5030	21	20	a	a	DET
aiua-5030	21	21	caudal	caudal	NOUN
aiua-5030	21	22	block	block	NOUN
aiua-5030	21	23	(	(	PUNCT
aiua-5030	21	24	1	1	NUM
aiua-5030	21	25	%	%	NOUN
aiua-5030	21	26	lidocaine	lidocaine	NOUN
aiua-5030	21	27	)	)	PUNCT
aiua-5030	21	28	according	accord	VERB
aiua-5030	21	29	to	to	ADP
aiua-5030	21	30	tp	tp	NOUN
aiua-5030	21	31	and	and	CCONJ
aiua-5030	22	1	tr	tr	PUNCT
aiua-5030	22	2	approaches	approach	NOUN
aiua-5030	22	3	,	,	PUNCT
aiua-5030	22	4	respectively	respectively	ADV
aiua-5030	22	5	.	.	PUNCT
aiua-5030	23	1	the	the	DET
aiua-5030	23	2	authors	author	NOUN
aiua-5030	23	3	did	do	AUX
aiua-5030	23	4	not	not	PART
aiua-5030	23	5	find	find	VERB
aiua-5030	23	6	any	any	DET
aiua-5030	23	7	significant	significant	ADJ
aiua-5030	23	8	difference	difference	NOUN
aiua-5030	23	9	in	in	ADP
aiua-5030	23	10	cancer	cancer	NOUN
aiua-5030	23	11	detection	detection	NOUN
aiua-5030	23	12	rate	rate	NOUN
aiua-5030	23	13	,	,	PUNCT
aiua-5030	23	14	cancer	cancer	NOUN
aiua-5030	23	15	core	core	NOUN
aiua-5030	23	16	rate	rate	NOUN
aiua-5030	23	17	or	or	CCONJ
aiua-5030	23	18	complications	complication	NOUN
aiua-5030	23	19	between	between	ADP
aiua-5030	23	20	the	the	DET
aiua-5030	23	21	two	two	NUM
aiua-5030	23	22	approaches	approach	NOUN
aiua-5030	23	23	:	:	PUNCT
aiua-5030	23	24	they	they	PRON
aiua-5030	23	25	concluded	conclude	VERB
aiua-5030	23	26	that	that	SCONJ
aiua-5030	23	27	the	the	DET
aiua-5030	23	28	preferred	preferred	ADJ
aiua-5030	23	29	approach	approach	NOUN
aiua-5030	23	30	,	,	PUNCT
aiua-5030	23	31	as	as	SCONJ
aiua-5030	23	32	the	the	DET
aiua-5030	23	33	initial	initial	ADJ
aiua-5030	23	34	prostate	prostate	NOUN
aiua-5030	23	35	biopsy	biopsy	NOUN
aiua-5030	23	36	,	,	PUNCT
aiua-5030	23	37	might	might	AUX
aiua-5030	23	38	be	be	AUX
aiua-5030	23	39	the	the	DET
aiua-5030	23	40	tr	tr	PUNCT
aiua-5030	23	41	one	one	NUM
aiua-5030	23	42	as	as	SCONJ
aiua-5030	23	43	it	it	PRON
aiua-5030	23	44	did	do	AUX
aiua-5030	23	45	not	not	PART
aiua-5030	23	46	require	require	VERB
aiua-5030	23	47	spinal	spinal	ADJ
aiua-5030	23	48	anaesthesia	anaesthesia	NOUN
aiua-5030	23	49	or	or	CCONJ
aiua-5030	23	50	other	other	ADJ
aiua-5030	23	51	burdensome	burdensome	ADJ
aiua-5030	23	52	related	relate	VERB
aiua-5030	23	53	processes	process	NOUN
aiua-5030	23	54	(	(	PUNCT
aiua-5030	23	55	3	3	NUM
aiua-5030	23	56	)	)	PUNCT
aiua-5030	23	57	.	.	PUNCT
aiua-5030	24	1	nevertheless	nevertheless	ADV
aiua-5030	24	2	,	,	PUNCT
aiua-5030	24	3	the	the	DET
aiua-5030	24	4	same	same	ADJ
aiua-5030	24	5	study	study	NOUN
aiua-5030	24	6	group	group	NOUN
aiua-5030	24	7	even	even	ADV
aiua-5030	24	8	reported	report	VERB
aiua-5030	24	9	that	that	SCONJ
aiua-5030	24	10	,	,	PUNCT
aiua-5030	24	11	with	with	ADP
aiua-5030	24	12	a	a	DET
aiua-5030	24	13	psa	psa	NOUN
aiua-5030	24	14	in	in	ADP
aiua-5030	24	15	the	the	DET
aiua-5030	24	16	so	so	ADV
aiua-5030	24	17	-	-	PUNCT
aiua-5030	24	18	called	call	VERB
aiua-5030	24	19	“	"	PUNCT
aiua-5030	24	20	grey	grey	ADJ
aiua-5030	24	21	zone	zone	NOUN
aiua-5030	24	22	”	"	PUNCT
aiua-5030	24	23	,	,	PUNCT
aiua-5030	24	24	significantly	significantly	ADV
aiua-5030	24	25	more	more	ADJ
aiua-5030	24	26	cores	core	NOUN
aiua-5030	24	27	were	be	AUX
aiua-5030	24	28	positive	positive	ADJ
aiua-5030	24	29	when	when	SCONJ
aiua-5030	24	30	the	the	DET
aiua-5030	24	31	tp	tp	NOUN
aiua-5030	24	32	approach	approach	NOUN
aiua-5030	24	33	was	be	AUX
aiua-5030	24	34	applied	apply	VERB
aiua-5030	24	35	,	,	PUNCT
aiua-5030	24	36	especially	especially	ADV
aiua-5030	24	37	for	for	ADP
aiua-5030	24	38	cores	core	NOUN
aiua-5030	24	39	coming	come	VERB
aiua-5030	24	40	from	from	ADP
aiua-5030	24	41	the	the	DET
aiua-5030	24	42	transition	transition	NOUN
aiua-5030	24	43	zone	zone	NOUN
aiua-5030	24	44	(	(	PUNCT
aiua-5030	24	45	4	4	NUM
aiua-5030	24	46	)	)	PUNCT
aiua-5030	24	47	.	.	PUNCT
aiua-5030	25	1	conclusions	conclusion	NOUN
aiua-5030	25	2	were	be	AUX
aiua-5030	25	3	that	that	SCONJ
aiua-5030	25	4	urologist	urologist	NOUN
aiua-5030	25	5	’s	’s	PART
aiua-5030	25	6	preference	preference	NOUN
aiua-5030	25	7	could	could	AUX
aiua-5030	25	8	be	be	AUX
aiua-5030	25	9	sufficient	sufficient	ADJ
aiua-5030	25	10	for	for	ADP
aiua-5030	25	11	choosing	choose	VERB
aiua-5030	25	12	the	the	DET
aiua-5030	25	13	ideal	ideal	ADJ
aiua-5030	25	14	approach	approach	NOUN
aiua-5030	25	15	,	,	PUNCT
aiua-5030	25	16	except	except	SCONJ
aiua-5030	25	17	for	for	ADP
aiua-5030	25	18	a	a	DET
aiua-5030	25	19	possible	possible	ADJ
aiua-5030	25	20	small	small	ADJ
aiua-5030	25	21	advantage	advantage	NOUN
aiua-5030	25	22	for	for	ADP
aiua-5030	25	23	tp	tp	PART
aiua-5030	25	24	biopsy	biopsy	NOUN
aiua-5030	25	25	when	when	SCONJ
aiua-5030	25	26	psa	psa	NOUN
aiua-5030	25	27	is	be	AUX
aiua-5030	25	28	in	in	ADP
aiua-5030	25	29	the	the	DET
aiua-5030	25	30	“	"	PUNCT
aiua-5030	25	31	grey	grey	ADJ
aiua-5030	25	32	zone	zone	NOUN
aiua-5030	25	33	”	"	PUNCT
aiua-5030	25	34	.	.	PUNCT
aiua-5030	26	1	just	just	ADV
aiua-5030	26	2	to	to	PART
aiua-5030	26	3	compare	compare	VERB
aiua-5030	26	4	tp	tp	NOUN
aiua-5030	26	5	and	and	CCONJ
aiua-5030	26	6	tr	tr	VERB
aiua-5030	26	7	approaches	approach	NOUN
aiua-5030	26	8	,	,	PUNCT
aiua-5030	26	9	in	in	ADP
aiua-5030	26	10	a	a	DET
aiua-5030	26	11	14	14	NUM
aiua-5030	26	12	-	-	PUNCT
aiua-5030	26	13	core	core	NOUN
aiua-5030	26	14	initial	initial	ADJ
aiua-5030	26	15	prostate	prostate	NOUN
aiua-5030	26	16	biopsy	biopsy	NOUN
aiua-5030	26	17	for	for	ADP
aiua-5030	26	18	cap	cap	NOUN
aiua-5030	26	19	detection	detection	NOUN
aiua-5030	26	20	,	,	PUNCT
aiua-5030	26	21	we	we	PRON
aiua-5030	26	22	have	have	AUX
aiua-5030	26	23	performed	perform	VERB
aiua-5030	26	24	a	a	DET
aiua-5030	26	25	prospective	prospective	ADJ
aiua-5030	26	26	controlled	control	VERB
aiua-5030	26	27	study	study	NOUN
aiua-5030	26	28	and	and	CCONJ
aiua-5030	26	29	these	these	DET
aiua-5030	26	30	results	result	NOUN
aiua-5030	26	31	are	be	AUX
aiua-5030	26	32	herein	herein	NOUN
aiua-5030	26	33	presented	present	VERB
aiua-5030	26	34	.	.	PUNCT
aiua-5030	27	1	doi	doi	NOUN
aiua-5030	27	2	:	:	PUNCT
aiua-5030	27	3	10.4081	10.4081	NUM
aiua-5030	27	4	/	/	SYM
aiua-5030	27	5	aiua.2014.4.284	aiua.2014.4.284	ADJ
aiua-5030	27	6	cerruto_stesura	cerruto_stesura	NOUN
aiua-5030	27	7	seveso	seveso	VERB
aiua-5030	27	8	15/01/15	15/01/15	PROPN
aiua-5030	27	9	13:18	13:18	NUM
aiua-5030	27	10	pagina	pagina	NOUN
aiua-5030	27	11	284	284	NUM
aiua-5030	27	12	285archivio	285archivio	PROPN
aiua-5030	27	13	italiano	italiano	NOUN
aiua-5030	27	14	di	di	NOUN
aiua-5030	27	15	urologia	urologia	PROPN
aiua-5030	27	16	e	e	PROPN
aiua-5030	27	17	andrologia	andrologia	NOUN
aiua-5030	27	18	2014	2014	NUM
aiua-5030	27	19	;	;	PUNCT
aiua-5030	27	20	86	86	NUM
aiua-5030	27	21	,	,	PUNCT
aiua-5030	27	22	4	4	NUM
aiua-5030	27	23	transrectal	transrectal	ADJ
aiua-5030	27	24	versus	versus	ADP
aiua-5030	27	25	transperineal	transperineal	NOUN
aiua-5030	27	26	prostate	prostate	NOUN
aiua-5030	27	27	biopsy	biopsy	NOUN
aiua-5030	27	28	:	:	PUNCT
aiua-5030	27	29	a	a	DET
aiua-5030	27	30	comparative	comparative	ADJ
aiua-5030	27	31	evaluation	evaluation	NOUN
aiua-5030	27	32	material	material	NOUN
aiua-5030	27	33	and	and	CCONJ
aiua-5030	27	34	methods	method	NOUN
aiua-5030	27	35	a	a	DET
aiua-5030	27	36	prospective	prospective	ADJ
aiua-5030	27	37	controlled	control	VERB
aiua-5030	27	38	study	study	NOUN
aiua-5030	27	39	was	be	AUX
aiua-5030	27	40	conducted	conduct	VERB
aiua-5030	27	41	enrolling	enrol	VERB
aiua-5030	27	42	108	108	NUM
aiua-5030	27	43	consecutive	consecutive	ADJ
aiua-5030	27	44	patients	patient	NOUN
aiua-5030	27	45	at	at	ADP
aiua-5030	27	46	our	our	PRON
aiua-5030	27	47	urological	urological	ADJ
aiua-5030	27	48	center	center	NOUN
aiua-5030	27	49	with	with	ADP
aiua-5030	27	50	a	a	DET
aiua-5030	27	51	psa	psa	NOUN
aiua-5030	27	52	level	level	NOUN
aiua-5030	27	53	greater	great	ADJ
aiua-5030	27	54	than	than	ADP
aiua-5030	27	55	4	4	NUM
aiua-5030	27	56	ng	ng	NOUN
aiua-5030	27	57	/	/	SYM
aiua-5030	27	58	ml	ml	ADP
aiua-5030	27	59	and/or	and/or	CCONJ
aiua-5030	27	60	an	an	DET
aiua-5030	27	61	abnormal	abnormal	ADJ
aiua-5030	27	62	digital	digital	ADJ
aiua-5030	27	63	rectal	rectal	ADJ
aiua-5030	27	64	examination	examination	NOUN
aiua-5030	27	65	(	(	PUNCT
aiua-5030	27	66	dre	dre	PROPN
aiua-5030	27	67	)	)	PUNCT
aiua-5030	27	68	.	.	PUNCT
aiua-5030	28	1	tr	tr	VERB
aiua-5030	29	1	versus	versus	ADP
aiua-5030	29	2	tp	tp	ADP
aiua-5030	29	3	14	14	NUM
aiua-5030	29	4	-	-	PUNCT
aiua-5030	29	5	core	core	NOUN
aiua-5030	29	6	initial	initial	ADJ
aiua-5030	29	7	prostatic	prostatic	ADJ
aiua-5030	29	8	biopsies	biopsy	NOUN
aiua-5030	29	9	were	be	AUX
aiua-5030	29	10	performed	perform	VERB
aiua-5030	29	11	on	on	ADP
aiua-5030	29	12	54	54	NUM
aiua-5030	29	13	and	and	CCONJ
aiua-5030	29	14	54	54	NUM
aiua-5030	29	15	patients	patient	NOUN
aiua-5030	29	16	,	,	PUNCT
aiua-5030	29	17	respectively	respectively	ADV
aiua-5030	29	18	,	,	PUNCT
aiua-5030	29	19	with	with	ADP
aiua-5030	29	20	a	a	DET
aiua-5030	29	21	randomisation	randomisation	NOUN
aiua-5030	29	22	ratio	ratio	NOUN
aiua-5030	29	23	of	of	ADP
aiua-5030	29	24	1:1	1:1	NUM
aiua-5030	29	25	.	.	PUNCT
aiua-5030	30	1	the	the	DET
aiua-5030	30	2	inclusion	inclusion	NOUN
aiua-5030	30	3	criteria	criterion	NOUN
aiua-5030	30	4	foresaw	foresee	VERB
aiua-5030	30	5	no	no	DET
aiua-5030	30	6	previous	previous	ADJ
aiua-5030	30	7	prostate	prostate	NOUN
aiua-5030	30	8	biopsy	biopsy	NOUN
aiua-5030	30	9	,	,	PUNCT
aiua-5030	30	10	no	no	DET
aiua-5030	30	11	history	history	NOUN
aiua-5030	30	12	of	of	ADP
aiua-5030	30	13	cap	cap	NOUN
aiua-5030	30	14	and	and	CCONJ
aiua-5030	30	15	no	no	DET
aiua-5030	30	16	clinical	clinical	ADJ
aiua-5030	30	17	evidence	evidence	NOUN
aiua-5030	30	18	of	of	ADP
aiua-5030	30	19	acute	acute	ADJ
aiua-5030	30	20	or	or	CCONJ
aiua-5030	30	21	chronic	chronic	ADJ
aiua-5030	30	22	prostatitis	prostatitis	NOUN
aiua-5030	30	23	.	.	PUNCT
aiua-5030	31	1	all	all	DET
aiua-5030	31	2	patients	patient	NOUN
aiua-5030	31	3	were	be	AUX
aiua-5030	31	4	adequately	adequately	ADV
aiua-5030	31	5	informed	inform	VERB
aiua-5030	31	6	on	on	ADP
aiua-5030	31	7	the	the	DET
aiua-5030	31	8	execution	execution	NOUN
aiua-5030	31	9	modalities	modality	NOUN
aiua-5030	31	10	of	of	ADP
aiua-5030	31	11	the	the	DET
aiua-5030	31	12	bioptic	bioptic	ADJ
aiua-5030	31	13	procedure	procedure	NOUN
aiua-5030	31	14	and	and	CCONJ
aiua-5030	31	15	on	on	ADP
aiua-5030	31	16	its	its	PRON
aiua-5030	31	17	potential	potential	ADJ
aiua-5030	31	18	complications	complication	NOUN
aiua-5030	31	19	.	.	PUNCT
aiua-5030	32	1	they	they	PRON
aiua-5030	32	2	were	be	AUX
aiua-5030	32	3	asked	ask	VERB
aiua-5030	32	4	to	to	PART
aiua-5030	32	5	provide	provide	VERB
aiua-5030	32	6	a	a	DET
aiua-5030	32	7	written	write	VERB
aiua-5030	32	8	consent	consent	NOUN
aiua-5030	32	9	.	.	PUNCT
aiua-5030	33	1	each	each	DET
aiua-5030	33	2	patient	patient	NOUN
aiua-5030	33	3	underwent	undergo	VERB
aiua-5030	33	4	a	a	DET
aiua-5030	33	5	clinical	clinical	ADJ
aiua-5030	33	6	evaluation	evaluation	NOUN
aiua-5030	33	7	that	that	PRON
aiua-5030	33	8	included	include	VERB
aiua-5030	33	9	dre	dre	NOUN
aiua-5030	33	10	and	and	CCONJ
aiua-5030	33	11	transrectal	transrectal	ADJ
aiua-5030	33	12	ultrasound	ultrasound	NOUN
aiua-5030	33	13	(	(	PUNCT
aiua-5030	33	14	trus	trus	NOUN
aiua-5030	33	15	)	)	PUNCT
aiua-5030	33	16	.	.	PUNCT
aiua-5030	34	1	prostate	prostate	NOUN
aiua-5030	34	2	volume	volume	NOUN
aiua-5030	34	3	(	(	PUNCT
aiua-5030	34	4	pv	pv	NOUN
aiua-5030	34	5	)	)	PUNCT
aiua-5030	34	6	was	be	AUX
aiua-5030	34	7	measured	measure	VERB
aiua-5030	34	8	by	by	ADP
aiua-5030	34	9	means	mean	NOUN
aiua-5030	34	10	of	of	ADP
aiua-5030	34	11	trus	trus	NOUN
aiua-5030	34	12	and	and	CCONJ
aiua-5030	34	13	was	be	AUX
aiua-5030	34	14	calculated	calculate	VERB
aiua-5030	34	15	as	as	ADP
aiua-5030	34	16	the	the	DET
aiua-5030	34	17	height	height	NOUN
aiua-5030	34	18	per	per	ADP
aiua-5030	34	19	the	the	DET
aiua-5030	34	20	width	width	NOUN
aiua-5030	34	21	per	per	ADP
aiua-5030	34	22	the	the	DET
aiua-5030	34	23	length	length	NOUN
aiua-5030	34	24	per	per	ADP
aiua-5030	34	25	0.52	0.52	NUM
aiua-5030	34	26	.	.	PUNCT
aiua-5030	35	1	table	table	NOUN
aiua-5030	35	2	1	1	NUM
aiua-5030	35	3	lists	list	NOUN
aiua-5030	35	4	patients	patient	NOUN
aiua-5030	35	5	’	'	PUNCT
aiua-5030	35	6	characteristics	characteristic	NOUN
aiua-5030	35	7	:	:	PUNCT
aiua-5030	35	8	no	no	DET
aiua-5030	35	9	significant	significant	ADJ
aiua-5030	35	10	differences	difference	NOUN
aiua-5030	35	11	were	be	AUX
aiua-5030	35	12	found	find	VERB
aiua-5030	35	13	in	in	ADP
aiua-5030	35	14	background	background	NOUN
aiua-5030	35	15	factors	factor	NOUN
aiua-5030	35	16	between	between	ADP
aiua-5030	35	17	the	the	DET
aiua-5030	35	18	two	two	NUM
aiua-5030	35	19	groups	group	NOUN
aiua-5030	35	20	.	.	PUNCT
aiua-5030	36	1	all	all	DET
aiua-5030	36	2	patients	patient	NOUN
aiua-5030	36	3	were	be	AUX
aiua-5030	36	4	instructed	instruct	VERB
aiua-5030	36	5	to	to	PART
aiua-5030	36	6	discontinue	discontinue	VERB
aiua-5030	36	7	an	an	DET
aiua-5030	36	8	eventual	eventual	ADJ
aiua-5030	36	9	anticoagulant	anticoagulant	NOUN
aiua-5030	36	10	therapy	therapy	NOUN
aiua-5030	36	11	for	for	ADP
aiua-5030	36	12	at	at	ADV
aiua-5030	36	13	least	least	ADV
aiua-5030	36	14	7	7	NUM
aiua-5030	36	15	days	day	NOUN
aiua-5030	36	16	before	before	ADV
aiua-5030	36	17	and	and	CCONJ
aiua-5030	36	18	after	after	ADP
aiua-5030	36	19	the	the	DET
aiua-5030	36	20	prostate	prostate	NOUN
aiua-5030	36	21	biopsy	biopsy	NOUN
aiua-5030	36	22	.	.	PUNCT
aiua-5030	37	1	all	all	DET
aiua-5030	37	2	patients	patient	NOUN
aiua-5030	37	3	were	be	AUX
aiua-5030	37	4	given	give	VERB
aiua-5030	37	5	an	an	DET
aiua-5030	37	6	enema	enema	NOUN
aiua-5030	37	7	the	the	DET
aiua-5030	37	8	same	same	ADJ
aiua-5030	37	9	morning	morning	NOUN
aiua-5030	37	10	of	of	ADP
aiua-5030	37	11	the	the	DET
aiua-5030	37	12	procedure	procedure	NOUN
aiua-5030	37	13	and	and	CCONJ
aiua-5030	37	14	an	an	DET
aiua-5030	37	15	antibiotic	antibiotic	ADJ
aiua-5030	37	16	coverage	coverage	NOUN
aiua-5030	37	17	was	be	AUX
aiua-5030	37	18	provided	provide	VERB
aiua-5030	37	19	in	in	ADP
aiua-5030	37	20	all	all	DET
aiua-5030	37	21	cases	case	NOUN
aiua-5030	37	22	using	use	VERB
aiua-5030	37	23	an	an	DET
aiua-5030	37	24	oral	oral	ADJ
aiua-5030	37	25	fluoroquinolone	fluoroquinolone	NOUN
aiua-5030	37	26	(	(	PUNCT
aiua-5030	37	27	prulifloxacin	prulifloxacin	VERB
aiua-5030	37	28	,	,	PUNCT
aiua-5030	37	29	600	600	NUM
aiua-5030	37	30	mg	mg	NOUN
aiua-5030	37	31	,	,	PUNCT
aiua-5030	37	32	once	once	ADV
aiua-5030	37	33	a	a	DET
aiua-5030	37	34	day	day	NOUN
aiua-5030	37	35	)	)	PUNCT
aiua-5030	37	36	for	for	ADP
aiua-5030	37	37	3	3	NUM
aiua-5030	37	38	days	day	NOUN
aiua-5030	37	39	,	,	PUNCT
aiua-5030	37	40	starting	start	VERB
aiua-5030	37	41	from	from	ADP
aiua-5030	37	42	the	the	DET
aiua-5030	37	43	day	day	NOUN
aiua-5030	37	44	before	before	ADP
aiua-5030	37	45	the	the	DET
aiua-5030	37	46	biopsy	biopsy	NOUN
aiua-5030	37	47	.	.	PUNCT
aiua-5030	38	1	for	for	ADP
aiua-5030	38	2	both	both	DET
aiua-5030	38	3	approaches	approach	NOUN
aiua-5030	38	4	,	,	PUNCT
aiua-5030	38	5	the	the	DET
aiua-5030	38	6	patients	patient	NOUN
aiua-5030	38	7	were	be	AUX
aiua-5030	38	8	placed	place	VERB
aiua-5030	38	9	in	in	ADP
aiua-5030	38	10	lithotomy	lithotomy	ADJ
aiua-5030	38	11	position	position	NOUN
aiua-5030	38	12	,	,	PUNCT
aiua-5030	38	13	and	and	CCONJ
aiua-5030	38	14	all	all	DET
aiua-5030	38	15	biopsies	biopsy	NOUN
aiua-5030	38	16	were	be	AUX
aiua-5030	38	17	carried	carry	VERB
aiua-5030	38	18	out	out	ADP
aiua-5030	38	19	only	only	ADV
aiua-5030	38	20	by	by	ADP
aiua-5030	38	21	two	two	NUM
aiua-5030	38	22	skilled	skilled	ADJ
aiua-5030	38	23	urologists	urologist	NOUN
aiua-5030	38	24	included	include	VERB
aiua-5030	38	25	as	as	ADP
aiua-5030	38	26	the	the	DET
aiua-5030	38	27	co	co	NOUN
aiua-5030	38	28	-	-	NOUN
aiua-5030	38	29	authors	author	NOUN
aiua-5030	38	30	of	of	ADP
aiua-5030	38	31	this	this	DET
aiua-5030	38	32	paper	paper	NOUN
aiua-5030	38	33	:	:	PUNCT
aiua-5030	39	1	gn	gn	PROPN
aiua-5030	39	2	for	for	ADP
aiua-5030	39	3	the	the	DET
aiua-5030	39	4	tp	tp	NOUN
aiua-5030	39	5	approach	approach	NOUN
aiua-5030	39	6	,	,	PUNCT
aiua-5030	39	7	and	and	CCONJ
aiua-5030	39	8	fv	fv	X
aiua-5030	39	9	for	for	ADP
aiua-5030	39	10	the	the	DET
aiua-5030	39	11	tr	tr	PUNCT
aiua-5030	39	12	one	one	NUM
aiua-5030	39	13	.	.	PUNCT
aiua-5030	40	1	all	all	DET
aiua-5030	40	2	the	the	DET
aiua-5030	40	3	tp	tp	NOUN
aiua-5030	40	4	biopsies	biopsy	NOUN
aiua-5030	40	5	were	be	AUX
aiua-5030	40	6	performed	perform	VERB
aiua-5030	40	7	using	use	VERB
aiua-5030	40	8	a	a	DET
aiua-5030	40	9	single	single	ADJ
aiua-5030	40	10	median	median	NOUN
aiua-5030	40	11	tp	tp	NOUN
aiua-5030	40	12	access	access	VERB
aiua-5030	40	13	1.5	1.5	NUM
aiua-5030	40	14	cm	cm	NOUN
aiua-5030	40	15	above	above	ADP
aiua-5030	40	16	the	the	DET
aiua-5030	40	17	anal	anal	ADJ
aiua-5030	40	18	sphincter	sphincter	NOUN
aiua-5030	40	19	,	,	PUNCT
aiua-5030	40	20	as	as	SCONJ
aiua-5030	40	21	previously	previously	ADV
aiua-5030	40	22	described	describe	VERB
aiua-5030	40	23	(	(	PUNCT
aiua-5030	40	24	5	5	NUM
aiua-5030	40	25	)	)	PUNCT
aiua-5030	40	26	.	.	PUNCT
aiua-5030	41	1	in	in	ADP
aiua-5030	41	2	all	all	DET
aiua-5030	41	3	cases	case	NOUN
aiua-5030	41	4	,	,	PUNCT
aiua-5030	41	5	local	local	ADJ
aiua-5030	41	6	anaesthesia	anaesthesia	NOUN
aiua-5030	41	7	was	be	AUX
aiua-5030	41	8	provided	provide	VERB
aiua-5030	41	9	releasing	release	VERB
aiua-5030	41	10	2	2	NUM
aiua-5030	41	11	ml	ml	NOUN
aiua-5030	41	12	of	of	ADP
aiua-5030	41	13	1	1	NUM
aiua-5030	41	14	%	%	NOUN
aiua-5030	41	15	mepivacaine	mepivacaine	NOUN
aiua-5030	41	16	at	at	ADP
aiua-5030	41	17	the	the	DET
aiua-5030	41	18	level	level	NOUN
aiua-5030	41	19	of	of	ADP
aiua-5030	41	20	the	the	DET
aiua-5030	41	21	prostate	prostate	NOUN
aiua-5030	41	22	apex	apex	NOUN
aiua-5030	41	23	.	.	PUNCT
aiua-5030	42	1	a	a	DET
aiua-5030	42	2	18	18	NUM
aiua-5030	42	3	-	-	PUNCT
aiua-5030	42	4	gauge	gauge	NOUN
aiua-5030	42	5	coaxial	coaxial	ADJ
aiua-5030	42	6	needle	needle	NOUN
aiua-5030	42	7	(	(	PUNCT
aiua-5030	42	8	truguide	truguide	NOUN
aiua-5030	42	9	bard	bard	NOUN
aiua-5030	42	10	,	,	PUNCT
aiua-5030	42	11	13	13	NUM
aiua-5030	42	12	cm	cm	NOUN
aiua-5030	42	13	long	long	ADV
aiua-5030	42	14	)	)	PUNCT
aiua-5030	42	15	was	be	AUX
aiua-5030	42	16	inserted	insert	VERB
aiua-5030	42	17	up	up	ADP
aiua-5030	42	18	to	to	ADP
aiua-5030	42	19	the	the	DET
aiua-5030	42	20	prostate	prostate	NOUN
aiua-5030	42	21	apex	apex	NOUN
aiua-5030	42	22	through	through	ADP
aiua-5030	42	23	the	the	DET
aiua-5030	42	24	anesthetised	anesthetise	VERB
aiua-5030	42	25	perineal	perineal	ADJ
aiua-5030	42	26	path	path	NOUN
aiua-5030	42	27	under	under	ADP
aiua-5030	42	28	trus	trus	PROPN
aiua-5030	42	29	guidance	guidance	NOUN
aiua-5030	42	30	.	.	PUNCT
aiua-5030	43	1	on	on	ADP
aiua-5030	43	2	the	the	DET
aiua-5030	43	3	removal	removal	NOUN
aiua-5030	43	4	of	of	ADP
aiua-5030	43	5	the	the	DET
aiua-5030	43	6	blunt	blunt	ADJ
aiua-5030	43	7	tip	tip	NOUN
aiua-5030	43	8	stylet	stylet	NOUN
aiua-5030	43	9	,	,	PUNCT
aiua-5030	43	10	the	the	DET
aiua-5030	43	11	guiding	guide	VERB
aiua-5030	43	12	cannula	cannula	NOUN
aiua-5030	43	13	of	of	ADP
aiua-5030	43	14	the	the	DET
aiua-5030	43	15	coaxial	coaxial	ADJ
aiua-5030	43	16	needle	needle	NOUN
aiua-5030	43	17	was	be	AUX
aiua-5030	43	18	used	use	VERB
aiua-5030	43	19	as	as	ADP
aiua-5030	43	20	a	a	DET
aiua-5030	43	21	tp	tp	NOUN
aiua-5030	43	22	metallic	metallic	ADJ
aiua-5030	43	23	path	path	NOUN
aiua-5030	43	24	for	for	ADP
aiua-5030	43	25	repeated	repeat	VERB
aiua-5030	43	26	atraumatic	atraumatic	ADJ
aiua-5030	43	27	passages	passage	NOUN
aiua-5030	43	28	of	of	ADP
aiua-5030	43	29	the	the	DET
aiua-5030	43	30	biopsy	biopsy	NOUN
aiua-5030	43	31	needle	needle	NOUN
aiua-5030	43	32	.	.	PUNCT
aiua-5030	44	1	with	with	ADP
aiua-5030	44	2	the	the	DET
aiua-5030	44	3	tp	tp	NOUN
aiua-5030	44	4	approach	approach	NOUN
aiua-5030	44	5	,	,	PUNCT
aiua-5030	44	6	firstly	firstly	ADV
aiua-5030	44	7	,	,	PUNCT
aiua-5030	44	8	a	a	DET
aiua-5030	44	9	traditional	traditional	ADJ
aiua-5030	44	10	sextant	sextant	ADJ
aiua-5030	44	11	biopsy	biopsy	NOUN
aiua-5030	44	12	was	be	AUX
aiua-5030	44	13	performed	perform	VERB
aiua-5030	44	14	;	;	PUNCT
aiua-5030	44	15	then	then	ADV
aiua-5030	44	16	,	,	PUNCT
aiua-5030	44	17	additional	additional	ADJ
aiua-5030	44	18	lateral	lateral	ADJ
aiua-5030	44	19	sextant	sextant	ADJ
aiua-5030	44	20	peripheral	peripheral	ADJ
aiua-5030	44	21	cores	core	NOUN
aiua-5030	44	22	were	be	AUX
aiua-5030	44	23	added	add	VERB
aiua-5030	44	24	and	and	CCONJ
aiua-5030	44	25	,	,	PUNCT
aiua-5030	44	26	lastly	lastly	ADV
aiua-5030	44	27	,	,	PUNCT
aiua-5030	44	28	two	two	NUM
aiua-5030	44	29	cores	core	NOUN
aiua-5030	44	30	were	be	AUX
aiua-5030	44	31	taken	take	VERB
aiua-5030	44	32	from	from	ADP
aiua-5030	44	33	the	the	DET
aiua-5030	44	34	anterior	anterior	ADJ
aiua-5030	44	35	transitional	transitional	ADJ
aiua-5030	44	36	zone	zone	NOUN
aiua-5030	44	37	(	(	PUNCT
aiua-5030	44	38	tz	tz	PROPN
aiua-5030	44	39	)	)	PUNCT
aiua-5030	44	40	(	(	PUNCT
aiua-5030	44	41	6	6	NUM
aiua-5030	44	42	)	)	PUNCT
aiua-5030	44	43	.	.	PUNCT
aiua-5030	45	1	for	for	ADP
aiua-5030	45	2	systematic	systematic	ADJ
aiua-5030	45	3	tr	tr	NOUN
aiua-5030	45	4	biopsy	biopsy	NOUN
aiua-5030	45	5	,	,	PUNCT
aiua-5030	45	6	a	a	DET
aiua-5030	45	7	bilateral	bilateral	ADJ
aiua-5030	45	8	periprostatic	periprostatic	ADJ
aiua-5030	45	9	nerve	nerve	NOUN
aiua-5030	45	10	block	block	NOUN
aiua-5030	45	11	was	be	AUX
aiua-5030	45	12	obtained	obtain	VERB
aiua-5030	45	13	using	use	VERB
aiua-5030	45	14	a	a	DET
aiua-5030	45	15	1	1	NUM
aiua-5030	45	16	%	%	NOUN
aiua-5030	45	17	lidocaine	lidocaine	NOUN
aiua-5030	45	18	solution	solution	NOUN
aiua-5030	45	19	,	,	PUNCT
aiua-5030	45	20	transrectally	transrectally	PROPN
aiua-5030	45	21	injected	inject	VERB
aiua-5030	45	22	under	under	ADP
aiua-5030	45	23	ultrasound	ultrasound	NOUN
aiua-5030	45	24	guidance	guidance	NOUN
aiua-5030	45	25	at	at	ADP
aiua-5030	45	26	the	the	DET
aiua-5030	45	27	prostate	prostate	NOUN
aiua-5030	45	28	apex	apex	NOUN
aiua-5030	45	29	and	and	CCONJ
aiua-5030	45	30	the	the	DET
aiua-5030	45	31	seminal	seminal	ADJ
aiua-5030	45	32	vesicle	vesicle	NOUN
aiua-5030	45	33	-	-	PUNCT
aiua-5030	45	34	prostatic	prostatic	ADJ
aiua-5030	45	35	angles	angle	NOUN
aiua-5030	45	36	.	.	PUNCT
aiua-5030	46	1	eight	eight	NUM
aiua-5030	46	2	cores	core	NOUN
aiua-5030	46	3	were	be	AUX
aiua-5030	46	4	added	add	VERB
aiua-5030	46	5	to	to	ADP
aiua-5030	46	6	the	the	DET
aiua-5030	46	7	standard	standard	NOUN
aiua-5030	46	8	tr	tr	NOUN
aiua-5030	46	9	protocol	protocol	NOUN
aiua-5030	46	10	described	describe	VERB
aiua-5030	46	11	by	by	ADP
aiua-5030	46	12	hodge	hodge	PROPN
aiua-5030	46	13	et	et	PROPN
aiua-5030	46	14	al	al	PROPN
aiua-5030	46	15	(	(	PUNCT
aiua-5030	46	16	7	7	NUM
aiua-5030	46	17	):	):	PUNCT
aiua-5030	46	18	six	six	NUM
aiua-5030	46	19	,	,	PUNCT
aiua-5030	46	20	far	far	ADV
aiua-5030	46	21	laterally	laterally	ADV
aiua-5030	46	22	in	in	ADP
aiua-5030	46	23	the	the	DET
aiua-5030	46	24	peripheral	peripheral	ADJ
aiua-5030	46	25	zone	zone	NOUN
aiua-5030	46	26	(	(	PUNCT
aiua-5030	46	27	pz	pz	NOUN
aiua-5030	46	28	)	)	PUNCT
aiua-5030	46	29	,	,	PUNCT
aiua-5030	46	30	and	and	CCONJ
aiua-5030	46	31	two	two	NUM
aiua-5030	46	32	in	in	ADP
aiua-5030	46	33	the	the	DET
aiua-5030	46	34	middle	middle	PROPN
aiua-5030	46	35	tz	tz	PROPN
aiua-5030	46	36	.	.	PUNCT
aiua-5030	47	1	tp	tp	PROPN
aiua-5030	47	2	and	and	CCONJ
aiua-5030	47	3	tr	tr	VERB
aiua-5030	47	4	approaches	approach	NOUN
aiua-5030	47	5	were	be	AUX
aiua-5030	47	6	both	both	PRON
aiua-5030	47	7	performed	perform	VERB
aiua-5030	47	8	under	under	ADP
aiua-5030	47	9	trus	trus	PROPN
aiua-5030	47	10	guidance	guidance	NOUN
aiua-5030	47	11	(	(	PUNCT
aiua-5030	47	12	siemens	siemens	PROPN
aiua-5030	47	13	sonoline	sonoline	NOUN
aiua-5030	47	14	omnia	omnia	PROPN
aiua-5030	47	15	diagnostic	diagnostic	ADJ
aiua-5030	47	16	ultrasound	ultrasound	NOUN
aiua-5030	47	17	system	system	NOUN
aiua-5030	47	18	with	with	ADP
aiua-5030	47	19	a	a	DET
aiua-5030	47	20	7.75	7.75	NUM
aiua-5030	47	21	-	-	PUNCT
aiua-5030	47	22	mhz	mhz	NOUN
aiua-5030	47	23	linear	linear	NOUN
aiua-5030	47	24	probe	probe	NOUN
aiua-5030	47	25	was	be	AUX
aiua-5030	47	26	used	use	VERB
aiua-5030	47	27	)	)	PUNCT
aiua-5030	47	28	.	.	PUNCT
aiua-5030	48	1	with	with	ADP
aiua-5030	48	2	both	both	DET
aiua-5030	48	3	approaches	approach	NOUN
aiua-5030	48	4	,	,	PUNCT
aiua-5030	48	5	an	an	DET
aiua-5030	48	6	18	18	NUM
aiua-5030	48	7	-	-	PUNCT
aiua-5030	48	8	gauge	gauge	NOUN
aiua-5030	48	9	tru	tru	NOUN
aiua-5030	48	10	-	-	PUNCT
aiua-5030	48	11	cut	cut	NOUN
aiua-5030	48	12	needle	needle	NOUN
aiua-5030	48	13	with	with	ADP
aiua-5030	48	14	a	a	DET
aiua-5030	48	15	cutting	cut	VERB
aiua-5030	48	16	length	length	NOUN
aiua-5030	48	17	of	of	ADP
aiua-5030	48	18	23	23	NUM
aiua-5030	48	19	mm	mm	NOUN
aiua-5030	48	20	was	be	AUX
aiua-5030	48	21	applied	apply	VERB
aiua-5030	48	22	to	to	PART
aiua-5030	48	23	obtain	obtain	VERB
aiua-5030	48	24	specimens	specimen	NOUN
aiua-5030	48	25	.	.	PUNCT
aiua-5030	49	1	overall	overall	ADJ
aiua-5030	49	2	14	14	NUM
aiua-5030	49	3	-	-	PUNCT
aiua-5030	49	4	core	core	NOUN
aiua-5030	49	5	trus	trus	NOUN
aiua-5030	49	6	guided	guide	VERB
aiua-5030	49	7	prostate	prostate	NOUN
aiua-5030	49	8	biopsies	biopsy	NOUN
aiua-5030	49	9	have	have	AUX
aiua-5030	49	10	been	be	AUX
aiua-5030	49	11	obtained	obtain	VERB
aiua-5030	49	12	:	:	PUNCT
aiua-5030	49	13	12	12	NUM
aiua-5030	49	14	specimens	specimen	NOUN
aiua-5030	49	15	from	from	ADP
aiua-5030	49	16	pz	pz	PROPN
aiua-5030	49	17	and	and	CCONJ
aiua-5030	49	18	two	two	NUM
aiua-5030	49	19	from	from	ADP
aiua-5030	49	20	tz	tz	NOUN
aiua-5030	49	21	for	for	ADP
aiua-5030	49	22	each	each	DET
aiua-5030	49	23	approach	approach	NOUN
aiua-5030	49	24	.	.	PUNCT
aiua-5030	50	1	cores	core	NOUN
aiua-5030	50	2	of	of	ADP
aiua-5030	50	3	the	the	DET
aiua-5030	50	4	standard	standard	ADJ
aiua-5030	50	5	sextant	sextant	NOUN
aiua-5030	50	6	were	be	AUX
aiua-5030	50	7	conventionally	conventionally	ADV
aiua-5030	50	8	labelled	label	VERB
aiua-5030	50	9	from	from	ADP
aiua-5030	50	10	1	1	NUM
aiua-5030	50	11	to	to	ADP
aiua-5030	50	12	6	6	NUM
aiua-5030	50	13	.	.	PUNCT
aiua-5030	51	1	likewise	likewise	ADV
aiua-5030	51	2	,	,	PUNCT
aiua-5030	51	3	additional	additional	ADJ
aiua-5030	51	4	peripheral	peripheral	ADJ
aiua-5030	51	5	cores	core	NOUN
aiua-5030	51	6	from	from	ADP
aiua-5030	51	7	the	the	DET
aiua-5030	51	8	lateral	lateral	ADJ
aiua-5030	51	9	part	part	NOUN
aiua-5030	51	10	of	of	ADP
aiua-5030	51	11	prostatic	prostatic	ADJ
aiua-5030	51	12	apex	apex	NOUN
aiua-5030	51	13	,	,	PUNCT
aiua-5030	51	14	were	be	AUX
aiua-5030	51	15	numbered	number	VERB
aiua-5030	51	16	as	as	ADP
aiua-5030	51	17	“	"	PUNCT
aiua-5030	51	18	7	7	NUM
aiua-5030	51	19	”	"	PUNCT
aiua-5030	51	20	and	and	CCONJ
aiua-5030	51	21	“	"	PUNCT
aiua-5030	51	22	8	8	NUM
aiua-5030	51	23	”	"	PUNCT
aiua-5030	51	24	.	.	PUNCT
aiua-5030	52	1	additional	additional	ADJ
aiua-5030	52	2	lateral	lateral	ADJ
aiua-5030	52	3	peripheral	peripheral	ADJ
aiua-5030	52	4	cores	core	NOUN
aiua-5030	52	5	,	,	PUNCT
aiua-5030	52	6	from	from	ADP
aiua-5030	52	7	the	the	DET
aiua-5030	52	8	mid	mid	ADJ
aiua-5030	52	9	prostate	prostate	NOUN
aiua-5030	52	10	,	,	PUNCT
aiua-5030	52	11	were	be	AUX
aiua-5030	52	12	numbered	number	VERB
aiua-5030	52	13	as	as	ADP
aiua-5030	52	14	“	"	PUNCT
aiua-5030	52	15	9	9	NUM
aiua-5030	52	16	”	"	PUNCT
aiua-5030	52	17	and	and	CCONJ
aiua-5030	52	18	“	"	PUNCT
aiua-5030	52	19	10	10	NUM
aiua-5030	52	20	”	"	PUNCT
aiua-5030	52	21	.	.	PUNCT
aiua-5030	53	1	other	other	ADJ
aiua-5030	53	2	cores	core	NOUN
aiua-5030	53	3	,	,	PUNCT
aiua-5030	53	4	from	from	ADP
aiua-5030	53	5	the	the	DET
aiua-5030	53	6	anterior	anterior	ADJ
aiua-5030	53	7	horn	horn	NOUN
aiua-5030	53	8	,	,	PUNCT
aiua-5030	53	9	were	be	AUX
aiua-5030	53	10	numbered	number	VERB
aiua-5030	53	11	as	as	ADP
aiua-5030	53	12	“	"	PUNCT
aiua-5030	53	13	11	11	NUM
aiua-5030	53	14	”	"	PUNCT
aiua-5030	53	15	and	and	CCONJ
aiua-5030	53	16	“	"	PUNCT
aiua-5030	53	17	12	12	NUM
aiua-5030	53	18	”	"	PUNCT
aiua-5030	53	19	.	.	PUNCT
aiua-5030	54	1	finally	finally	ADV
aiua-5030	54	2	,	,	PUNCT
aiua-5030	54	3	biopsies	biopsy	NOUN
aiua-5030	54	4	taken	take	VERB
aiua-5030	54	5	from	from	ADP
aiua-5030	54	6	the	the	DET
aiua-5030	54	7	tz	tz	NOUN
aiua-5030	54	8	were	be	AUX
aiua-5030	54	9	labelled	label	VERB
aiua-5030	54	10	as	as	ADP
aiua-5030	54	11	“	"	PUNCT
aiua-5030	54	12	13	13	NUM
aiua-5030	54	13	”	"	PUNCT
aiua-5030	54	14	and	and	CCONJ
aiua-5030	54	15	“	"	PUNCT
aiua-5030	54	16	14	14	NUM
aiua-5030	54	17	”	"	PUNCT
aiua-5030	54	18	.	.	PUNCT
aiua-5030	55	1	in	in	ADP
aiua-5030	55	2	all	all	DET
aiua-5030	55	3	cases	case	NOUN
aiua-5030	55	4	,	,	PUNCT
aiua-5030	55	5	pain	pain	NOUN
aiua-5030	55	6	level	level	NOUN
aiua-5030	55	7	during	during	ADP
aiua-5030	55	8	the	the	DET
aiua-5030	55	9	bioptic	bioptic	ADJ
aiua-5030	55	10	procedure	procedure	NOUN
aiua-5030	55	11	,	,	PUNCT
aiua-5030	55	12	was	be	AUX
aiua-5030	55	13	evaluated	evaluate	VERB
aiua-5030	55	14	by	by	ADP
aiua-5030	55	15	means	mean	NOUN
aiua-5030	55	16	of	of	ADP
aiua-5030	55	17	a	a	DET
aiua-5030	55	18	visual	visual	ADJ
aiua-5030	55	19	analogue	analogue	NOUN
aiua-5030	55	20	scale	scale	NOUN
aiua-5030	55	21	/	/	SYM
aiua-5030	55	22	numeric	numeric	ADJ
aiua-5030	55	23	analogue	analogue	NOUN
aiua-5030	55	24	scale	scale	NOUN
aiua-5030	55	25	in	in	ADP
aiua-5030	55	26	which	which	PRON
aiua-5030	55	27	0	0	NUM
aiua-5030	55	28	corresponded	correspond	VERB
aiua-5030	55	29	to	to	ADP
aiua-5030	55	30	“	"	PUNCT
aiua-5030	55	31	no	no	DET
aiua-5030	55	32	pain	pain	NOUN
aiua-5030	55	33	”	"	PUNCT
aiua-5030	55	34	and	and	CCONJ
aiua-5030	55	35	10	10	NUM
aiua-5030	55	36	to	to	ADP
aiua-5030	55	37	“	"	PUNCT
aiua-5030	55	38	the	the	DET
aiua-5030	55	39	worst	bad	ADJ
aiua-5030	55	40	,	,	PUNCT
aiua-5030	55	41	imaginable	imaginable	ADJ
aiua-5030	55	42	pain	pain	NOUN
aiua-5030	55	43	”	"	PUNCT
aiua-5030	55	44	(	(	PUNCT
aiua-5030	55	45	5	5	NUM
aiua-5030	55	46	,	,	PUNCT
aiua-5030	55	47	6	6	NUM
aiua-5030	55	48	)	)	PUNCT
aiua-5030	55	49	.	.	PUNCT
aiua-5030	56	1	all	all	DET
aiua-5030	56	2	patients	patient	NOUN
aiua-5030	56	3	were	be	AUX
aiua-5030	56	4	clinically	clinically	ADV
aiua-5030	56	5	evaluated	evaluate	VERB
aiua-5030	56	6	30	30	NUM
aiua-5030	56	7	days	day	NOUN
aiua-5030	56	8	after	after	SCONJ
aiua-5030	56	9	the	the	DET
aiua-5030	56	10	biopsy	biopsy	NOUN
aiua-5030	56	11	to	to	PART
aiua-5030	56	12	record	record	VERB
aiua-5030	56	13	eventual	eventual	ADJ
aiua-5030	56	14	complications	complication	NOUN
aiua-5030	56	15	related	relate	VERB
aiua-5030	56	16	to	to	ADP
aiua-5030	56	17	procedures	procedure	NOUN
aiua-5030	56	18	(	(	PUNCT
aiua-5030	56	19	5	5	NUM
aiua-5030	56	20	)	)	PUNCT
aiua-5030	56	21	.	.	PUNCT
aiua-5030	57	1	we	we	PRON
aiua-5030	57	2	determined	determine	VERB
aiua-5030	57	3	the	the	DET
aiua-5030	57	4	cap	cap	NOUN
aiua-5030	57	5	detection	detection	NOUN
aiua-5030	57	6	rate	rate	NOUN
aiua-5030	57	7	,	,	PUNCT
aiua-5030	57	8	the	the	DET
aiua-5030	57	9	cancer	cancer	NOUN
aiua-5030	57	10	core	core	NOUN
aiua-5030	57	11	rate	rate	NOUN
aiua-5030	57	12	(	(	PUNCT
aiua-5030	57	13	ratio	ratio	NOUN
aiua-5030	57	14	of	of	ADP
aiua-5030	57	15	the	the	DET
aiua-5030	57	16	number	number	NOUN
aiua-5030	57	17	of	of	ADP
aiua-5030	57	18	cancer	cancer	NOUN
aiua-5030	57	19	-	-	PUNCT
aiua-5030	57	20	positive	positive	ADJ
aiua-5030	57	21	cores	core	NOUN
aiua-5030	57	22	to	to	ADP
aiua-5030	57	23	the	the	DET
aiua-5030	57	24	total	total	ADJ
aiua-5030	57	25	number	number	NOUN
aiua-5030	57	26	of	of	ADP
aiua-5030	57	27	biopsy	biopsy	NOUN
aiua-5030	57	28	specimens	specimen	NOUN
aiua-5030	57	29	)	)	PUNCT
aiua-5030	57	30	and	and	CCONJ
aiua-5030	57	31	any	any	DET
aiua-5030	57	32	complications	complication	NOUN
aiua-5030	57	33	occurred	occur	VERB
aiua-5030	57	34	in	in	ADP
aiua-5030	57	35	order	order	NOUN
aiua-5030	57	36	to	to	PART
aiua-5030	57	37	define	define	VERB
aiua-5030	57	38	efficacy	efficacy	NOUN
aiua-5030	57	39	and	and	CCONJ
aiua-5030	57	40	tolerability	tolerability	NOUN
aiua-5030	57	41	of	of	ADP
aiua-5030	57	42	the	the	DET
aiua-5030	57	43	tp	tp	NOUN
aiua-5030	57	44	biopsy	biopsy	NOUN
aiua-5030	57	45	compared	compare	VERB
aiua-5030	57	46	with	with	ADP
aiua-5030	57	47	the	the	DET
aiua-5030	57	48	tr	tr	SYM
aiua-5030	57	49	one	one	NUM
aiua-5030	57	50	.	.	PUNCT
aiua-5030	58	1	for	for	ADP
aiua-5030	58	2	statistical	statistical	ADJ
aiua-5030	58	3	analysis	analysis	NOUN
aiua-5030	58	4	,	,	PUNCT
aiua-5030	58	5	chi	chi	NOUN
aiua-5030	58	6	-	-	PUNCT
aiua-5030	58	7	square	square	NOUN
aiua-5030	58	8	and	and	CCONJ
aiua-5030	58	9	the	the	DET
aiua-5030	58	10	mannwhitney	mannwhitney	ADJ
aiua-5030	58	11	u	u	NOUN
aiua-5030	58	12	tests	test	NOUN
aiua-5030	58	13	were	be	AUX
aiua-5030	58	14	used	use	VERB
aiua-5030	58	15	and	and	CCONJ
aiua-5030	58	16	a	a	DET
aiua-5030	58	17	p	p	X
aiua-5030	58	18	<	<	X
aiua-5030	58	19	0.05	0.05	NUM
aiua-5030	58	20	was	be	AUX
aiua-5030	58	21	considered	consider	VERB
aiua-5030	58	22	significant	significant	ADJ
aiua-5030	58	23	.	.	PUNCT
aiua-5030	59	1	results	result	VERB
aiua-5030	59	2	patients	patient	NOUN
aiua-5030	59	3	’	'	PUNCT
aiua-5030	59	4	characteristics	characteristic	NOUN
aiua-5030	59	5	are	be	AUX
aiua-5030	59	6	listed	list	VERB
aiua-5030	59	7	in	in	ADP
aiua-5030	59	8	table	table	NOUN
aiua-5030	59	9	1	1	NUM
aiua-5030	59	10	.	.	PUNCT
aiua-5030	60	1	the	the	DET
aiua-5030	60	2	cancer	cancer	NOUN
aiua-5030	60	3	detection	detection	NOUN
aiua-5030	60	4	rates	rate	NOUN
aiua-5030	60	5	were	be	AUX
aiua-5030	60	6	46.29	46.29	NUM
aiua-5030	60	7	(	(	PUNCT
aiua-5030	60	8	25	25	NUM
aiua-5030	60	9	out	out	ADP
aiua-5030	60	10	of	of	ADP
aiua-5030	60	11	54	54	NUM
aiua-5030	60	12	patients	patient	NOUN
aiua-5030	60	13	)	)	PUNCT
aiua-5030	60	14	,	,	PUNCT
aiua-5030	60	15	and	and	CCONJ
aiua-5030	60	16	44.44	44.44	NUM
aiua-5030	60	17	%	%	NOUN
aiua-5030	60	18	(	(	PUNCT
aiua-5030	60	19	24	24	NUM
aiua-5030	60	20	out	out	ADP
aiua-5030	60	21	of	of	ADP
aiua-5030	60	22	54	54	NUM
aiua-5030	60	23	patients	patient	NOUN
aiua-5030	60	24	)	)	PUNCT
aiua-5030	60	25	,	,	PUNCT
aiua-5030	60	26	respectively	respectively	ADV
aiua-5030	60	27	,	,	PUNCT
aiua-5030	60	28	using	use	VERB
aiua-5030	60	29	the	the	DET
aiua-5030	60	30	tr	tr	NOUN
aiua-5030	60	31	or	or	CCONJ
aiua-5030	60	32	the	the	DET
aiua-5030	60	33	tp	tp	NOUN
aiua-5030	60	34	approach	approach	NOUN
aiua-5030	60	35	(	(	PUNCT
aiua-5030	60	36	p	p	X
aiua-5030	60	37	=	=	NOUN
aiua-5030	60	38	0.846	0.846	NUM
aiua-5030	60	39	)	)	PUNCT
aiua-5030	60	40	.	.	PUNCT
aiua-5030	61	1	among	among	ADP
aiua-5030	61	2	patients	patient	NOUN
aiua-5030	61	3	with	with	ADP
aiua-5030	61	4	psa	psa	NOUN
aiua-5030	61	5	levels	level	NOUN
aiua-5030	61	6	of	of	ADP
aiua-5030	61	7	less	less	ADJ
aiua-5030	61	8	than	than	ADP
aiua-5030	61	9	10.0	10.0	NUM
aiua-5030	61	10	ng	ng	NOUN
aiua-5030	61	11	/	/	SYM
aiua-5030	61	12	ml	ml	PROPN
aiua-5030	61	13	,	,	PUNCT
aiua-5030	61	14	the	the	DET
aiua-5030	61	15	detection	detection	NOUN
aiua-5030	61	16	rate	rate	NOUN
aiua-5030	61	17	was	be	AUX
aiua-5030	61	18	42.22	42.22	NUM
aiua-5030	61	19	characteristics	characteristic	NOUN
aiua-5030	61	20	tp	tp	AUX
aiua-5030	61	21	approach	approach	NOUN
aiua-5030	61	22	tr	tr	PUNCT
aiua-5030	61	23	approach	approach	NOUN
aiua-5030	61	24	p	p	NOUN
aiua-5030	61	25	value	value	NOUN
aiua-5030	61	26	patients	patient	NOUN
aiua-5030	61	27	(	(	PUNCT
aiua-5030	61	28	n	n	CCONJ
aiua-5030	61	29	)	)	PUNCT
aiua-5030	61	30	54	54	NUM
aiua-5030	61	31	54	54	NUM
aiua-5030	61	32	ns	ns	NUM
aiua-5030	61	33	mean	mean	NOUN
aiua-5030	61	34	age	age	NOUN
aiua-5030	61	35	(	(	PUNCT
aiua-5030	61	36	year	year	NOUN
aiua-5030	61	37	)	)	PUNCT
aiua-5030	61	38	(	(	PUNCT
aiua-5030	61	39	sd	sd	NOUN
aiua-5030	61	40	)	)	PUNCT
aiua-5030	61	41	66.50	66.50	NUM
aiua-5030	61	42	±	±	NUM
aiua-5030	61	43	8.87	8.87	NUM
aiua-5030	61	44	67.30	67.30	NUM
aiua-5030	61	45	±	±	NUM
aiua-5030	61	46	8.05	8.05	NUM
aiua-5030	61	47	0.627	0.627	NUM
aiua-5030	61	48	mean	mean	VERB
aiua-5030	62	1	psa	psa	NOUN
aiua-5030	62	2	(	(	PUNCT
aiua-5030	62	3	ng	ng	PROPN
aiua-5030	62	4	/	/	SYM
aiua-5030	62	5	ml	ml	NOUN
aiua-5030	62	6	)	)	PUNCT
aiua-5030	62	7	(	(	PUNCT
aiua-5030	62	8	sd	sd	NOUN
aiua-5030	62	9	)	)	PUNCT
aiua-5030	62	10	15.95	15.95	NUM
aiua-5030	62	11	±	±	NUM
aiua-5030	62	12	41.04	41.04	NUM
aiua-5030	62	13	12.36	12.36	NUM
aiua-5030	62	14	±	±	NUM
aiua-5030	62	15	39.65	39.65	NUM
aiua-5030	62	16	0.646	0.646	NUM
aiua-5030	62	17	bmi	bmi	NOUN
aiua-5030	62	18	(	(	PUNCT
aiua-5030	62	19	kg	kg	NOUN
aiua-5030	62	20	/	/	SYM
aiua-5030	62	21	cm2	cm2	NOUN
aiua-5030	62	22	)	)	PUNCT
aiua-5030	62	23	(	(	PUNCT
aiua-5030	62	24	sd	sd	NOUN
aiua-5030	62	25	)	)	PUNCT
aiua-5030	62	26	27.16	27.16	NUM
aiua-5030	62	27	±	±	NUM
aiua-5030	62	28	3.18	3.18	NUM
aiua-5030	62	29	27.00	27.00	NUM
aiua-5030	62	30	±	±	NUM
aiua-5030	62	31	3.12	3.12	NUM
aiua-5030	62	32	0.794	0.794	NUM
aiua-5030	62	33	mean	mean	NOUN
aiua-5030	62	34	prostate	prostate	NOUN
aiua-5030	62	35	volume	volume	NOUN
aiua-5030	62	36	56.29	56.29	NUM
aiua-5030	62	37	±	±	NUM
aiua-5030	62	38	31.33	31.33	NUM
aiua-5030	62	39	61.49	61.49	NUM
aiua-5030	62	40	±	±	NUM
aiua-5030	62	41	33.39	33.39	NUM
aiua-5030	62	42	0.408	0.408	NUM
aiua-5030	62	43	(	(	PUNCT
aiua-5030	62	44	cm3	cm3	NOUN
aiua-5030	62	45	)	)	PUNCT
aiua-5030	62	46	(	(	PUNCT
aiua-5030	62	47	sd	sd	NOUN
aiua-5030	62	48	)	)	PUNCT
aiua-5030	62	49	abnormal	abnormal	ADJ
aiua-5030	62	50	dre	dre	PROPN
aiua-5030	62	51	11/54	11/54	NUM
aiua-5030	62	52	(	(	PUNCT
aiua-5030	62	53	20.37	20.37	NUM
aiua-5030	62	54	)	)	PUNCT
aiua-5030	62	55	10/54	10/54	NUM
aiua-5030	62	56	(	(	PUNCT
aiua-5030	62	57	18.52	18.52	NUM
aiua-5030	62	58	%	%	NOUN
aiua-5030	62	59	)	)	PUNCT
aiua-5030	62	60	0.810	0.810	NUM
aiua-5030	62	61	sd	sd	X
aiua-5030	62	62	=	=	SYM
aiua-5030	62	63	standard	standard	ADJ
aiua-5030	62	64	deviation	deviation	NOUN
aiua-5030	62	65	;	;	PUNCT
aiua-5030	62	66	ns	ns	NUM
aiua-5030	62	67	=	=	NOUN
aiua-5030	62	68	not	not	PART
aiua-5030	62	69	significant	significant	ADJ
aiua-5030	62	70	.	.	PUNCT
aiua-5030	63	1	table	table	NOUN
aiua-5030	63	2	1	1	NUM
aiua-5030	63	3	.	.	PUNCT
aiua-5030	64	1	patients	patient	NOUN
aiua-5030	64	2	’	'	PUNCT
aiua-5030	64	3	characteristics	characteristic	NOUN
aiua-5030	64	4	.	.	PUNCT
aiua-5030	65	1	variables	variable	NOUN
aiua-5030	65	2	tp	tp	AUX
aiua-5030	65	3	approach	approach	VERB
aiua-5030	65	4	(	(	PUNCT
aiua-5030	65	5	%	%	INTJ
aiua-5030	65	6	)	)	PUNCT
aiua-5030	65	7	tr	tr	NOUN
aiua-5030	65	8	approach	approach	NOUN
aiua-5030	65	9	(	(	PUNCT
aiua-5030	65	10	%	%	INTJ
aiua-5030	65	11	)	)	PUNCT
aiua-5030	65	12	p	p	NOUN
aiua-5030	65	13	value	value	NOUN
aiua-5030	65	14	overall	overall	ADJ
aiua-5030	65	15	24/54	24/54	NUM
aiua-5030	65	16	(	(	PUNCT
aiua-5030	65	17	44.44	44.44	NUM
aiua-5030	65	18	)	)	PUNCT
aiua-5030	65	19	25/54	25/54	NUM
aiua-5030	65	20	(	(	PUNCT
aiua-5030	65	21	46.29	46.29	NUM
aiua-5030	65	22	)	)	PUNCT
aiua-5030	65	23	0.846	0.846	NUM
aiua-5030	65	24	(	(	PUNCT
aiua-5030	65	25	ns	ns	NUM
aiua-5030	65	26	)	)	PUNCT
aiua-5030	65	27	psa	psa	NOUN
aiua-5030	65	28	(	(	PUNCT
aiua-5030	65	29	ng(ml	ng(ml	NOUN
aiua-5030	65	30	)	)	PUNCT
aiua-5030	65	31	0.303	0.303	NUM
aiua-5030	65	32	(	(	PUNCT
aiua-5030	65	33	ns	ns	NUM
aiua-5030	65	34	)	)	PUNCT
aiua-5030	65	35	≤	≤	NUM
aiua-5030	65	36	10	10	NUM
aiua-5030	65	37	15/39	15/39	NUM
aiua-5030	65	38	(	(	PUNCT
aiua-5030	65	39	38.46	38.46	NUM
aiua-5030	65	40	)	)	PUNCT
aiua-5030	65	41	19/45	19/45	NUM
aiua-5030	65	42	(	(	PUNCT
aiua-5030	65	43	42.22	42.22	NUM
aiua-5030	65	44	)	)	PUNCT
aiua-5030	65	45	>	>	X
aiua-5030	66	1	10.1	10.1	NUM
aiua-5030	66	2	9/15	9/15	NUM
aiua-5030	66	3	(	(	PUNCT
aiua-5030	66	4	60.00	60.00	NUM
aiua-5030	66	5	)	)	PUNCT
aiua-5030	66	6	6/9	6/9	NUM
aiua-5030	66	7	(	(	PUNCT
aiua-5030	66	8	66.67	66.67	NUM
aiua-5030	66	9	)	)	PUNCT
aiua-5030	66	10	prostate	prostate	NOUN
aiua-5030	66	11	volume	volume	NOUN
aiua-5030	66	12	(	(	PUNCT
aiua-5030	66	13	cm3	cm3	NOUN
aiua-5030	66	14	)	)	PUNCT
aiua-5030	66	15	0.283	0.283	NUM
aiua-5030	66	16	(	(	PUNCT
aiua-5030	66	17	ns	ns	NUM
aiua-5030	66	18	)	)	PUNCT
aiua-5030	66	19	<	<	X
aiua-5030	66	20	30	30	NUM
aiua-5030	66	21	8/9	8/9	NUM
aiua-5030	66	22	(	(	PUNCT
aiua-5030	66	23	88.89	88.89	NUM
aiua-5030	66	24	)	)	PUNCT
aiua-5030	66	25	8/10	8/10	NUM
aiua-5030	66	26	(	(	PUNCT
aiua-5030	66	27	80	80	NUM
aiua-5030	66	28	)	)	PUNCT
aiua-5030	66	29	30	30	NUM
aiua-5030	66	30	-	-	SYM
aiua-5030	66	31	50	50	NUM
aiua-5030	66	32	11/20	11/20	NUM
aiua-5030	66	33	(	(	PUNCT
aiua-5030	66	34	55.00	55.00	NUM
aiua-5030	66	35	)	)	PUNCT
aiua-5030	66	36	7/13	7/13	NUM
aiua-5030	66	37	(	(	PUNCT
aiua-5030	66	38	53.85	53.85	NUM
aiua-5030	66	39	)	)	PUNCT
aiua-5030	66	40	>	>	X
aiua-5030	66	41	50	50	NUM
aiua-5030	66	42	5/25	5/25	NUM
aiua-5030	66	43	(	(	PUNCT
aiua-5030	66	44	20.00	20.00	NUM
aiua-5030	66	45	)	)	PUNCT
aiua-5030	66	46	10/30	10/30	NUM
aiua-5030	66	47	(	(	PUNCT
aiua-5030	66	48	33.33	33.33	NUM
aiua-5030	66	49	)	)	PUNCT
aiua-5030	66	50	ns	ns	NOUN
aiua-5030	66	51	=	=	NOUN
aiua-5030	66	52	not	not	PART
aiua-5030	66	53	significant	significant	ADJ
aiua-5030	66	54	.	.	PUNCT
aiua-5030	66	55	table	table	NOUN
aiua-5030	67	1	2	2	NUM
aiua-5030	67	2	.	.	PUNCT
aiua-5030	67	3	comparison	comparison	NOUN
aiua-5030	67	4	of	of	ADP
aiua-5030	67	5	cancer	cancer	NOUN
aiua-5030	67	6	detection	detection	NOUN
aiua-5030	67	7	rate	rate	NOUN
aiua-5030	67	8	according	accord	VERB
aiua-5030	67	9	to	to	ADP
aiua-5030	67	10	psa	psa	VERB
aiua-5030	67	11	level	level	NOUN
aiua-5030	67	12	and	and	CCONJ
aiua-5030	67	13	prostate	prostate	NOUN
aiua-5030	67	14	volume	volume	NOUN
aiua-5030	67	15	(	(	PUNCT
aiua-5030	67	16	determined	determine	VERB
aiua-5030	67	17	by	by	ADP
aiua-5030	67	18	trus	trus	NOUN
aiua-5030	67	19	)	)	PUNCT
aiua-5030	67	20	,	,	PUNCT
aiua-5030	67	21	between	between	ADP
aiua-5030	67	22	tp	tp	PRON
aiua-5030	67	23	and	and	CCONJ
aiua-5030	67	24	tr	tr	NOUN
aiua-5030	67	25	approach	approach	NOUN
aiua-5030	67	26	.	.	PUNCT
aiua-5030	68	1	cerruto_stesura	cerruto_stesura	NOUN
aiua-5030	68	2	seveso	seveso	VERB
aiua-5030	68	3	15/01/15	15/01/15	PROPN
aiua-5030	68	4	13:18	13:18	NUM
aiua-5030	68	5	pagina	pagina	NOUN
aiua-5030	68	6	285	285	NUM
aiua-5030	68	7	archivio	archivio	NOUN
aiua-5030	68	8	italiano	italiano	NOUN
aiua-5030	68	9	di	di	X
aiua-5030	68	10	urologia	urologia	PROPN
aiua-5030	68	11	e	e	PROPN
aiua-5030	68	12	andrologia	andrologia	NOUN
aiua-5030	68	13	2014	2014	NUM
aiua-5030	68	14	;	;	PUNCT
aiua-5030	68	15	86	86	NUM
aiua-5030	68	16	,	,	PUNCT
aiua-5030	68	17	4	4	NUM
aiua-5030	68	18	m.a	m.a	PROPN
aiua-5030	68	19	.	.	PROPN
aiua-5030	68	20	cerruto	cerruto	PROPN
aiua-5030	68	21	,	,	PUNCT
aiua-5030	68	22	f.	f.	PROPN
aiua-5030	68	23	vianello	vianello	PROPN
aiua-5030	68	24	,	,	PUNCT
aiua-5030	68	25	c.	c.	PROPN
aiua-5030	68	26	d’elia	d’elia	PROPN
aiua-5030	68	27	,	,	PUNCT
aiua-5030	68	28	w.	w.	PROPN
aiua-5030	68	29	artibani	artibani	PROPN
aiua-5030	68	30	,	,	PUNCT
aiua-5030	68	31	gi	gi	PROPN
aiua-5030	68	32	.	.	PUNCT
aiua-5030	68	33	novella	novella	PROPN
aiua-5030	68	34	286	286	NUM
aiua-5030	68	35	(	(	PUNCT
aiua-5030	68	36	19	19	NUM
aiua-5030	68	37	out	out	ADP
aiua-5030	68	38	of	of	ADP
aiua-5030	68	39	45	45	NUM
aiua-5030	68	40	)	)	PUNCT
aiua-5030	68	41	and	and	CCONJ
aiua-5030	68	42	38.46	38.46	NUM
aiua-5030	68	43	%	%	NOUN
aiua-5030	68	44	(	(	PUNCT
aiua-5030	68	45	15	15	NUM
aiua-5030	68	46	out	out	ADP
aiua-5030	68	47	of	of	ADP
aiua-5030	68	48	39	39	NUM
aiua-5030	68	49	)	)	PUNCT
aiua-5030	68	50	when	when	SCONJ
aiua-5030	68	51	the	the	DET
aiua-5030	68	52	tr	tr	NOUN
aiua-5030	68	53	or	or	CCONJ
aiua-5030	68	54	the	the	DET
aiua-5030	68	55	tp	tp	NOUN
aiua-5030	68	56	approach	approach	NOUN
aiua-5030	68	57	was	be	AUX
aiua-5030	68	58	applied	apply	VERB
aiua-5030	68	59	,	,	PUNCT
aiua-5030	68	60	respectively	respectively	ADV
aiua-5030	68	61	(	(	PUNCT
aiua-5030	68	62	p	p	X
aiua-5030	68	63	=	=	NOUN
aiua-5030	68	64	0.728	0.728	NUM
aiua-5030	68	65	)	)	PUNCT
aiua-5030	68	66	.	.	PUNCT
aiua-5030	69	1	stratifying	stratify	VERB
aiua-5030	69	2	patients	patient	NOUN
aiua-5030	69	3	for	for	ADP
aiua-5030	69	4	either	either	CCONJ
aiua-5030	69	5	psa	psa	NOUN
aiua-5030	69	6	level	level	NOUN
aiua-5030	69	7	or	or	CCONJ
aiua-5030	69	8	pv	pv	INTJ
aiua-5030	69	9	,	,	PUNCT
aiua-5030	69	10	no	no	DET
aiua-5030	69	11	significant	significant	ADJ
aiua-5030	69	12	differences	difference	NOUN
aiua-5030	69	13	were	be	AUX
aiua-5030	69	14	found	find	VERB
aiua-5030	69	15	in	in	ADP
aiua-5030	69	16	the	the	DET
aiua-5030	69	17	two	two	NUM
aiua-5030	69	18	groups	group	NOUN
aiua-5030	69	19	(	(	PUNCT
aiua-5030	69	20	table	table	NOUN
aiua-5030	69	21	2	2	NUM
aiua-5030	69	22	)	)	PUNCT
aiua-5030	69	23	.	.	PUNCT
aiua-5030	70	1	the	the	DET
aiua-5030	70	2	overall	overall	ADJ
aiua-5030	70	3	cancer	cancer	NOUN
aiua-5030	70	4	core	core	NOUN
aiua-5030	70	5	rate	rate	NOUN
aiua-5030	70	6	was	be	AUX
aiua-5030	70	7	significantly	significantly	ADV
aiua-5030	70	8	higher	high	ADJ
aiua-5030	70	9	when	when	SCONJ
aiua-5030	70	10	the	the	DET
aiua-5030	70	11	tp	tp	NOUN
aiua-5030	70	12	approach	approach	NOUN
aiua-5030	70	13	was	be	AUX
aiua-5030	70	14	used	use	VERB
aiua-5030	70	15	:	:	PUNCT
aiua-5030	70	16	21.43	21.43	NUM
aiua-5030	70	17	%	%	NOUN
aiua-5030	70	18	(	(	PUNCT
aiua-5030	70	19	162	162	NUM
aiua-5030	70	20	out	out	ADP
aiua-5030	70	21	of	of	ADP
aiua-5030	70	22	756	756	NUM
aiua-5030	70	23	cores	core	NOUN
aiua-5030	70	24	)	)	PUNCT
aiua-5030	70	25	and	and	CCONJ
aiua-5030	70	26	16.79	16.79	NUM
aiua-5030	70	27	%	%	NOUN
aiua-5030	70	28	(	(	PUNCT
aiua-5030	70	29	127	127	NUM
aiua-5030	70	30	out	out	ADP
aiua-5030	70	31	of	of	ADP
aiua-5030	70	32	756	756	NUM
aiua-5030	70	33	cores	core	NOUN
aiua-5030	70	34	)	)	PUNCT
aiua-5030	70	35	,	,	PUNCT
aiua-5030	70	36	with	with	ADP
aiua-5030	70	37	the	the	DET
aiua-5030	70	38	tp	tp	NOUN
aiua-5030	70	39	and	and	CCONJ
aiua-5030	70	40	the	the	DET
aiua-5030	70	41	tr	tr	NOUN
aiua-5030	70	42	approach	approach	NOUN
aiua-5030	70	43	,	,	PUNCT
aiua-5030	70	44	respectively	respectively	ADV
aiua-5030	70	45	(	(	PUNCT
aiua-5030	70	46	p	p	X
aiua-5030	70	47	=	=	NOUN
aiua-5030	70	48	0.022	0.022	NUM
aiua-5030	70	49	)	)	PUNCT
aiua-5030	70	50	.	.	PUNCT
aiua-5030	71	1	the	the	DET
aiua-5030	71	2	cancer	cancer	NOUN
aiua-5030	71	3	core	core	NOUN
aiua-5030	71	4	rate	rate	NOUN
aiua-5030	71	5	,	,	PUNCT
aiua-5030	71	6	in	in	ADP
aiua-5030	71	7	pz	pz	NOUN
aiua-5030	71	8	cores	core	NOUN
aiua-5030	71	9	,	,	PUNCT
aiua-5030	71	10	was	be	AUX
aiua-5030	71	11	17.59	17.59	NUM
aiua-5030	71	12	%	%	NOUN
aiua-5030	71	13	(	(	PUNCT
aiua-5030	71	14	114	114	NUM
aiua-5030	71	15	out	out	ADP
aiua-5030	71	16	of	of	ADP
aiua-5030	71	17	648	648	NUM
aiua-5030	71	18	cores	core	NOUN
aiua-5030	71	19	)	)	PUNCT
aiua-5030	71	20	in	in	ADP
aiua-5030	71	21	case	case	NOUN
aiua-5030	71	22	of	of	ADP
aiua-5030	71	23	tr	tr	NOUN
aiua-5030	71	24	approach	approach	NOUN
aiua-5030	71	25	,	,	PUNCT
aiua-5030	71	26	and	and	CCONJ
aiua-5030	71	27	21.43	21.43	NUM
aiua-5030	71	28	%	%	NOUN
aiua-5030	71	29	(	(	PUNCT
aiua-5030	71	30	140	140	NUM
aiua-5030	71	31	out	out	ADP
aiua-5030	71	32	of	of	ADP
aiua-5030	71	33	648	648	NUM
aiua-5030	71	34	cores	core	NOUN
aiua-5030	71	35	)	)	PUNCT
aiua-5030	71	36	going	go	VERB
aiua-5030	71	37	transperineally	transperineally	ADV
aiua-5030	71	38	(	(	PUNCT
aiua-5030	71	39	p	p	X
aiua-5030	71	40	=	=	NOUN
aiua-5030	71	41	0.068	0.068	NUM
aiua-5030	71	42	)	)	PUNCT
aiua-5030	71	43	.	.	PUNCT
aiua-5030	72	1	in	in	ADP
aiua-5030	72	2	tz	tz	PROPN
aiua-5030	72	3	,	,	PUNCT
aiua-5030	72	4	the	the	DET
aiua-5030	72	5	corresponding	corresponding	ADJ
aiua-5030	72	6	rate	rate	NOUN
aiua-5030	72	7	was	be	AUX
aiua-5030	72	8	12.04	12.04	NUM
aiua-5030	72	9	(	(	PUNCT
aiua-5030	72	10	13	13	NUM
aiua-5030	72	11	out	out	ADP
aiua-5030	72	12	of	of	ADP
aiua-5030	72	13	108	108	NUM
aiua-5030	72	14	cores	core	NOUN
aiua-5030	72	15	)	)	PUNCT
aiua-5030	72	16	versus	versus	ADP
aiua-5030	72	17	20.37	20.37	NUM
aiua-5030	72	18	%	%	NOUN
aiua-5030	72	19	(	(	PUNCT
aiua-5030	72	20	22	22	NUM
aiua-5030	72	21	out	out	ADP
aiua-5030	72	22	of	of	ADP
aiua-5030	72	23	108	108	NUM
aiua-5030	72	24	cores	core	NOUN
aiua-5030	72	25	)	)	PUNCT
aiua-5030	72	26	,	,	PUNCT
aiua-5030	72	27	respectively	respectively	ADV
aiua-5030	72	28	(	(	PUNCT
aiua-5030	72	29	p	p	X
aiua-5030	72	30	=	=	NOUN
aiua-5030	72	31	0.097	0.097	NUM
aiua-5030	72	32	)	)	PUNCT
aiua-5030	72	33	(	(	PUNCT
aiua-5030	72	34	table	table	NOUN
aiua-5030	72	35	3	3	NUM
aiua-5030	72	36	)	)	PUNCT
aiua-5030	72	37	.	.	PUNCT
aiua-5030	73	1	the	the	DET
aiua-5030	73	2	cores	core	NOUN
aiua-5030	73	3	were	be	AUX
aiua-5030	73	4	significantly	significantly	ADV
aiua-5030	73	5	longer	long	ADV
aiua-5030	73	6	performing	perform	VERB
aiua-5030	73	7	tp	tp	ADP
aiua-5030	73	8	approach	approach	NOUN
aiua-5030	73	9	,	,	PUNCT
aiua-5030	73	10	as	as	SCONJ
aiua-5030	73	11	it	it	PRON
aiua-5030	73	12	follows	follow	VERB
aiua-5030	73	13	:	:	PUNCT
aiua-5030	73	14	at	at	ADP
aiua-5030	73	15	the	the	DET
aiua-5030	73	16	site	site	NOUN
aiua-5030	73	17	“	"	PUNCT
aiua-5030	73	18	1	1	NUM
aiua-5030	73	19	”	"	PUNCT
aiua-5030	73	20	(	(	PUNCT
aiua-5030	73	21	14.92	14.92	NUM
aiua-5030	73	22	versus	versus	ADP
aiua-5030	73	23	12.97	12.97	NUM
aiua-5030	73	24	mm	mm	NOUN
aiua-5030	73	25	,	,	PUNCT
aiua-5030	73	26	p	p	X
aiua-5030	73	27	=	=	NOUN
aiua-5030	73	28	0.02	0.02	NUM
aiua-5030	73	29	)	)	PUNCT
aiua-5030	73	30	;	;	PUNCT
aiua-5030	73	31	at	at	ADP
aiua-5030	73	32	“	"	PUNCT
aiua-5030	73	33	5	5	NUM
aiua-5030	73	34	”	"	PUNCT
aiua-5030	73	35	(	(	PUNCT
aiua-5030	73	36	15.53	15.53	NUM
aiua-5030	73	37	versus	versus	ADP
aiua-5030	73	38	13.69	13.69	NUM
aiua-5030	73	39	mm	mm	NOUN
aiua-5030	73	40	,	,	PUNCT
aiua-5030	73	41	p	p	X
aiua-5030	73	42	=	=	NOUN
aiua-5030	73	43	0.037	0.037	NUM
aiua-5030	73	44	)	)	PUNCT
aiua-5030	73	45	;	;	PUNCT
aiua-5030	73	46	at	at	ADP
aiua-5030	73	47	“	"	PUNCT
aiua-5030	73	48	7	7	NUM
aiua-5030	73	49	”	"	PUNCT
aiua-5030	73	50	(	(	PUNCT
aiua-5030	73	51	15.06	15.06	NUM
aiua-5030	73	52	versus	versus	ADP
aiua-5030	73	53	12.86	12.86	NUM
aiua-5030	73	54	mm	mm	NOUN
aiua-5030	73	55	,	,	PUNCT
aiua-5030	73	56	p	p	NOUN
aiua-5030	73	57	=	=	NOUN
aiua-5030	73	58	0.001	0.001	NUM
aiua-5030	73	59	)	)	PUNCT
aiua-5030	73	60	;	;	PUNCT
aiua-5030	73	61	at	at	ADP
aiua-5030	73	62	“	"	PUNCT
aiua-5030	73	63	9	9	NUM
aiua-5030	73	64	”	"	PUNCT
aiua-5030	73	65	(	(	PUNCT
aiua-5030	73	66	14.92	14.92	NUM
aiua-5030	73	67	versus	versus	ADP
aiua-5030	73	68	13.38	13.38	NUM
aiua-5030	73	69	mm	mm	NOUN
aiua-5030	73	70	,	,	PUNCT
aiua-5030	73	71	p	p	X
aiua-5030	73	72	=	=	NOUN
aiua-5030	73	73	0.038	0.038	NUM
aiua-5030	73	74	)	)	PUNCT
aiua-5030	73	75	;	;	PUNCT
aiua-5030	73	76	at	at	ADP
aiua-5030	73	77	“	"	PUNCT
aiua-5030	73	78	11	11	NUM
aiua-5030	73	79	”	"	PUNCT
aiua-5030	73	80	(	(	PUNCT
aiua-5030	73	81	16.32	16.32	NUM
aiua-5030	73	82	versus	versus	ADP
aiua-5030	73	83	12.31	12.31	NUM
aiua-5030	73	84	mm	mm	NOUN
aiua-5030	73	85	,	,	PUNCT
aiua-5030	73	86	p	p	NOUN
aiua-5030	73	87	=	=	NOUN
aiua-5030	73	88	0.0001	0.0001	NUM
aiua-5030	73	89	)	)	PUNCT
aiua-5030	73	90	;	;	PUNCT
aiua-5030	73	91	at	at	ADP
aiua-5030	73	92	“	"	PUNCT
aiua-5030	73	93	12	12	NUM
aiua-5030	73	94	”	"	PUNCT
aiua-5030	73	95	(	(	PUNCT
aiua-5030	73	96	15.14	15.14	NUM
aiua-5030	73	97	versus	versus	ADP
aiua-5030	73	98	12.19	12.19	NUM
aiua-5030	73	99	mm	mm	NOUN
aiua-5030	73	100	,	,	PUNCT
aiua-5030	73	101	p	p	X
aiua-5030	73	102	=	=	NOUN
aiua-5030	73	103	0.0001	0.0001	NUM
aiua-5030	73	104	)	)	PUNCT
aiua-5030	73	105	;	;	PUNCT
aiua-5030	73	106	at	at	ADP
aiua-5030	73	107	“	"	PUNCT
aiua-5030	73	108	13	13	NUM
aiua-5030	73	109	”	"	PUNCT
aiua-5030	73	110	(	(	PUNCT
aiua-5030	73	111	17.49	17.49	NUM
aiua-5030	73	112	versus	versus	ADP
aiua-5030	73	113	13.98	13.98	NUM
aiua-5030	73	114	mm	mm	NOUN
aiua-5030	73	115	,	,	PUNCT
aiua-5030	73	116	p	p	NOUN
aiua-5030	73	117	=	=	NOUN
aiua-5030	73	118	0.0001	0.0001	NUM
aiua-5030	73	119	)	)	PUNCT
aiua-5030	73	120	;	;	PUNCT
aiua-5030	73	121	at	at	ADP
aiua-5030	73	122	“	"	PUNCT
aiua-5030	73	123	14	14	NUM
aiua-5030	73	124	”	"	PUNCT
aiua-5030	73	125	(	(	PUNCT
aiua-5030	73	126	16.77	16.77	NUM
aiua-5030	73	127	versus	versus	ADP
aiua-5030	73	128	13.36	13.36	NUM
aiua-5030	73	129	mm	mm	NOUN
aiua-5030	73	130	,	,	PUNCT
aiua-5030	73	131	p	p	NOUN
aiua-5030	73	132	=	=	NOUN
aiua-5030	73	133	0.0001	0.0001	NUM
aiua-5030	73	134	)	)	PUNCT
aiua-5030	73	135	.	.	PUNCT
aiua-5030	74	1	overall	overall	ADV
aiua-5030	74	2	,	,	PUNCT
aiua-5030	74	3	no	no	DET
aiua-5030	74	4	significant	significant	ADJ
aiua-5030	74	5	differences	difference	NOUN
aiua-5030	74	6	were	be	AUX
aiua-5030	74	7	found	find	VERB
aiua-5030	74	8	in	in	ADP
aiua-5030	74	9	terms	term	NOUN
aiua-5030	74	10	of	of	ADP
aiua-5030	74	11	post	post	ADJ
aiua-5030	74	12	-	-	ADJ
aiua-5030	74	13	biopsy	biopsy	ADJ
aiua-5030	74	14	complications	complication	NOUN
aiua-5030	74	15	between	between	ADP
aiua-5030	74	16	the	the	DET
aiua-5030	74	17	two	two	NUM
aiua-5030	74	18	groups	group	NOUN
aiua-5030	74	19	(	(	PUNCT
aiua-5030	74	20	table	table	NOUN
aiua-5030	74	21	4	4	NUM
aiua-5030	74	22	)	)	PUNCT
aiua-5030	74	23	.	.	PUNCT
aiua-5030	75	1	as	as	ADP
aiua-5030	75	2	to	to	ADP
aiua-5030	75	3	the	the	DET
aiua-5030	75	4	biopsy	biopsy	NOUN
aiua-5030	75	5	related	relate	VERB
aiua-5030	75	6	pain	pain	NOUN
aiua-5030	75	7	,	,	PUNCT
aiua-5030	75	8	the	the	DET
aiua-5030	75	9	mean	mean	ADJ
aiua-5030	75	10	pain	pain	NOUN
aiua-5030	75	11	level	level	NOUN
aiua-5030	75	12	perceived	perceive	VERB
aiua-5030	75	13	by	by	ADP
aiua-5030	75	14	patients	patient	NOUN
aiua-5030	75	15	during	during	ADP
aiua-5030	75	16	the	the	DET
aiua-5030	75	17	tr	tr	PUNCT
aiua-5030	75	18	approach	approach	NOUN
aiua-5030	75	19	was	be	AUX
aiua-5030	75	20	1.56	1.56	NUM
aiua-5030	75	21	±	±	NUM
aiua-5030	75	22	1.73	1.73	NUM
aiua-5030	75	23	versus	versus	ADP
aiua-5030	75	24	1.42	1.42	NUM
aiua-5030	75	25	±	±	NUM
aiua-5030	75	26	1.37	1.37	NUM
aiua-5030	75	27	registered	register	VERB
aiua-5030	75	28	during	during	ADP
aiua-5030	75	29	tp	tp	ADP
aiua-5030	75	30	approach	approach	NOUN
aiua-5030	75	31	(	(	PUNCT
aiua-5030	75	32	p	p	X
aiua-5030	75	33	=	=	NOUN
aiua-5030	75	34	0.591	0.591	NUM
aiua-5030	75	35	)	)	PUNCT
aiua-5030	75	36	.	.	PUNCT
aiua-5030	76	1	discussion	discussion	NOUN
aiua-5030	76	2	to	to	ADP
aiua-5030	76	3	our	our	PRON
aiua-5030	76	4	knowledge	knowledge	NOUN
aiua-5030	76	5	,	,	PUNCT
aiua-5030	76	6	the	the	DET
aiua-5030	76	7	present	present	ADJ
aiua-5030	76	8	study	study	NOUN
aiua-5030	76	9	is	be	AUX
aiua-5030	76	10	the	the	DET
aiua-5030	76	11	first	first	ADJ
aiua-5030	76	12	prospective	prospective	ADJ
aiua-5030	76	13	controlled	control	VERB
aiua-5030	76	14	evaluation	evaluation	NOUN
aiua-5030	76	15	that	that	PRON
aiua-5030	76	16	compares	compare	VERB
aiua-5030	76	17	systematic	systematic	ADJ
aiua-5030	76	18	14	14	NUM
aiua-5030	76	19	-	-	PUNCT
aiua-5030	76	20	core	core	NOUN
aiua-5030	76	21	biopsy	biopsy	NOUN
aiua-5030	76	22	using	use	VERB
aiua-5030	76	23	tr	tr	PUNCT
aiua-5030	76	24	and	and	CCONJ
aiua-5030	76	25	tp	tp	ADP
aiua-5030	76	26	approaches	approach	NOUN
aiua-5030	76	27	,	,	PUNCT
aiua-5030	76	28	both	both	CCONJ
aiua-5030	76	29	under	under	ADP
aiua-5030	76	30	local	local	ADJ
aiua-5030	76	31	anaesthesia	anaesthesia	NOUN
aiua-5030	76	32	.	.	PUNCT
aiua-5030	77	1	in	in	ADP
aiua-5030	77	2	2003	2003	NUM
aiua-5030	77	3	,	,	PUNCT
aiua-5030	77	4	emiliozzi	emiliozzi	AUX
aiua-5030	77	5	et	et	PROPN
aiua-5030	77	6	al	al	PROPN
aiua-5030	77	7	.	.	PROPN
aiua-5030	77	8	reported	report	VERB
aiua-5030	77	9	a	a	DET
aiua-5030	77	10	comparison	comparison	NOUN
aiua-5030	77	11	between	between	ADP
aiua-5030	77	12	the	the	DET
aiua-5030	77	13	two	two	NUM
aiua-5030	77	14	approaches	approach	NOUN
aiua-5030	77	15	,	,	PUNCT
aiua-5030	77	16	using	use	VERB
aiua-5030	77	17	the	the	DET
aiua-5030	77	18	same	same	ADJ
aiua-5030	77	19	patients	patient	NOUN
aiua-5030	77	20	,	,	PUNCT
aiua-5030	77	21	under	under	ADP
aiua-5030	77	22	local	local	ADJ
aiua-5030	77	23	anaesthesia	anaesthesia	NOUN
aiua-5030	77	24	.	.	PUNCT
aiua-5030	78	1	the	the	DET
aiua-5030	78	2	aim	aim	NOUN
aiua-5030	78	3	of	of	ADP
aiua-5030	78	4	that	that	DET
aiua-5030	78	5	study	study	NOUN
aiua-5030	78	6	was	be	AUX
aiua-5030	78	7	to	to	PART
aiua-5030	78	8	compare	compare	VERB
aiua-5030	78	9	the	the	DET
aiua-5030	78	10	efficacy	efficacy	NOUN
aiua-5030	78	11	of	of	ADP
aiua-5030	78	12	tp	tp	PRON
aiua-5030	78	13	versus	versus	ADP
aiua-5030	78	14	tr	tr	VERB
aiua-5030	78	15	six	six	NUM
aiua-5030	78	16	-	-	PUNCT
aiua-5030	78	17	core	core	NOUN
aiua-5030	78	18	prostate	prostate	NOUN
aiua-5030	78	19	biopsies	biopsy	NOUN
aiua-5030	78	20	,	,	PUNCT
aiua-5030	78	21	performing	perform	VERB
aiua-5030	78	22	six	six	NUM
aiua-5030	78	23	tp	tp	NOUN
aiua-5030	78	24	plus	plus	CCONJ
aiua-5030	78	25	six	six	NUM
aiua-5030	78	26	tr	tr	NOUN
aiua-5030	78	27	biopsies	biopsy	NOUN
aiua-5030	78	28	in	in	ADP
aiua-5030	78	29	a	a	DET
aiua-5030	78	30	group	group	NOUN
aiua-5030	78	31	of	of	ADP
aiua-5030	78	32	107	107	NUM
aiua-5030	78	33	patients	patient	NOUN
aiua-5030	78	34	with	with	ADP
aiua-5030	78	35	psa	psa	VERB
aiua-5030	78	36	greater	great	ADJ
aiua-5030	78	37	than	than	ADP
aiua-5030	78	38	4	4	NUM
aiua-5030	78	39	ng	ng	NOUN
aiua-5030	78	40	/	/	SYM
aiua-5030	78	41	ml	ml	PROPN
aiua-5030	78	42	.	.	PUNCT
aiua-5030	79	1	the	the	DET
aiua-5030	79	2	authors	author	NOUN
aiua-5030	79	3	highlighted	highlight	VERB
aiua-5030	79	4	the	the	DET
aiua-5030	79	5	superiority	superiority	NOUN
aiua-5030	79	6	of	of	ADP
aiua-5030	79	7	the	the	DET
aiua-5030	79	8	tp	tp	NOUN
aiua-5030	79	9	approach	approach	NOUN
aiua-5030	79	10	with	with	ADP
aiua-5030	79	11	a	a	DET
aiua-5030	79	12	cancer	cancer	NOUN
aiua-5030	79	13	detection	detection	NOUN
aiua-5030	79	14	rate	rate	NOUN
aiua-5030	79	15	of	of	ADP
aiua-5030	79	16	40	40	NUM
aiua-5030	79	17	%	%	NOUN
aiua-5030	79	18	(	(	PUNCT
aiua-5030	79	19	43	43	NUM
aiua-5030	79	20	out	out	ADP
aiua-5030	79	21	of	of	ADP
aiua-5030	79	22	107	107	NUM
aiua-5030	79	23	)	)	PUNCT
aiua-5030	79	24	using	use	VERB
aiua-5030	79	25	the	the	DET
aiua-5030	79	26	combination	combination	NOUN
aiua-5030	79	27	of	of	ADP
aiua-5030	79	28	both	both	DET
aiua-5030	79	29	approaches	approach	NOUN
aiua-5030	79	30	;	;	PUNCT
aiua-5030	79	31	of	of	ADP
aiua-5030	79	32	38	38	NUM
aiua-5030	79	33	%	%	NOUN
aiua-5030	79	34	(	(	PUNCT
aiua-5030	79	35	41	41	NUM
aiua-5030	79	36	of	of	ADP
aiua-5030	79	37	107	107	NUM
aiua-5030	79	38	)	)	PUNCT
aiua-5030	79	39	with	with	ADP
aiua-5030	79	40	the	the	DET
aiua-5030	79	41	tp	tp	NOUN
aiua-5030	79	42	approach	approach	NOUN
aiua-5030	79	43	alone	alone	ADV
aiua-5030	79	44	,	,	PUNCT
aiua-5030	79	45	and	and	CCONJ
aiua-5030	79	46	32	32	NUM
aiua-5030	79	47	%	%	NOUN
aiua-5030	79	48	(	(	PUNCT
aiua-5030	79	49	34	34	NUM
aiua-5030	79	50	of	of	ADP
aiua-5030	79	51	107	107	NUM
aiua-5030	79	52	)	)	PUNCT
aiua-5030	79	53	when	when	SCONJ
aiua-5030	79	54	the	the	DET
aiua-5030	79	55	tr	tr	NOUN
aiua-5030	79	56	approach	approach	NOUN
aiua-5030	79	57	had	have	AUX
aiua-5030	79	58	been	be	AUX
aiua-5030	79	59	applied	apply	VERB
aiua-5030	79	60	alone	alone	ADV
aiua-5030	79	61	(	(	PUNCT
aiua-5030	79	62	1	1	NUM
aiua-5030	79	63	)	)	PUNCT
aiua-5030	79	64	.	.	PUNCT
aiua-5030	80	1	more	more	ADV
aiua-5030	80	2	recently	recently	ADV
aiua-5030	80	3	,	,	PUNCT
aiua-5030	80	4	hara	hara	PROPN
aiua-5030	80	5	et	et	PROPN
aiua-5030	80	6	al	al	PROPN
aiua-5030	80	7	prospectively	prospectively	ADV
aiua-5030	80	8	compared	compare	VERB
aiua-5030	80	9	tp	tp	ADP
aiua-5030	80	10	and	and	CCONJ
aiua-5030	80	11	tr	tr	NOUN
aiua-5030	80	12	approaches	approach	NOUN
aiua-5030	80	13	and	and	CCONJ
aiua-5030	80	14	they	they	PRON
aiua-5030	80	15	did	do	AUX
aiua-5030	80	16	not	not	PART
aiua-5030	80	17	show	show	VERB
aiua-5030	80	18	any	any	DET
aiua-5030	80	19	significant	significant	ADJ
aiua-5030	80	20	differences	difference	NOUN
aiua-5030	80	21	in	in	ADP
aiua-5030	80	22	overall	overall	ADJ
aiua-5030	80	23	cancer	cancer	NOUN
aiua-5030	80	24	detection	detection	NOUN
aiua-5030	80	25	rate	rate	NOUN
aiua-5030	80	26	(	(	PUNCT
aiua-5030	80	27	3	3	NUM
aiua-5030	80	28	)	)	PUNCT
aiua-5030	80	29	.	.	PUNCT
aiua-5030	81	1	as	as	ADP
aiua-5030	81	2	to	to	ADP
aiua-5030	81	3	the	the	DET
aiua-5030	81	4	suggested	suggest	VERB
aiua-5030	81	5	superiority	superiority	NOUN
aiua-5030	81	6	of	of	ADP
aiua-5030	81	7	the	the	DET
aiua-5030	81	8	tp	tp	NOUN
aiua-5030	81	9	approach	approach	NOUN
aiua-5030	81	10	in	in	ADP
aiua-5030	81	11	detecting	detect	VERB
aiua-5030	81	12	tz	tz	NOUN
aiua-5030	81	13	cancer	cancer	NOUN
aiua-5030	81	14	,	,	PUNCT
aiua-5030	81	15	shannon	shannon	PROPN
aiua-5030	81	16	et	et	PROPN
aiua-5030	81	17	al	al	PROPN
aiua-5030	81	18	.	.	PROPN
aiua-5030	81	19	reported	report	VERB
aiua-5030	81	20	that	that	SCONJ
aiua-5030	81	21	the	the	DET
aiua-5030	81	22	tp	tp	NOUN
aiua-5030	81	23	approach	approach	NOUN
aiua-5030	81	24	was	be	AUX
aiua-5030	81	25	more	more	ADV
aiua-5030	81	26	successful	successful	ADJ
aiua-5030	81	27	in	in	ADP
aiua-5030	81	28	detecting	detect	VERB
aiua-5030	81	29	tz	tz	NOUN
aiua-5030	81	30	cancer	cancer	NOUN
aiua-5030	81	31	because	because	SCONJ
aiua-5030	81	32	the	the	DET
aiua-5030	81	33	correct	correct	ADJ
aiua-5030	81	34	diagnosis	diagnosis	NOUN
aiua-5030	81	35	rate	rate	NOUN
aiua-5030	81	36	was	be	AUX
aiua-5030	81	37	greater	great	ADJ
aiua-5030	81	38	when	when	SCONJ
aiua-5030	81	39	the	the	DET
aiua-5030	81	40	tp	tp	NOUN
aiua-5030	81	41	approach	approach	NOUN
aiua-5030	81	42	was	be	AUX
aiua-5030	81	43	used	use	VERB
aiua-5030	81	44	in	in	ADP
aiua-5030	81	45	comparison	comparison	NOUN
aiua-5030	81	46	with	with	ADP
aiua-5030	81	47	the	the	DET
aiua-5030	81	48	tr	tr	PUNCT
aiua-5030	81	49	approach	approach	NOUN
aiua-5030	81	50	(	(	PUNCT
aiua-5030	81	51	89	89	NUM
aiua-5030	81	52	versus	versus	ADP
aiua-5030	81	53	68%)(8	68%)(8	NUM
aiua-5030	81	54	)	)	PUNCT
aiua-5030	81	55	.	.	PUNCT
aiua-5030	82	1	furthermore	furthermore	ADV
aiua-5030	82	2	,	,	PUNCT
aiua-5030	82	3	furuno	furuno	PROPN
aiua-5030	82	4	et	et	PROPN
aiua-5030	82	5	al	al	PROPN
aiua-5030	82	6	.	.	PROPN
aiua-5030	82	7	,	,	PUNCT
aiua-5030	82	8	performing	perform	VERB
aiua-5030	82	9	a	a	DET
aiua-5030	82	10	tp	tp	NOUN
aiua-5030	82	11	ultrasound	ultrasound	NOUN
aiua-5030	82	12	-	-	PUNCT
aiua-5030	82	13	guided	guide	VERB
aiua-5030	82	14	template	template	NOUN
aiua-5030	82	15	biopsy	biopsy	NOUN
aiua-5030	82	16	in	in	ADP
aiua-5030	82	17	men	man	NOUN
aiua-5030	82	18	with	with	ADP
aiua-5030	82	19	psa	psa	NOUN
aiua-5030	82	20	levels	level	NOUN
aiua-5030	82	21	ranging	range	VERB
aiua-5030	82	22	between	between	ADP
aiua-5030	82	23	4	4	NUM
aiua-5030	82	24	and	and	CCONJ
aiua-5030	82	25	10	10	NUM
aiua-5030	82	26	ng	ng	PROPN
aiua-5030	82	27	/	/	SYM
aiua-5030	82	28	ml	ml	PROPN
aiua-5030	82	29	,	,	PUNCT
aiua-5030	82	30	reported	report	VERB
aiua-5030	82	31	that	that	SCONJ
aiua-5030	82	32	the	the	DET
aiua-5030	82	33	cancer	cancer	NOUN
aiua-5030	82	34	core	core	NOUN
aiua-5030	82	35	rate	rate	NOUN
aiua-5030	82	36	of	of	ADP
aiua-5030	82	37	the	the	DET
aiua-5030	82	38	biopsies	biopsy	NOUN
aiua-5030	82	39	from	from	ADP
aiua-5030	82	40	the	the	DET
aiua-5030	82	41	anterior	anterior	ADJ
aiua-5030	82	42	part	part	NOUN
aiua-5030	82	43	of	of	ADP
aiua-5030	82	44	the	the	DET
aiua-5030	82	45	prostate	prostate	NOUN
aiua-5030	82	46	was	be	AUX
aiua-5030	82	47	significantly	significantly	ADV
aiua-5030	82	48	greater	great	ADJ
aiua-5030	82	49	than	than	ADP
aiua-5030	82	50	that	that	PRON
aiua-5030	82	51	from	from	ADP
aiua-5030	82	52	the	the	DET
aiua-5030	82	53	posterior	posterior	ADJ
aiua-5030	82	54	region	region	NOUN
aiua-5030	82	55	(	(	PUNCT
aiua-5030	82	56	9	9	NUM
aiua-5030	82	57	)	)	PUNCT
aiua-5030	82	58	.	.	PUNCT
aiua-5030	83	1	they	they	PRON
aiua-5030	83	2	suggested	suggest	VERB
aiua-5030	83	3	that	that	SCONJ
aiua-5030	83	4	tr	tr	NOUN
aiua-5030	83	5	sextant	sextant	ADJ
aiua-5030	83	6	biopsy	biopsy	NOUN
aiua-5030	83	7	might	might	AUX
aiua-5030	83	8	be	be	AUX
aiua-5030	83	9	inadequate	inadequate	ADJ
aiua-5030	83	10	for	for	ADP
aiua-5030	83	11	detecting	detect	VERB
aiua-5030	83	12	cancer	cancer	NOUN
aiua-5030	83	13	localized	localize	VERB
aiua-5030	83	14	in	in	ADP
aiua-5030	83	15	the	the	DET
aiua-5030	83	16	anterior	anterior	ADJ
aiua-5030	83	17	region	region	NOUN
aiua-5030	83	18	.	.	PUNCT
aiua-5030	84	1	on	on	ADP
aiua-5030	84	2	the	the	DET
aiua-5030	84	3	contrary	contrary	NOUN
aiua-5030	84	4	,	,	PUNCT
aiua-5030	84	5	hara	hara	PROPN
aiua-5030	84	6	et	et	PROPN
aiua-5030	84	7	al	al	PROPN
aiua-5030	84	8	.	.	PROPN
aiua-5030	84	9	did	do	AUX
aiua-5030	84	10	not	not	PART
aiua-5030	84	11	find	find	VERB
aiua-5030	84	12	any	any	DET
aiua-5030	84	13	differences	difference	NOUN
aiua-5030	84	14	in	in	ADP
aiua-5030	84	15	cancer	cancer	NOUN
aiua-5030	84	16	core	core	NOUN
aiua-5030	84	17	rates	rate	NOUN
aiua-5030	84	18	whatever	whatever	PRON
aiua-5030	84	19	zones	zone	NOUN
aiua-5030	84	20	or	or	CCONJ
aiua-5030	84	21	approaches	approach	NOUN
aiua-5030	84	22	were	be	AUX
aiua-5030	84	23	(	(	PUNCT
aiua-5030	84	24	3	3	NUM
aiua-5030	84	25	)	)	PUNCT
aiua-5030	84	26	.	.	PUNCT
aiua-5030	85	1	in	in	ADP
aiua-5030	85	2	authors	author	NOUN
aiua-5030	85	3	’	’	PART
aiua-5030	85	4	opinion	opinion	NOUN
aiua-5030	85	5	,	,	PUNCT
aiua-5030	85	6	the	the	DET
aiua-5030	85	7	increased	increase	VERB
aiua-5030	85	8	number	number	NOUN
aiua-5030	85	9	of	of	ADP
aiua-5030	85	10	biopsy	biopsy	NOUN
aiua-5030	85	11	specimens	specimen	NOUN
aiua-5030	85	12	to	to	ADP
aiua-5030	85	13	12	12	NUM
aiua-5030	85	14	might	might	AUX
aiua-5030	85	15	reduce	reduce	VERB
aiua-5030	85	16	the	the	DET
aiua-5030	85	17	differences	difference	NOUN
aiua-5030	85	18	in	in	ADP
aiua-5030	85	19	cancer	cancer	NOUN
aiua-5030	85	20	detection	detection	NOUN
aiua-5030	85	21	rates	rate	NOUN
aiua-5030	85	22	between	between	ADP
aiua-5030	85	23	the	the	DET
aiua-5030	85	24	two	two	NUM
aiua-5030	85	25	approaches	approach	NOUN
aiua-5030	85	26	.	.	PUNCT
aiua-5030	86	1	in	in	ADP
aiua-5030	86	2	our	our	PRON
aiua-5030	86	3	study	study	NOUN
aiua-5030	86	4	,	,	PUNCT
aiua-5030	86	5	cancer	cancer	NOUN
aiua-5030	86	6	core	core	NOUN
aiua-5030	86	7	rates	rate	NOUN
aiua-5030	86	8	in	in	ADP
aiua-5030	86	9	pz	pz	PROPN
aiua-5030	86	10	,	,	PUNCT
aiua-5030	86	11	tz	tz	PROPN
aiua-5030	86	12	,	,	PUNCT
aiua-5030	86	13	apex	apex	NOUN
aiua-5030	86	14	and	and	CCONJ
aiua-5030	86	15	mid	mid	ADJ
aiua-5030	86	16	prostate	prostate	NOUN
aiua-5030	86	17	were	be	AUX
aiua-5030	86	18	always	always	ADV
aiua-5030	86	19	higher	high	ADJ
aiua-5030	86	20	when	when	SCONJ
aiua-5030	86	21	tp	tp	NOUN
aiua-5030	86	22	approach	approach	NOUN
aiua-5030	86	23	was	be	AUX
aiua-5030	86	24	used	use	VERB
aiua-5030	86	25	,	,	PUNCT
aiua-5030	86	26	but	but	CCONJ
aiua-5030	86	27	without	without	ADP
aiua-5030	86	28	reaching	reach	VERB
aiua-5030	86	29	any	any	DET
aiua-5030	86	30	statistical	statistical	ADJ
aiua-5030	86	31	significance	significance	NOUN
aiua-5030	86	32	.	.	PUNCT
aiua-5030	87	1	more	more	ADV
aiua-5030	87	2	recently	recently	ADV
aiua-5030	87	3	,	,	PUNCT
aiua-5030	87	4	takenada	takenada	PROPN
aiua-5030	87	5	,	,	PUNCT
aiua-5030	87	6	hara	hara	PROPN
aiua-5030	87	7	et	et	PROPN
aiua-5030	87	8	al	al	PROPN
aiua-5030	87	9	.	.	PROPN
aiua-5030	87	10	found	find	VERB
aiua-5030	87	11	that	that	SCONJ
aiua-5030	87	12	,	,	PUNCT
aiua-5030	87	13	in	in	ADP
aiua-5030	87	14	patients	patient	NOUN
aiua-5030	87	15	with	with	ADP
aiua-5030	87	16	psa	psa	NOUN
aiua-5030	87	17	in	in	ADP
aiua-5030	87	18	the	the	DET
aiua-5030	87	19	“	"	PUNCT
aiua-5030	87	20	grey	grey	ADJ
aiua-5030	87	21	zone	zone	NOUN
aiua-5030	87	22	”	"	PUNCT
aiua-5030	87	23	(	(	PUNCT
aiua-5030	87	24	ranging	range	VERB
aiua-5030	87	25	between	between	ADP
aiua-5030	87	26	4.1	4.1	NUM
aiua-5030	87	27	and	and	CCONJ
aiua-5030	87	28	10.0	10.0	NUM
aiua-5030	87	29	ng	ng	NOUN
aiua-5030	87	30	/	/	SYM
aiua-5030	87	31	ml	ml	PROPN
aiua-5030	87	32	)	)	PUNCT
aiua-5030	87	33	,	,	PUNCT
aiua-5030	87	34	significantly	significantly	ADV
aiua-5030	87	35	more	more	ADJ
aiua-5030	87	36	cores	core	NOUN
aiua-5030	87	37	were	be	AUX
aiua-5030	87	38	positive	positive	ADJ
aiua-5030	87	39	when	when	SCONJ
aiua-5030	87	40	tp	tp	PART
aiua-5030	87	41	approach	approach	NOUN
aiua-5030	87	42	was	be	AUX
aiua-5030	87	43	applied	apply	VERB
aiua-5030	87	44	,	,	PUNCT
aiua-5030	87	45	especially	especially	ADV
aiua-5030	87	46	regarding	regard	VERB
aiua-5030	87	47	to	to	ADP
aiua-5030	87	48	tz	tz	PROPN
aiua-5030	87	49	cores	core	NOUN
aiua-5030	87	50	(	(	PUNCT
aiua-5030	87	51	4	4	NUM
aiua-5030	87	52	)	)	PUNCT
aiua-5030	87	53	.	.	PUNCT
aiua-5030	88	1	they	they	PRON
aiua-5030	88	2	concluded	conclude	VERB
aiua-5030	88	3	that	that	SCONJ
aiua-5030	88	4	urologists	urologist	NOUN
aiua-5030	88	5	’	'	PUNCT
aiua-5030	88	6	preferences	preference	NOUN
aiua-5030	88	7	should	should	AUX
aiua-5030	88	8	be	be	AUX
aiua-5030	88	9	sufficient	sufficient	ADJ
aiua-5030	88	10	for	for	ADP
aiua-5030	88	11	choosing	choose	VERB
aiua-5030	88	12	the	the	DET
aiua-5030	88	13	best	good	ADJ
aiua-5030	88	14	approach	approach	NOUN
aiua-5030	88	15	,	,	PUNCT
aiua-5030	88	16	except	except	SCONJ
aiua-5030	88	17	for	for	ADP
aiua-5030	88	18	possible	possible	ADJ
aiua-5030	88	19	small	small	ADJ
aiua-5030	88	20	advantages	advantage	NOUN
aiua-5030	88	21	for	for	ADP
aiua-5030	88	22	tp	tp	PART
aiua-5030	88	23	biopsy	biopsy	NOUN
aiua-5030	88	24	when	when	SCONJ
aiua-5030	88	25	psa	psa	NOUN
aiua-5030	88	26	is	be	AUX
aiua-5030	88	27	in	in	ADP
aiua-5030	88	28	the	the	DET
aiua-5030	88	29	“	"	PUNCT
aiua-5030	88	30	grey	grey	ADJ
aiua-5030	88	31	zone	zone	NOUN
aiua-5030	88	32	”	"	PUNCT
aiua-5030	88	33	.	.	PUNCT
aiua-5030	89	1	the	the	DET
aiua-5030	89	2	results	result	NOUN
aiua-5030	89	3	of	of	ADP
aiua-5030	89	4	our	our	PRON
aiua-5030	89	5	study	study	NOUN
aiua-5030	89	6	might	might	AUX
aiua-5030	89	7	even	even	ADV
aiua-5030	89	8	support	support	VERB
aiua-5030	89	9	this	this	DET
aiua-5030	89	10	trend	trend	NOUN
aiua-5030	89	11	towards	towards	ADP
aiua-5030	89	12	a	a	DET
aiua-5030	89	13	possible	possible	ADJ
aiua-5030	89	14	advantage	advantage	NOUN
aiua-5030	89	15	of	of	ADP
aiua-5030	89	16	tp	tp	PART
aiua-5030	89	17	biopsy	biopsy	VERB
aiua-5030	89	18	in	in	ADP
aiua-5030	89	19	better	well	ADJ
aiua-5030	89	20	sampling	sample	VERB
aiua-5030	89	21	both	both	PRON
aiua-5030	89	22	tz	tz	NOUN
aiua-5030	89	23	and	and	CCONJ
aiua-5030	89	24	prostate	prostate	NOUN
aiua-5030	89	25	apex	apex	NOUN
aiua-5030	89	26	.	.	PUNCT
aiua-5030	90	1	some	some	PRON
aiua-5030	90	2	of	of	ADP
aiua-5030	90	3	our	our	PRON
aiua-5030	90	4	group	group	NOUN
aiua-5030	90	5	had	have	AUX
aiua-5030	90	6	previously	previously	ADV
aiua-5030	90	7	reported	report	VERB
aiua-5030	90	8	that	that	SCONJ
aiua-5030	90	9	tp	tp	NOUN
aiua-5030	90	10	approach	approach	NOUN
aiua-5030	90	11	would	would	AUX
aiua-5030	90	12	allow	allow	VERB
aiua-5030	90	13	a	a	DET
aiua-5030	90	14	greater	great	ADJ
aiua-5030	90	15	sampling	sampling	NOUN
aiua-5030	90	16	of	of	ADP
aiua-5030	90	17	the	the	DET
aiua-5030	90	18	prostate	prostate	NOUN
aiua-5030	90	19	apex	apex	NOUN
aiua-5030	90	20	compared	compare	VERB
aiua-5030	90	21	with	with	ADP
aiua-5030	90	22	midgland	midgland	NOUN
aiua-5030	90	23	and	and	CCONJ
aiua-5030	90	24	prostate	prostate	NOUN
aiua-5030	90	25	base	base	NOUN
aiua-5030	90	26	(	(	PUNCT
aiua-5030	90	27	p	p	X
aiua-5030	90	28	<	<	X
aiua-5030	90	29	0.001	0.001	NUM
aiua-5030	90	30	)	)	PUNCT
aiua-5030	90	31	(	(	PUNCT
aiua-5030	90	32	10	10	NUM
aiua-5030	90	33	)	)	PUNCT
aiua-5030	90	34	.	.	PUNCT
aiua-5030	91	1	to	to	PART
aiua-5030	91	2	possibly	possibly	ADV
aiua-5030	91	3	characteristics	characteristic	VERB
aiua-5030	91	4	tp	tp	PART
aiua-5030	91	5	approach	approach	NOUN
aiua-5030	91	6	tr	tr	PUNCT
aiua-5030	91	7	approach	approach	NOUN
aiua-5030	91	8	p	p	NOUN
aiua-5030	91	9	value	value	NOUN
aiua-5030	91	10	overall	overall	ADJ
aiua-5030	91	11	(	(	PUNCT
aiua-5030	91	12	%	%	INTJ
aiua-5030	91	13	)	)	PUNCT
aiua-5030	91	14	7/54	7/54	NUM
aiua-5030	91	15	(	(	PUNCT
aiua-5030	91	16	12.96	12.96	NUM
aiua-5030	91	17	)	)	PUNCT
aiua-5030	91	18	7/54	7/54	NUM
aiua-5030	91	19	(	(	PUNCT
aiua-5030	91	20	12.96	12.96	NUM
aiua-5030	91	21	)	)	PUNCT
aiua-5030	91	22	ns	ns	NUM
aiua-5030	91	23	rectal	rectal	ADJ
aiua-5030	91	24	bleeding	bleeding	NOUN
aiua-5030	91	25	(	(	PUNCT
aiua-5030	91	26	%	%	NOUN
aiua-5030	91	27	)	)	PUNCT
aiua-5030	91	28	0	0	NUM
aiua-5030	92	1	(	(	PUNCT
aiua-5030	92	2	0	0	NUM
aiua-5030	92	3	)	)	PUNCT
aiua-5030	92	4	4	4	NUM
aiua-5030	92	5	(	(	PUNCT
aiua-5030	92	6	57.16	57.16	NUM
aiua-5030	92	7	)	)	PUNCT
aiua-5030	93	1	0.04	0.04	NUM
aiua-5030	93	2	urinary	urinary	ADJ
aiua-5030	93	3	retention	retention	NOUN
aiua-5030	93	4	(	(	PUNCT
aiua-5030	93	5	%	%	NOUN
aiua-5030	93	6	)	)	PUNCT
aiua-5030	93	7	0	0	NUM
aiua-5030	93	8	(	(	PUNCT
aiua-5030	93	9	0	0	NUM
aiua-5030	93	10	)	)	SYM
aiua-5030	93	11	1	1	NUM
aiua-5030	93	12	(	(	PUNCT
aiua-5030	93	13	14.28	14.28	NUM
aiua-5030	93	14	)	)	PUNCT
aiua-5030	93	15	0.315	0.315	NUM
aiua-5030	93	16	(	(	PUNCT
aiua-5030	93	17	ns	ns	ADJ
aiua-5030	93	18	)	)	PUNCT
aiua-5030	93	19	urethral	urethral	ADJ
aiua-5030	93	20	bleeding	bleeding	NOUN
aiua-5030	93	21	(	(	PUNCT
aiua-5030	93	22	%	%	INTJ
aiua-5030	93	23	)	)	PUNCT
aiua-5030	93	24	5	5	NUM
aiua-5030	93	25	(	(	PUNCT
aiua-5030	93	26	71.43	71.43	NUM
aiua-5030	93	27	)	)	PUNCT
aiua-5030	93	28	0	0	NUM
aiua-5030	93	29	(	(	PUNCT
aiua-5030	93	30	0	0	NUM
aiua-5030	93	31	)	)	PUNCT
aiua-5030	93	32	0.022	0.022	NUM
aiua-5030	93	33	vasovagal	vasovagal	ADJ
aiua-5030	93	34	event	event	NOUN
aiua-5030	93	35	(	(	PUNCT
aiua-5030	93	36	%	%	INTJ
aiua-5030	93	37	)	)	PUNCT
aiua-5030	93	38	2	2	NUM
aiua-5030	93	39	(	(	PUNCT
aiua-5030	93	40	28.57	28.57	NUM
aiua-5030	93	41	)	)	PUNCT
aiua-5030	93	42	1	1	NUM
aiua-5030	93	43	(	(	PUNCT
aiua-5030	93	44	14.28	14.28	NUM
aiua-5030	93	45	)	)	PUNCT
aiua-5030	93	46	0.56	0.56	NUM
aiua-5030	93	47	(	(	PUNCT
aiua-5030	93	48	ns	ns	NOUN
aiua-5030	93	49	)	)	PUNCT
aiua-5030	93	50	fever	fever	NOUN
aiua-5030	93	51	>	>	X
aiua-5030	93	52	38.5	38.5	NUM
aiua-5030	93	53	°	°	NOUN
aiua-5030	93	54	c	c	NOUN
aiua-5030	93	55	(	(	PUNCT
aiua-5030	93	56	%	%	NOUN
aiua-5030	93	57	)	)	PUNCT
aiua-5030	93	58	0	0	NUM
aiua-5030	93	59	(	(	PUNCT
aiua-5030	93	60	0	0	NUM
aiua-5030	93	61	)	)	SYM
aiua-5030	93	62	1	1	NUM
aiua-5030	93	63	(	(	PUNCT
aiua-5030	93	64	14.28	14.28	NUM
aiua-5030	93	65	)	)	PUNCT
aiua-5030	93	66	0.315	0.315	NUM
aiua-5030	93	67	(	(	PUNCT
aiua-5030	93	68	ns	ns	INTJ
aiua-5030	93	69	)	)	PUNCT
aiua-5030	93	70	not	not	PART
aiua-5030	93	71	significant	significant	ADJ
aiua-5030	93	72	.	.	PUNCT
aiua-5030	93	73	table	table	NOUN
aiua-5030	93	74	4	4	NUM
aiua-5030	93	75	.	.	PUNCT
aiua-5030	93	76	complication	complication	NOUN
aiua-5030	93	77	rates	rate	NOUN
aiua-5030	93	78	.	.	PUNCT
aiua-5030	94	1	approach	approach	NOUN
aiua-5030	94	2	total	total	NOUN
aiua-5030	94	3	pz	pz	PROPN
aiua-5030	94	4	tz	tz	PROPN
aiua-5030	94	5	apex	apex	NOUN
aiua-5030	94	6	mid	mid	ADJ
aiua-5030	94	7	prostate	prostate	NOUN
aiua-5030	94	8	base	base	NOUN
aiua-5030	94	9	tp	tp	PART
aiua-5030	94	10	biopsy	biopsy	NOUN
aiua-5030	94	11	cores	core	NOUN
aiua-5030	94	12	(	(	PUNCT
aiua-5030	94	13	n	n	CCONJ
aiua-5030	94	14	)	)	PUNCT
aiua-5030	94	15	756	756	NUM
aiua-5030	94	16	648	648	NUM
aiua-5030	94	17	108	108	NUM
aiua-5030	94	18	216	216	NUM
aiua-5030	94	19	216	216	NUM
aiua-5030	94	20	216	216	NUM
aiua-5030	94	21	162	162	NUM
aiua-5030	94	22	140	140	NUM
aiua-5030	94	23	22	22	NUM
aiua-5030	94	24	49	49	NUM
aiua-5030	94	25	48	48	NUM
aiua-5030	94	26	46	46	NUM
aiua-5030	94	27	21.43	21.43	NUM
aiua-5030	94	28	%	%	NOUN
aiua-5030	94	29	21.60	21.60	NUM
aiua-5030	94	30	%	%	NOUN
aiua-5030	94	31	20.37	20.37	NUM
aiua-5030	94	32	%	%	NOUN
aiua-5030	94	33	22.68	22.68	NUM
aiua-5030	94	34	%	%	NOUN
aiua-5030	94	35	22.22	22.22	NUM
aiua-5030	94	36	%	%	NOUN
aiua-5030	94	37	21.30	21.30	NUM
aiua-5030	94	38	%	%	NOUN
aiua-5030	94	39	tr	tr	NOUN
aiua-5030	94	40	biopsy	biopsy	NOUN
aiua-5030	94	41	cores	core	NOUN
aiua-5030	94	42	(	(	PUNCT
aiua-5030	94	43	n	n	CCONJ
aiua-5030	94	44	)	)	PUNCT
aiua-5030	94	45	756	756	NUM
aiua-5030	94	46	648	648	NUM
aiua-5030	94	47	108	108	NUM
aiua-5030	94	48	216	216	NUM
aiua-5030	94	49	216	216	NUM
aiua-5030	94	50	216	216	NUM
aiua-5030	94	51	cancer	cancer	NOUN
aiua-5030	94	52	cores	core	NOUN
aiua-5030	94	53	(	(	PUNCT
aiua-5030	94	54	n	n	CCONJ
aiua-5030	94	55	)	)	PUNCT
aiua-5030	94	56	127	127	NUM
aiua-5030	94	57	114	114	NUM
aiua-5030	94	58	13	13	NUM
aiua-5030	94	59	38	38	NUM
aiua-5030	94	60	40	40	NUM
aiua-5030	94	61	44	44	NUM
aiua-5030	94	62	cancer	cancer	NOUN
aiua-5030	94	63	core	core	NOUN
aiua-5030	94	64	rate	rate	NOUN
aiua-5030	94	65	(	(	PUNCT
aiua-5030	94	66	%	%	INTJ
aiua-5030	94	67	)	)	PUNCT
aiua-5030	94	68	16.7	16.7	NUM
aiua-5030	94	69	%	%	NOUN
aiua-5030	94	70	17.59	17.59	NUM
aiua-5030	94	71	%	%	NOUN
aiua-5030	94	72	12.04	12.04	NUM
aiua-5030	94	73	%	%	NOUN
aiua-5030	94	74	17.59	17.59	NUM
aiua-5030	94	75	%	%	NOUN
aiua-5030	94	76	18.52	18.52	NUM
aiua-5030	94	77	%	%	NOUN
aiua-5030	94	78	20.47	20.47	NUM
aiua-5030	94	79	%	%	NOUN
aiua-5030	94	80	p	p	NOUN
aiua-5030	94	81	value	value	NOUN
aiua-5030	94	82	0.022	0.022	NUM
aiua-5030	94	83	0.068	0.068	NUM
aiua-5030	94	84	0.097	0.097	NUM
aiua-5030	94	85	0.186	0.186	NUM
aiua-5030	94	86	0.340	0.340	NUM
aiua-5030	94	87	0.814	0.814	NUM
aiua-5030	94	88	(	(	PUNCT
aiua-5030	94	89	ns	ns	NUM
aiua-5030	94	90	)	)	PUNCT
aiua-5030	94	91	(	(	PUNCT
aiua-5030	94	92	ns	ns	NUM
aiua-5030	94	93	)	)	PUNCT
aiua-5030	94	94	(	(	PUNCT
aiua-5030	94	95	ns	ns	NUM
aiua-5030	94	96	)	)	PUNCT
aiua-5030	94	97	(	(	PUNCT
aiua-5030	94	98	ns	ns	NUM
aiua-5030	94	99	)	)	PUNCT
aiua-5030	94	100	(	(	PUNCT
aiua-5030	94	101	ns	ns	X
aiua-5030	94	102	)	)	PUNCT
aiua-5030	94	103	ns	ns	NOUN
aiua-5030	94	104	=	=	NOUN
aiua-5030	94	105	not	not	PART
aiua-5030	94	106	significant	significant	ADJ
aiua-5030	94	107	.	.	PUNCT
aiua-5030	94	108	table	table	NOUN
aiua-5030	94	109	3	3	NUM
aiua-5030	94	110	.	.	PUNCT
aiua-5030	94	111	comparison	comparison	NOUN
aiua-5030	94	112	of	of	ADP
aiua-5030	94	113	cancer	cancer	NOUN
aiua-5030	94	114	-	-	PUNCT
aiua-5030	94	115	positive	positive	ADJ
aiua-5030	94	116	core	core	NOUN
aiua-5030	94	117	rate	rate	NOUN
aiua-5030	94	118	by	by	ADP
aiua-5030	94	119	anatomic	anatomic	ADJ
aiua-5030	94	120	location	location	NOUN
aiua-5030	94	121	between	between	ADP
aiua-5030	94	122	transperineal	transperineal	NOUN
aiua-5030	94	123	and	and	CCONJ
aiua-5030	94	124	transrectal	transrectal	ADJ
aiua-5030	94	125	approaches	approach	NOUN
aiua-5030	94	126	cerruto_stesura	cerruto_stesura	NOUN
aiua-5030	94	127	seveso	seveso	VERB
aiua-5030	94	128	15/01/15	15/01/15	PROPN
aiua-5030	94	129	13:18	13:18	NUM
aiua-5030	94	130	pagina	pagina	NOUN
aiua-5030	94	131	286	286	NUM
aiua-5030	94	132	287archivio	287archivio	PROPN
aiua-5030	94	133	italiano	italiano	NOUN
aiua-5030	94	134	di	di	X
aiua-5030	94	135	urologia	urologia	PROPN
aiua-5030	94	136	e	e	PROPN
aiua-5030	94	137	andrologia	andrologia	NOUN
aiua-5030	94	138	2014	2014	NUM
aiua-5030	94	139	;	;	PUNCT
aiua-5030	94	140	86	86	NUM
aiua-5030	94	141	,	,	PUNCT
aiua-5030	94	142	4	4	NUM
aiua-5030	94	143	transrectal	transrectal	ADJ
aiua-5030	94	144	versus	versus	ADP
aiua-5030	94	145	transperineal	transperineal	NOUN
aiua-5030	94	146	prostate	prostate	NOUN
aiua-5030	94	147	biopsy	biopsy	NOUN
aiua-5030	94	148	:	:	PUNCT
aiua-5030	94	149	a	a	DET
aiua-5030	94	150	comparative	comparative	ADJ
aiua-5030	94	151	evaluation	evaluation	NOUN
aiua-5030	94	152	confirm	confirm	VERB
aiua-5030	94	153	this	this	DET
aiua-5030	94	154	statement	statement	NOUN
aiua-5030	94	155	,	,	PUNCT
aiua-5030	94	156	in	in	ADP
aiua-5030	94	157	the	the	DET
aiua-5030	94	158	present	present	ADJ
aiua-5030	94	159	series	series	NOUN
aiua-5030	94	160	,	,	PUNCT
aiua-5030	94	161	the	the	DET
aiua-5030	94	162	cores	core	NOUN
aiua-5030	94	163	resulted	result	VERB
aiua-5030	94	164	significantly	significantly	ADV
aiua-5030	94	165	longer	long	ADV
aiua-5030	94	166	with	with	ADP
aiua-5030	94	167	the	the	DET
aiua-5030	94	168	tp	tp	NOUN
aiua-5030	94	169	rather	rather	ADV
aiua-5030	94	170	than	than	ADP
aiua-5030	94	171	with	with	ADP
aiua-5030	94	172	the	the	DET
aiua-5030	94	173	tr	tr	NOUN
aiua-5030	94	174	approach	approach	NOUN
aiua-5030	94	175	,	,	PUNCT
aiua-5030	94	176	mainly	mainly	ADV
aiua-5030	94	177	at	at	ADP
aiua-5030	94	178	the	the	DET
aiua-5030	94	179	apex	apex	NOUN
aiua-5030	94	180	and	and	CCONJ
aiua-5030	94	181	in	in	ADP
aiua-5030	94	182	the	the	DET
aiua-5030	94	183	tz	tz	NOUN
aiua-5030	94	184	.	.	PUNCT
aiua-5030	95	1	however	however	ADV
aiua-5030	95	2	,	,	PUNCT
aiua-5030	95	3	the	the	DET
aiua-5030	95	4	real	real	ADJ
aiua-5030	95	5	advantage	advantage	NOUN
aiua-5030	95	6	of	of	ADP
aiua-5030	95	7	these	these	DET
aiua-5030	95	8	data	datum	NOUN
aiua-5030	95	9	is	be	AUX
aiua-5030	95	10	still	still	ADV
aiua-5030	95	11	uncertain	uncertain	ADJ
aiua-5030	95	12	as	as	SCONJ
aiua-5030	95	13	these	these	DET
aiua-5030	95	14	findings	finding	NOUN
aiua-5030	95	15	are	be	AUX
aiua-5030	95	16	supported	support	VERB
aiua-5030	95	17	by	by	ADP
aiua-5030	95	18	no	no	DET
aiua-5030	95	19	significant	significant	ADJ
aiua-5030	95	20	differences	difference	NOUN
aiua-5030	95	21	in	in	ADP
aiua-5030	95	22	terms	term	NOUN
aiua-5030	95	23	of	of	ADP
aiua-5030	95	24	cancer	cancer	NOUN
aiua-5030	95	25	detection	detection	NOUN
aiua-5030	95	26	rate	rate	NOUN
aiua-5030	95	27	reached	reach	VERB
aiua-5030	95	28	when	when	SCONJ
aiua-5030	95	29	the	the	DET
aiua-5030	95	30	two	two	NUM
aiua-5030	95	31	approaches	approach	NOUN
aiua-5030	95	32	are	be	AUX
aiua-5030	95	33	used	use	VERB
aiua-5030	95	34	.	.	PUNCT
aiua-5030	96	1	as	as	ADP
aiua-5030	96	2	to	to	ADP
aiua-5030	96	3	the	the	DET
aiua-5030	96	4	adverse	adverse	ADJ
aiua-5030	96	5	events	event	NOUN
aiua-5030	96	6	,	,	PUNCT
aiua-5030	96	7	no	no	DET
aiua-5030	96	8	differences	difference	NOUN
aiua-5030	96	9	were	be	AUX
aiua-5030	96	10	found	find	VERB
aiua-5030	96	11	in	in	ADP
aiua-5030	96	12	the	the	DET
aiua-5030	96	13	overall	overall	ADJ
aiua-5030	96	14	incidence	incidence	NOUN
aiua-5030	96	15	of	of	ADP
aiua-5030	96	16	complications	complication	NOUN
aiua-5030	96	17	as	as	ADP
aiua-5030	96	18	a	a	DET
aiua-5030	96	19	result	result	NOUN
aiua-5030	96	20	occurring	occur	VERB
aiua-5030	96	21	with	with	ADP
aiua-5030	96	22	the	the	DET
aiua-5030	96	23	two	two	NUM
aiua-5030	96	24	approaches	approach	NOUN
aiua-5030	96	25	,	,	PUNCT
aiua-5030	96	26	except	except	SCONJ
aiua-5030	96	27	for	for	ADP
aiua-5030	96	28	the	the	DET
aiua-5030	96	29	urethral	urethral	ADJ
aiua-5030	96	30	bleeding	bleeding	NOUN
aiua-5030	96	31	in	in	ADP
aiua-5030	96	32	tp	tp	ADP
aiua-5030	96	33	group	group	NOUN
aiua-5030	96	34	,	,	PUNCT
aiua-5030	96	35	and	and	CCONJ
aiua-5030	96	36	the	the	DET
aiua-5030	96	37	rectal	rectal	ADJ
aiua-5030	96	38	bleeding	bleeding	NOUN
aiua-5030	96	39	in	in	ADP
aiua-5030	96	40	tr	tr	NOUN
aiua-5030	96	41	group	group	NOUN
aiua-5030	96	42	.	.	PUNCT
aiua-5030	97	1	as	as	ADP
aiua-5030	97	2	to	to	ADP
aiua-5030	97	3	some	some	DET
aiua-5030	97	4	technical	technical	ADJ
aiua-5030	97	5	difficulties	difficulty	NOUN
aiua-5030	97	6	,	,	PUNCT
aiua-5030	97	7	many	many	ADJ
aiua-5030	97	8	authors	author	NOUN
aiua-5030	97	9	stated	state	VERB
aiua-5030	97	10	the	the	DET
aiua-5030	97	11	tr	tr	PUNCT
aiua-5030	97	12	approach	approach	NOUN
aiua-5030	97	13	is	be	AUX
aiua-5030	97	14	a	a	PRON
aiua-5030	97	15	by	by	ADP
aiua-5030	97	16	far	far	ADV
aiua-5030	97	17	easier	easy	ADJ
aiua-5030	97	18	procedure	procedure	NOUN
aiua-5030	97	19	and	and	CCONJ
aiua-5030	97	20	patients	patient	NOUN
aiua-5030	97	21	’	'	PUNCT
aiua-5030	97	22	discomfort	discomfort	NOUN
aiua-5030	97	23	may	may	AUX
aiua-5030	97	24	be	be	AUX
aiua-5030	97	25	prevented	prevent	VERB
aiua-5030	97	26	,	,	PUNCT
aiua-5030	97	27	using	use	VERB
aiua-5030	97	28	only	only	ADJ
aiua-5030	97	29	local	local	ADJ
aiua-5030	97	30	anaesthesia	anaesthesia	NOUN
aiua-5030	97	31	.	.	PUNCT
aiua-5030	98	1	moreover	moreover	ADV
aiua-5030	98	2	,	,	PUNCT
aiua-5030	98	3	the	the	DET
aiua-5030	98	4	tp	tp	NOUN
aiua-5030	98	5	approach	approach	NOUN
aiua-5030	98	6	may	may	AUX
aiua-5030	98	7	be	be	AUX
aiua-5030	98	8	not	not	PART
aiua-5030	98	9	familiar	familiar	ADJ
aiua-5030	98	10	to	to	ADP
aiua-5030	98	11	the	the	DET
aiua-5030	98	12	majority	majority	NOUN
aiua-5030	98	13	of	of	ADP
aiua-5030	98	14	the	the	DET
aiua-5030	98	15	urologists	urologist	NOUN
aiua-5030	98	16	and	and	CCONJ
aiua-5030	98	17	many	many	ADJ
aiua-5030	98	18	patients	patient	NOUN
aiua-5030	98	19	may	may	AUX
aiua-5030	98	20	complain	complain	VERB
aiua-5030	98	21	of	of	ADP
aiua-5030	98	22	some	some	DET
aiua-5030	98	23	pain	pain	NOUN
aiua-5030	98	24	when	when	SCONJ
aiua-5030	98	25	only	only	ADV
aiua-5030	98	26	local	local	ADJ
aiua-5030	98	27	anaesthesia	anaesthesia	NOUN
aiua-5030	98	28	is	be	AUX
aiua-5030	98	29	used	use	VERB
aiua-5030	98	30	.	.	PUNCT
aiua-5030	99	1	however	however	ADV
aiua-5030	99	2	,	,	PUNCT
aiua-5030	99	3	in	in	ADP
aiua-5030	99	4	our	our	PRON
aiua-5030	99	5	hands	hand	NOUN
aiua-5030	99	6	,	,	PUNCT
aiua-5030	99	7	both	both	DET
aiua-5030	99	8	approaches	approach	NOUN
aiua-5030	99	9	showed	show	VERB
aiua-5030	99	10	a	a	DET
aiua-5030	99	11	similar	similar	ADJ
aiua-5030	99	12	,	,	PUNCT
aiua-5030	99	13	small	small	ADJ
aiua-5030	99	14	,	,	PUNCT
aiua-5030	99	15	and	and	CCONJ
aiua-5030	99	16	acceptable	acceptable	ADJ
aiua-5030	99	17	discomfort	discomfort	NOUN
aiua-5030	99	18	.	.	PUNCT
aiua-5030	100	1	in	in	ADP
aiua-5030	100	2	our	our	PRON
aiua-5030	100	3	opinion	opinion	NOUN
aiua-5030	100	4	,	,	PUNCT
aiua-5030	100	5	both	both	DET
aiua-5030	100	6	methods	method	NOUN
aiua-5030	100	7	should	should	AUX
aiua-5030	100	8	be	be	AUX
aiua-5030	100	9	or	or	CCONJ
aiua-5030	100	10	become	become	VERB
aiua-5030	100	11	equally	equally	ADV
aiua-5030	100	12	familiar	familiar	ADJ
aiua-5030	100	13	to	to	ADP
aiua-5030	100	14	urologists	urologist	NOUN
aiua-5030	100	15	.	.	PUNCT
aiua-5030	101	1	conclusions	conclusion	NOUN
aiua-5030	101	2	our	our	PRON
aiua-5030	101	3	results	result	NOUN
aiua-5030	101	4	confirmed	confirm	VERB
aiua-5030	101	5	no	no	DET
aiua-5030	101	6	significant	significant	ADJ
aiua-5030	101	7	differences	difference	NOUN
aiua-5030	101	8	were	be	AUX
aiua-5030	101	9	found	find	VERB
aiua-5030	101	10	in	in	ADP
aiua-5030	101	11	cancer	cancer	NOUN
aiua-5030	101	12	detection	detection	NOUN
aiua-5030	101	13	rate	rate	NOUN
aiua-5030	101	14	,	,	PUNCT
aiua-5030	101	15	cancer	cancer	NOUN
aiua-5030	101	16	core	core	NOUN
aiua-5030	101	17	rate	rate	NOUN
aiua-5030	101	18	between	between	ADP
aiua-5030	101	19	tp	tp	NOUN
aiua-5030	101	20	and	and	CCONJ
aiua-5030	101	21	tr	tr	NOUN
aiua-5030	101	22	approaches	approach	NOUN
aiua-5030	101	23	for	for	ADP
aiua-5030	101	24	prostatic	prostatic	ADJ
aiua-5030	101	25	biopsy	biopsy	NOUN
aiua-5030	101	26	.	.	PUNCT
aiua-5030	102	1	even	even	ADV
aiua-5030	102	2	in	in	ADP
aiua-5030	102	3	terms	term	NOUN
aiua-5030	102	4	of	of	ADP
aiua-5030	102	5	complication	complication	NOUN
aiua-5030	102	6	rate	rate	NOUN
aiua-5030	102	7	or	or	CCONJ
aiua-5030	102	8	pain	pain	NOUN
aiua-5030	102	9	level	level	NOUN
aiua-5030	102	10	,	,	PUNCT
aiua-5030	102	11	it	it	PRON
aiua-5030	102	12	can	can	AUX
aiua-5030	102	13	not	not	PART
aiua-5030	102	14	be	be	AUX
aiua-5030	102	15	concluded	conclude	VERB
aiua-5030	102	16	that	that	SCONJ
aiua-5030	102	17	one	one	NUM
aiua-5030	102	18	procedure	procedure	NOUN
aiua-5030	102	19	is	be	AUX
aiua-5030	102	20	superior	superior	ADJ
aiua-5030	102	21	to	to	ADP
aiua-5030	102	22	the	the	DET
aiua-5030	102	23	other	other	ADJ
aiua-5030	102	24	one	one	NUM
aiua-5030	102	25	.	.	PUNCT
aiua-5030	103	1	apparently	apparently	ADV
aiua-5030	103	2	,	,	PUNCT
aiua-5030	103	3	strictly	strictly	ADV
aiua-5030	103	4	following	follow	VERB
aiua-5030	103	5	our	our	PRON
aiua-5030	103	6	protocol	protocol	NOUN
aiua-5030	103	7	,	,	PUNCT
aiua-5030	103	8	tp	tp	NOUN
aiua-5030	103	9	approach	approach	NOUN
aiua-5030	103	10	seems	seem	VERB
aiua-5030	103	11	to	to	PART
aiua-5030	103	12	offer	offer	VERB
aiua-5030	103	13	a	a	DET
aiua-5030	103	14	better	well	ADJ
aiua-5030	103	15	sampling	sampling	NOUN
aiua-5030	103	16	at	at	ADP
aiua-5030	103	17	the	the	DET
aiua-5030	103	18	level	level	NOUN
aiua-5030	103	19	of	of	ADP
aiua-5030	103	20	the	the	DET
aiua-5030	103	21	apex	apex	NOUN
aiua-5030	103	22	and	and	CCONJ
aiua-5030	103	23	the	the	DET
aiua-5030	103	24	tz	tz	NOUN
aiua-5030	103	25	,	,	PUNCT
aiua-5030	103	26	however	however	ADV
aiua-5030	103	27	without	without	ADP
aiua-5030	103	28	adding	add	VERB
aiua-5030	103	29	any	any	DET
aiua-5030	103	30	significant	significant	ADJ
aiua-5030	103	31	advantage	advantage	NOUN
aiua-5030	103	32	in	in	ADP
aiua-5030	103	33	terms	term	NOUN
aiua-5030	103	34	of	of	ADP
aiua-5030	103	35	overall	overall	ADJ
aiua-5030	103	36	cancer	cancer	NOUN
aiua-5030	103	37	detection	detection	NOUN
aiua-5030	103	38	rate	rate	NOUN
aiua-5030	103	39	.	.	PUNCT
aiua-5030	104	1	references	reference	NOUN
aiua-5030	104	2	1	1	NUM
aiua-5030	104	3	.	.	PUNCT
aiua-5030	104	4	emiliozzi	emiliozzi	PROPN
aiua-5030	104	5	p	p	NOUN
aiua-5030	104	6	,	,	PUNCT
aiua-5030	104	7	corsetti	corsetti	PROPN
aiua-5030	104	8	a	a	NOUN
aiua-5030	104	9	,	,	PUNCT
aiua-5030	104	10	tassi	tassi	PROPN
aiua-5030	104	11	b	b	NOUN
aiua-5030	104	12	,	,	PUNCT
aiua-5030	104	13	et	et	PROPN
aiua-5030	104	14	al	al	PROPN
aiua-5030	104	15	.	.	PUNCT
aiua-5030	105	1	best	good	ADJ
aiua-5030	105	2	approach	approach	NOUN
aiua-5030	105	3	for	for	ADP
aiua-5030	105	4	prostate	prostate	NOUN
aiua-5030	105	5	cancer	cancer	NOUN
aiua-5030	105	6	detection	detection	NOUN
aiua-5030	105	7	:	:	PUNCT
aiua-5030	105	8	a	a	DET
aiua-5030	105	9	prospective	prospective	ADJ
aiua-5030	105	10	study	study	NOUN
aiua-5030	105	11	on	on	ADP
aiua-5030	105	12	transperineal	transperineal	NOUN
aiua-5030	105	13	versus	versus	ADP
aiua-5030	105	14	transrectal	transrectal	ADJ
aiua-5030	105	15	six	six	NUM
aiua-5030	105	16	-	-	PUNCT
aiua-5030	105	17	core	core	NOUN
aiua-5030	105	18	prostate	prostate	NOUN
aiua-5030	105	19	biopsy	biopsy	NOUN
aiua-5030	105	20	.	.	PUNCT
aiua-5030	106	1	urology	urology	NOUN
aiua-5030	106	2	.	.	PUNCT
aiua-5030	107	1	2003	2003	NUM
aiua-5030	107	2	;	;	PUNCT
aiua-5030	108	1	61:961	61:961	PROPN
aiua-5030	108	2	-	-	SYM
aiua-5030	108	3	6	6	NUM
aiua-5030	108	4	.	.	NOUN
aiua-5030	108	5	2	2	NUM
aiua-5030	108	6	.	.	X
aiua-5030	108	7	kawakami	kawakami	PROPN
aiua-5030	108	8	s	s	PROPN
aiua-5030	108	9	,	,	PUNCT
aiua-5030	108	10	yamamoto	yamamoto	PROPN
aiua-5030	108	11	s	s	PROPN
aiua-5030	108	12	,	,	PUNCT
aiua-5030	108	13	numao	numao	ADJ
aiua-5030	108	14	n	n	CCONJ
aiua-5030	108	15	,	,	PUNCT
aiua-5030	108	16	et	et	PROPN
aiua-5030	108	17	al	al	PROPN
aiua-5030	108	18	.	.	PUNCT
aiua-5030	109	1	direct	direct	ADJ
aiua-5030	109	2	comparison	comparison	NOUN
aiua-5030	109	3	between	between	ADP
aiua-5030	109	4	transrectal	transrectal	ADJ
aiua-5030	109	5	and	and	CCONJ
aiua-5030	109	6	transperineal	transperineal	NOUN
aiua-5030	109	7	extended	extended	ADJ
aiua-5030	109	8	prostate	prostate	NOUN
aiua-5030	109	9	biopsy	biopsy	NOUN
aiua-5030	109	10	for	for	ADP
aiua-5030	109	11	detection	detection	NOUN
aiua-5030	109	12	of	of	ADP
aiua-5030	109	13	cancer	cancer	NOUN
aiua-5030	109	14	.	.	PUNCT
aiua-5030	110	1	int	int	PROPN
aiua-5030	110	2	j	j	PROPN
aiua-5030	110	3	urol	urol	PROPN
aiua-5030	110	4	.	.	PUNCT
aiua-5030	111	1	2007	2007	NUM
aiua-5030	111	2	;	;	PUNCT
aiua-5030	111	3	14:719	14:719	NUM
aiua-5030	111	4	-	-	SYM
aiua-5030	111	5	24	24	NUM
aiua-5030	111	6	.	.	PUNCT
aiua-5030	112	1	3	3	X
aiua-5030	112	2	.	.	X
aiua-5030	112	3	hara	hara	PROPN
aiua-5030	112	4	r	r	PROPN
aiua-5030	112	5	,	,	PUNCT
aiua-5030	112	6	jo	jo	PROPN
aiua-5030	112	7	y	y	PROPN
aiua-5030	112	8	,	,	PUNCT
aiua-5030	112	9	fuji	fuji	PROPN
aiua-5030	112	10	t	t	PROPN
aiua-5030	112	11	,	,	PUNCT
aiua-5030	112	12	et	et	PROPN
aiua-5030	112	13	al	al	PROPN
aiua-5030	112	14	:	:	PUNCT
aiua-5030	112	15	optimal	optimal	ADJ
aiua-5030	112	16	approach	approach	NOUN
aiua-5030	112	17	for	for	ADP
aiua-5030	112	18	prostate	prostate	NOUN
aiua-5030	112	19	cancer	cancer	NOUN
aiua-5030	112	20	detection	detection	NOUN
aiua-5030	112	21	as	as	ADP
aiua-5030	112	22	initial	initial	ADJ
aiua-5030	112	23	biopsy	biopsy	NOUN
aiua-5030	112	24	:	:	PUNCT
aiua-5030	112	25	prospective	prospective	ADJ
aiua-5030	112	26	randomized	randomized	ADJ
aiua-5030	112	27	study	study	NOUN
aiua-5030	112	28	comparing	compare	VERB
aiua-5030	112	29	transperineal	transperineal	NOUN
aiua-5030	112	30	versus	versus	ADP
aiua-5030	112	31	transrectal	transrectal	ADJ
aiua-5030	112	32	systematic	systematic	ADJ
aiua-5030	112	33	12	12	NUM
aiua-5030	112	34	-	-	PUNCT
aiua-5030	112	35	core	core	NOUN
aiua-5030	112	36	biopsy	biopsy	NOUN
aiua-5030	112	37	.	.	PUNCT
aiua-5030	113	1	urology	urology	NOUN
aiua-5030	113	2	.	.	PUNCT
aiua-5030	113	3	2008	2008	NUM
aiua-5030	113	4	;	;	PUNCT
aiua-5030	114	1	71:191	71:191	NUM
aiua-5030	114	2	-	-	SYM
aiua-5030	114	3	5	5	NUM
aiua-5030	114	4	.	.	NOUN
aiua-5030	114	5	4	4	NUM
aiua-5030	114	6	.	.	NUM
aiua-5030	114	7	takenaka	takenaka	VERB
aiua-5030	114	8	a	a	X
aiua-5030	114	9	,	,	PUNCT
aiua-5030	114	10	hara	hara	PROPN
aiua-5030	114	11	r	r	NOUN
aiua-5030	114	12	,	,	PUNCT
aiua-5030	114	13	ishimura	ishimura	PROPN
aiua-5030	114	14	t	t	PROPN
aiua-5030	114	15	,	,	PUNCT
aiua-5030	114	16	et	et	PROPN
aiua-5030	114	17	al	al	PROPN
aiua-5030	114	18	.	.	PUNCT
aiua-5030	115	1	a	a	DET
aiua-5030	115	2	prospective	prospective	ADJ
aiua-5030	115	3	randomized	randomized	ADJ
aiua-5030	115	4	comparison	comparison	NOUN
aiua-5030	115	5	of	of	ADP
aiua-5030	115	6	diagnostic	diagnostic	ADJ
aiua-5030	115	7	efficacy	efficacy	NOUN
aiua-5030	115	8	between	between	ADP
aiua-5030	115	9	transperineal	transperineal	NOUN
aiua-5030	115	10	and	and	CCONJ
aiua-5030	115	11	transrectal12	transrectal12	ADJ
aiua-5030	115	12	-	-	PUNCT
aiua-5030	115	13	core	core	NOUN
aiua-5030	115	14	prostate	prostate	NOUN
aiua-5030	115	15	biopsy	biopsy	NOUN
aiua-5030	115	16	.	.	PUNCT
aiua-5030	116	1	prostate	prostate	NOUN
aiua-5030	116	2	cancer	cancer	NOUN
aiua-5030	116	3	prostatic	prostatic	ADJ
aiua-5030	116	4	dis	dis	PROPN
aiua-5030	116	5	.	.	PUNCT
aiua-5030	116	6	2008	2008	NUM
aiua-5030	116	7	;	;	PUNCT
aiua-5030	116	8	11:134	11:134	NUM
aiua-5030	116	9	-	-	SYM
aiua-5030	116	10	8	8	NUM
aiua-5030	116	11	.	.	NOUN
aiua-5030	116	12	5	5	NUM
aiua-5030	116	13	.	.	X
aiua-5030	116	14	novella	novella	NOUN
aiua-5030	116	15	g	g	PROPN
aiua-5030	116	16	,	,	PUNCT
aiua-5030	116	17	ficarra	ficarra	PROPN
aiua-5030	116	18	v	v	ADP
aiua-5030	116	19	,	,	PUNCT
aiua-5030	116	20	galfano	galfano	VERB
aiua-5030	116	21	a	a	PRON
aiua-5030	116	22	,	,	PUNCT
aiua-5030	116	23	et	et	PROPN
aiua-5030	116	24	al	al	PROPN
aiua-5030	116	25	.	.	PUNCT
aiua-5030	117	1	pain	pain	NOUN
aiua-5030	117	2	assessment	assessment	NOUN
aiua-5030	117	3	after	after	ADP
aiua-5030	117	4	original	original	ADJ
aiua-5030	117	5	transperineal	transperineal	NOUN
aiua-5030	117	6	prostate	prostate	NOUN
aiua-5030	117	7	biopsy	biopsy	NOUN
aiua-5030	117	8	using	use	VERB
aiua-5030	117	9	a	a	DET
aiua-5030	117	10	coaxial	coaxial	ADJ
aiua-5030	117	11	needle	needle	NOUN
aiua-5030	117	12	.	.	PUNCT
aiua-5030	118	1	urology	urology	NOUN
aiua-5030	118	2	.	.	PUNCT
aiua-5030	119	1	2003	2003	NUM
aiua-5030	119	2	;	;	PUNCT
aiua-5030	120	1	62:689	62:689	NUM
aiua-5030	120	2	-	-	SYM
aiua-5030	120	3	92	92	NUM
aiua-5030	120	4	.	.	PUNCT
aiua-5030	121	1	6	6	X
aiua-5030	121	2	.	.	X
aiua-5030	122	1	ficarra	ficarra	PROPN
aiua-5030	122	2	v	v	NOUN
aiua-5030	122	3	,	,	PUNCT
aiua-5030	122	4	novella	novella	NOUN
aiua-5030	122	5	g	g	PROPN
aiua-5030	122	6	,	,	PUNCT
aiua-5030	122	7	novara	novara	PROPN
aiua-5030	122	8	g	g	PROPN
aiua-5030	122	9	et	et	PROPN
aiua-5030	122	10	al	al	PROPN
aiua-5030	122	11	.	.	PUNCT
aiua-5030	123	1	the	the	DET
aiua-5030	123	2	potential	potential	ADJ
aiua-5030	123	3	impact	impact	NOUN
aiua-5030	123	4	of	of	ADP
aiua-5030	123	5	prostate	prostate	NOUN
aiua-5030	123	6	volume	volume	NOUN
aiua-5030	123	7	in	in	ADP
aiua-5030	123	8	the	the	DET
aiua-5030	123	9	planning	planning	NOUN
aiua-5030	123	10	of	of	ADP
aiua-5030	123	11	optimal	optimal	ADJ
aiua-5030	123	12	number	number	NOUN
aiua-5030	123	13	of	of	ADP
aiua-5030	123	14	cores	core	NOUN
aiua-5030	123	15	in	in	ADP
aiua-5030	123	16	the	the	DET
aiua-5030	123	17	systematic	systematic	ADJ
aiua-5030	123	18	transperineal	transperineal	NOUN
aiua-5030	123	19	prostate	prostate	NOUN
aiua-5030	123	20	biopsy	biopsy	NOUN
aiua-5030	123	21	.	.	PUNCT
aiua-5030	124	1	eur	eur	PROPN
aiua-5030	124	2	urol	urol	PROPN
aiua-5030	124	3	.	.	PUNCT
aiua-5030	125	1	2005	2005	NUM
aiua-5030	125	2	;	;	PUNCT
aiua-5030	125	3	48:932	48:932	NUM
aiua-5030	125	4	-	-	SYM
aiua-5030	125	5	7	7	NUM
aiua-5030	125	6	.	.	NOUN
aiua-5030	125	7	7	7	NUM
aiua-5030	125	8	.	.	PUNCT
aiua-5030	126	1	hodge	hodge	PROPN
aiua-5030	126	2	kk	kk	PROPN
aiua-5030	126	3	,	,	PUNCT
aiua-5030	126	4	mcneal	mcneal	PROPN
aiua-5030	126	5	je	je	PROPN
aiua-5030	126	6	,	,	PUNCT
aiua-5030	126	7	terris	terris	PROPN
aiua-5030	126	8	mk	mk	PROPN
aiua-5030	126	9	,	,	PUNCT
aiua-5030	126	10	et	et	PROPN
aiua-5030	126	11	al	al	PROPN
aiua-5030	126	12	:	:	PUNCT
aiua-5030	126	13	random	random	ADJ
aiua-5030	126	14	systematic	systematic	ADJ
aiua-5030	126	15	versus	versus	ADP
aiua-5030	126	16	directed	direct	VERB
aiua-5030	126	17	ultrasound	ultrasound	NOUN
aiua-5030	126	18	guided	guide	VERB
aiua-5030	126	19	transrectal	transrectal	ADJ
aiua-5030	126	20	core	core	NOUN
aiua-5030	126	21	biopsies	biopsy	NOUN
aiua-5030	126	22	of	of	ADP
aiua-5030	126	23	the	the	DET
aiua-5030	126	24	prostate	prostate	NOUN
aiua-5030	126	25	.	.	PUNCT
aiua-5030	127	1	j	j	PROPN
aiua-5030	127	2	urol	urol	PROPN
aiua-5030	127	3	.	.	PUNCT
aiua-5030	127	4	1989	1989	NUM
aiua-5030	127	5	;	;	PUNCT
aiua-5030	127	6	142:71	142:71	NUM
aiua-5030	127	7	-	-	SYM
aiua-5030	127	8	5	5	NUM
aiua-5030	127	9	.	.	NOUN
aiua-5030	127	10	8	8	NUM
aiua-5030	127	11	.	.	PUNCT
aiua-5030	127	12	shannon	shannon	PROPN
aiua-5030	127	13	ba	ba	PROPN
aiua-5030	127	14	,	,	PUNCT
aiua-5030	127	15	mcneal	mcneal	PROPN
aiua-5030	127	16	je	je	PROPN
aiua-5030	127	17	,	,	PUNCT
aiua-5030	128	1	cohen	cohen	PROPN
aiua-5030	128	2	rj	rj	PROPN
aiua-5030	128	3	.	.	PROPN
aiua-5030	128	4	transitional	transitional	ADJ
aiua-5030	128	5	zone	zone	NOUN
aiua-5030	128	6	carcinoma	carcinoma	NOUN
aiua-5030	128	7	of	of	ADP
aiua-5030	128	8	the	the	DET
aiua-5030	128	9	prostate	prostate	NOUN
aiua-5030	128	10	gland	gland	NOUN
aiua-5030	128	11	:	:	PUNCT
aiua-5030	128	12	a	a	DET
aiua-5030	128	13	common	common	ADJ
aiua-5030	128	14	indolent	indolent	ADJ
aiua-5030	128	15	tumor	tumor	NOUN
aiua-5030	128	16	type	type	NOUN
aiua-5030	128	17	that	that	PRON
aiua-5030	128	18	occasionally	occasionally	ADV
aiua-5030	128	19	manifests	manifest	VERB
aiua-5030	128	20	aggressive	aggressive	ADJ
aiua-5030	128	21	behaviour	behaviour	NOUN
aiua-5030	128	22	.	.	PUNCT
aiua-5030	129	1	pathology	pathology	NOUN
aiua-5030	129	2	.	.	PUNCT
aiua-5030	130	1	2003	2003	NUM
aiua-5030	130	2	;	;	PUNCT
aiua-5030	130	3	35:467	35:467	NUM
aiua-5030	130	4	-	-	SYM
aiua-5030	130	5	71	71	NUM
aiua-5030	130	6	.	.	NOUN
aiua-5030	131	1	9	9	NUM
aiua-5030	131	2	.	.	PUNCT
aiua-5030	132	1	furuno	furuno	PROPN
aiua-5030	132	2	t	t	PROPN
aiua-5030	132	3	,	,	PUNCT
aiua-5030	132	4	demura	demura	PROPN
aiua-5030	132	5	t	t	PROPN
aiua-5030	132	6	,	,	PUNCT
aiua-5030	132	7	kaneta	kaneta	PROPN
aiua-5030	132	8	t	t	PROPN
aiua-5030	132	9	,	,	PUNCT
aiua-5030	132	10	et	et	PROPN
aiua-5030	132	11	al	al	PROPN
aiua-5030	132	12	.	.	PROPN
aiua-5030	132	13	difference	difference	NOUN
aiua-5030	132	14	of	of	ADP
aiua-5030	132	15	cancer	cancer	NOUN
aiua-5030	132	16	core	core	NOUN
aiua-5030	132	17	distribution	distribution	NOUN
aiua-5030	132	18	between	between	ADP
aiua-5030	132	19	first	first	ADJ
aiua-5030	132	20	and	and	CCONJ
aiua-5030	132	21	repeat	repeat	VERB
aiua-5030	132	22	biopsy	biopsy	NOUN
aiua-5030	132	23	in	in	ADP
aiua-5030	132	24	patients	patient	NOUN
aiua-5030	132	25	diagnosed	diagnose	VERB
aiua-5030	132	26	by	by	ADP
aiua-5030	132	27	extensive	extensive	ADJ
aiua-5030	132	28	transperineal	transperineal	NOUN
aiua-5030	132	29	ultrasound	ultrasound	NOUN
aiua-5030	132	30	guided	guide	VERB
aiua-5030	132	31	template	template	NOUN
aiua-5030	132	32	prostate	prostate	NOUN
aiua-5030	132	33	biopsy	biopsy	NOUN
aiua-5030	132	34	.	.	PUNCT
aiua-5030	133	1	prostate	prostate	NOUN
aiua-5030	133	2	.	.	PUNCT
aiua-5030	134	1	2004	2004	NUM
aiua-5030	134	2	;	;	PUNCT
aiua-5030	135	1	58:76	58:76	NUM
aiua-5030	135	2	-	-	SYM
aiua-5030	135	3	81	81	NUM
aiua-5030	135	4	.	.	PUNCT
aiua-5030	136	1	10	10	NUM
aiua-5030	136	2	.	.	PUNCT
aiua-5030	137	1	ficarra	ficarra	PROPN
aiua-5030	137	2	v	v	NOUN
aiua-5030	137	3	,	,	PUNCT
aiua-5030	137	4	martignoni	martignoni	NOUN
aiua-5030	137	5	g	g	NOUN
aiua-5030	137	6	,	,	PUNCT
aiua-5030	137	7	novella	novella	NOUN
aiua-5030	137	8	g	g	NOUN
aiua-5030	137	9	,	,	PUNCT
aiua-5030	137	10	et	et	PROPN
aiua-5030	137	11	al	al	PROPN
aiua-5030	137	12	.	.	PROPN
aiua-5030	137	13	needle	needle	PROPN
aiua-5030	137	14	core	core	NOUN
aiua-5030	137	15	length	length	NOUN
aiua-5030	137	16	is	be	AUX
aiua-5030	137	17	a	a	DET
aiua-5030	137	18	quality	quality	NOUN
aiua-5030	137	19	indicator	indicator	NOUN
aiua-5030	137	20	of	of	ADP
aiua-5030	137	21	systematic	systematic	ADJ
aiua-5030	137	22	transperineal	transperineal	NOUN
aiua-5030	137	23	prostate	prostate	NOUN
aiua-5030	137	24	biopsy	biopsy	NOUN
aiua-5030	137	25	.	.	PUNCT
aiua-5030	138	1	eur	eur	PROPN
aiua-5030	138	2	urol	urol	PROPN
aiua-5030	138	3	.	.	PUNCT
aiua-5030	139	1	2006	2006	NUM
aiua-5030	139	2	;	;	PUNCT
aiua-5030	140	1	50:266	50:266	NUM
aiua-5030	140	2	-	-	SYM
aiua-5030	140	3	71	71	NUM
aiua-5030	140	4	.	.	PUNCT
aiua-5030	141	1	correspondence	correspondence	NOUN
aiua-5030	141	2	maria	maria	PROPN
aiua-5030	141	3	angela	angela	PROPN
aiua-5030	141	4	cerruto	cerruto	PROPN
aiua-5030	141	5	,	,	PUNCT
aiua-5030	141	6	md	md	PROPN
aiua-5030	141	7	mariaangela.cerruto@univr.it	mariaangela.cerruto@univr.it	PROPN
aiua-5030	141	8	carolina	carolina	PROPN
aiua-5030	141	9	d’elia	d’elia	PROPN
aiua-5030	141	10	,	,	PUNCT
aiua-5030	141	11	md	md	PROPN
aiua-5030	141	12	,	,	PUNCT
aiua-5030	141	13	febu	febu	NOUN
aiua-5030	141	14	(	(	PUNCT
aiua-5030	141	15	corresponding	correspond	VERB
aiua-5030	141	16	author	author	NOUN
aiua-5030	141	17	)	)	PUNCT
aiua-5030	141	18	karolinedelia@gmail.com	karolinedelia@gmail.com	X
aiua-5030	142	1	walter	walter	PROPN
aiua-5030	142	2	artibani	artibani	PROPN
aiua-5030	142	3	,	,	PUNCT
aiua-5030	142	4	md	md	PROPN
aiua-5030	142	5	walter.artibani@univr.it	walter.artibani@univr.it	PROPN
aiua-5030	142	6	giovanni	giovanni	PROPN
aiua-5030	142	7	novella	novella	PROPN
aiua-5030	142	8	,	,	PUNCT
aiua-5030	142	9	md	md	PROPN
aiua-5030	142	10	giovanni.novella@ospedaleuniverona.ir	giovanni.novella@ospedaleuniverona.ir	VERB
aiua-5030	142	11	urology	urology	NOUN
aiua-5030	142	12	clinic	clinic	NOUN
aiua-5030	142	13	,	,	PUNCT
aiua-5030	142	14	aoui	aoui	PROPN
aiua-5030	142	15	verona	verona	PROPN
aiua-5030	142	16	piazzale	piazzale	PROPN
aiua-5030	142	17	l.	l.	PROPN
aiua-5030	142	18	scuro	scuro	PROPN
aiua-5030	142	19	10	10	NUM
aiua-5030	142	20	37134	37134	NUM
aiua-5030	142	21	verona	verona	PROPN
aiua-5030	142	22	,	,	PUNCT
aiua-5030	142	23	italy	italy	PROPN
aiua-5030	142	24	fabio	fabio	PROPN
aiua-5030	142	25	vianello	vianello	PROPN
aiua-5030	142	26	,	,	PUNCT
aiua-5030	142	27	md	md	PROPN
aiua-5030	142	28	fabio.vianello@unipd.it	fabio.vianello@unipd.it	PROPN
aiua-5030	142	29	urology	urology	NOUN
aiua-5030	142	30	clinic	clinic	NOUN
aiua-5030	142	31	,	,	PUNCT
aiua-5030	142	32	university	university	PROPN
aiua-5030	142	33	of	of	ADP
aiua-5030	142	34	padua	padua	PROPN
aiua-5030	142	35	,	,	PUNCT
aiua-5030	142	36	padova	padova	PROPN
aiua-5030	142	37	,	,	PUNCT
aiua-5030	142	38	italy	italy	PROPN
aiua-5030	142	39	cerruto_stesura	cerruto_stesura	PROPN
aiua-5030	142	40	seveso	seveso	VERB
aiua-5030	142	41	15/01/15	15/01/15	PROPN
aiua-5030	142	42	13:18	13:18	NUM
aiua-5030	142	43	pagina	pagina	NOUN
aiua-5030	142	44	287	287	NUM